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ABSTRACT  
V(D)J recombination is responsible for generating an enormous repertoire 
of immunoglobulins and T cell receptors, therefore it is a centerpiece to 
the formation of the adaptive immune system. The V(D)J recombination 
process proceeds through two steps, site-specific cleavage at RSS 
(Recombination Signal Sequence) site mediated by the RAG recombinase 
(RAG1/2) and the subsequent imprecise resolution of the DNA ends, 
which is carried out by the ubiquitous non-homologous end joining 
pathway (NHEJ). The V(D)J recombination reaction is obliged to be tightly 
controlled under all circumstances, as it involves generations of DNA 
double strand breaks, which are considered the most dangerous lesion to 
a cell. Multifaceted regulatory mechanisms have been evolved to create 
great diversity of the antigen receptor repertoire while ensuring genome 
stability. The RAG-mediated cleavage reaction is stringently regulated at 
both the pre-cleavage stage and the post-cleavage stage. Specifically, 
RAG1/2 first forms a pre-cleavage complex assembled at the boarder of 
RSS and coding flank, which ensures the appropriate DNA targeting. 
Subsequently, this complex initiates site-specific cleavage, generating two 
types of double stranded DNA breaks, hairpin-ended coding ends (HP-
CEs) and blunt signal ends (SEs). After the cleavage, RAG1/2 proteins 
bind and retain the recombination ends to form post-cleavage complexes 
(PCC), which collaborates with the NHEJ machinery for appropriate 
transfer of recombination ends to NHEJ for proper end resolution. 
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However, little is known about the molecular basis of this collaboration, 
partly attributed to the lack of sensitive assays to reveal the interaction of 
PCC with HP-CEs. Here, for the first time, by using two complementary 
fluorescence-based techniques, fluorescence anisotropy and fluorescence 
resonance energy transfer (FRET), I managed to monitor the RAG1/2-
catalyzed cleavage reaction in real time, from the pre-cleavage to the 
post-cleavage stages. By examining the dynamic fluorescence changes 
during the RAG-mediated cleavage reactions, and by manipulating the 
reaction conditions, I was able to characterize some fundamental 
properties of RAG-DNA interactions before and after cleavage. Firstly, 
Mg2+, known as a physiological cofactor at the excision step, also 
promotes the HP-CEs retention in the RAG complex after cleavage. 
Secondly, the structure of pre-cleavage complex may affect the 
subsequent collaborations with NHEJ for end resolution. Thirdly, the non-
core region of RAG2 may have differential influences on the PCC 
retention of HP-CEs and SEs. Furthermore, I also provide the first 
evidence of RAG1-mediated regulation of RAG2. Our study provides 
important insights into the multilayered regulatory mechanisms, in 
modulating recombination events in developing lymphocytes and paves 
the way for possible development of detection and diagnotic markers for 
defective recombination events that are often associated 
immunodeficiency and/or lymphoid malignancy. 
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CHAPTER 1 
INTRODUCTION 
Overview Of V(D)J Recombination 
Despite the constant exposure to a wide range of pathogenic 
microorganisms and environmental hazards, it is remarkable that we are 
healthy in general, owing to both the innate and the adaptive immune 
systems, which provide an excellent defense against these microbes and 
harmful agents. The adaptive immune system renders high specificity and 
great diversity against virtually any invaders (1). These two unique 
features, specificity and diversity, of the adaptive immune response are 
achieved by the production of an enormous repertoire of antigen receptor 
molecules, including immunoglobulins and T-cell receptors, where each 
individual receptor molecule bares a unique antigen-binding specificity 
conferred by the distinctive structure at the antigen binding site (known as 
variable or V region) (2). However, the diverse repertoire of antigen 
receptors contrasts with our limited genome size, which would not 
accommodate such a vast number of individual genes that encode these 
antigen receptor proteins. Instead, a sophisticated and elegant 
mechanism, known as V(D)J recombination, has evolved to fulfill the 
mission of generating the immense repertoire of antigen receptors (3–5). 
V(D)J recombination is a somatic recombination mechanism that 
assembles separate pieces of gene segments that include the variable 
(V), diversity (D) and joining (J) region into one complete gene encoding 
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the variable region of Ig genes (2, 3, 6, 7). Much of the diversity seen in 
the adaptive immune system is generated through combinations of V, D 
and J gene segments located at Ig or Tcr loci, and random assortment of 
H and L chains, as well as additional junctional variations introduced 
during the process of V(D)J recombination (8, 9). Thus, the V(D)J 
recombination process is pivotal to the formation of the adaptive immune 
system. 
For successful assembly of antigen receptor genes, the loci 
corresponding to variable gene segments (i.e., V, D, and J) is first cleaved 
to generate double stranded breaks (DSBs), then the appropriate 
“excised” V, D or J segments are brought together into close juxtaposition 
(10, 11). The initial cleavage phase is mediated by lymphocyte specific 
recombinase complex, encoded by recombination activating gene 1 and 2 
(rag1 and rag2, respectively), while the subsequent joining is mediated 
primarily by the ubiquitous non-homologous end joining (NHEJ) pathway. 
RAG1 protein contains both a DNA-binding and an endonuclease catalytic 
domain while RAG2 protein functions to regulate RAG1, together, both 
RAG1 and RAG2 proteins are essential for initiating site-specific DNA 
recognition and the excision step (12, 13). Specifically, the RAG1 and 
RAG2 complex (RAG1/2) recognizes and binds to unique sequences 
flanking the rearranging gene segments. These sequences, known as 
recombination signal sequence (RSS), are composed of a conserved 
heptamer with the consensus sequence “CACAGTG” and a conserved 
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nonamer with the preferable sequence “ACAAAAACC”, The heptamer and 
nonamer is separated by a spacer region composed of either 12 or 23 
base pairs. The length of spacer defines two types of RSS: 12RSS and 
23RSS. The 12RSS and 23RSS play a major role in regulating the correct 
order of joining, known as the “12/23” rule, i.e. gene segment containing 
12RSS can only be recombined with the one that contains 23RSS (14–16) 
,see Figure 1. After recognizing the RSS, the RAG1/2 recombinase 
introduces a site-specific nicking at the coding-signal junction, thereby 
leaving a free 3’-OH group at the end of coding segment. Then two coding 
gene segments containing different RSSs (obeying the “12/23” rule) are 
brought together to form a synaptic complex, followed by a direct 
transesterification using the free 3’OH to attack the opposing strand, 
yielding two hairpin coding ends (CEs) and two blunt signal ends (SEs) 
(11, 17, 18), as illustrated in Figure 2. 
The cleavage reaction has been recapitulated in a cell-free system, 
which allows extensive biochemical characterization of this reaction (14). 
In addition to the RAG recombinase and RSSs, several other components 
are also required for the cleavage phase of V(D)J recombination, such as 
a high mobility group (HMG) and divalent metal ions. The HMG stimulates 
synaptic complex formation and coupled cleavage by facilitating DNA 
conformational changes such that the DNA substrates are more 
accommodative to RAG-mediated binding and subsequent cleavage (19, 
20). In addition, divalent metal ions are essential cofactors for the catalytic 
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activity of the RAG recombinase, where Mg2+ is believed to be a 
physiological cofactor in cells (14, 21). 
In the second phase of V(D)J recombination, the non homologous 
end joining pathway (NHEJ) is primarily utilized to repair the RAG 
recombinase mediated double strand breaks (DSB) (22–24). In 
comparison to homologous recombination (HR), another major pathway 
for DSB repair, NHEJ is intrinsically error-prone, because it introduces 
deletions and insertions at the junction of rearranged products (25, 26). 
The imprecision of NHEJ-mediated end resolution further diversifies the 
antigen receptor gene pool (27, 28).  
NHEJ machinery consists of a series of proteins, including 
Ku70/Ku80, DNA-PKcs, Artemis, poly mu, poly lambda, TdT, XRCC4: 
DNA ligase IV: XLF. Ku70/Ku80 heterodimer serves as the sensors of 
DSB, detecting and binding to DNA ends (29, 30). DNA-PKcs (DNA-
dependent protein kinase catalytic subunit) is then recruited to the ends in 
a Ku-dependent manner and the interaction with the DNA ends of DNA-
PKcs stimulates its serine/threonine kinase activity (31, 32). The potential 
substrate of DNA-PKcs is thought to be DNA-PKcs itself or Artemis, and 
the phosphorylation of which activates the endonuclease activity of 
Artemis (9, 33–35). Thus, by collaborating with DNA-PKcs, Artemis serves 
as an endonuclease to nick and open the hairpin coding ends (36). The 
opened ends are then processed to be compatible for ligation by Pol mu, 
pol lambda, and TdT (Terminal deoxynucleotidyl transferase). TdT 
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mediates non-template nucleotide addition at the junction, introducing 
further variations to the repertoire of immunoglobulins and T-cell receptors 
(28, 37). The actual end joining is carried out by XRCC4: DNA ligase IV, 
with XLF (also known as Cernunnos) stimulating incompatible DNA end 
ligation (38). 
Together, the combinatorial diversity generated during the first 
phase of V(D)J recombination achieved by randomly selecting from a 
large repertoire of V, D and J gene segments and the junctional diversity 
created during the joining phase, accounts for an exceedingly diverse 
repertoire of immunoglobulins and TCRs.   
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Figure 1. The first phase of V(D)J recombination. 
The RAG recombinase-mediated lymphocyte specific cleavage on the 
antigen-receptor loci.  
  
  7 
 
 
Figure 2. Biochemical procedures of in vivo V(D)J recombination  
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Figure 3. Second phase of V(D)J recombination. 
Ubiquitous NHEJ pathway mediated joining of HP-CEs and SEs 
generated by the RAG recombinase. 
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The machinery of V(D)J recombination 
Historical perspective of RAG recombinase and its origin and 
evolution 
Like all other scientific studies, the mechanism underlying V(D)J 
recombination was revealed through a series of breakthroughs, among 
which was the discovery of  RAG1 and RAG2 proteins as lymphoid-
specific recombinase (12, 13). The development of extra-chromosomal 
recombination assays and subsequent demonstration of a cell-free 
recombination system made it possible to determine the structural and 
functional properties of the RAG recombinase and to delineate the 
biochemical steps of the recombination cleavage, and the subsequent end 
resolution (14, 17). 
It is now clear that RAG1/2 play a major role in the first phase of 
V(D)J recombination, by generating DSBs at different gene segments for 
rearrangement to occur. In addition, the RAG recombinase is also 
believed to be critical in the subsequent joining phase as RAG mutations 
were found to lead to abnormal rearranged products (39–41). Further 
more, RAG proteins have been shown to catalyze transposition by 
inserting the signals ends fragment into a non-specific DNA tarets, or 
forming other non-standard joints made between signal ends and coding 
ends, including hybrid joints and open-shut junctions (42–46). Together, 
the “cut and paste” nature of the RAG recombinase resembles bona fide 
transposes and retroviral integrases, suggesting that the RAG 
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recombinase might have been originated from a mobile DNA element (47, 
48). The origination of RAG from an DNA transposon was further 
supported by the following findings: 1) the compact structure of RAG gene 
locus, such that RAG1 and RAG2 lie adjacent to each other without 
introns that are often present in most eukaryotic genes (12); 2) the 
structural feature of RAG1 protein, including a specific DNA binding 
domain that recognizes targeted DNA (49) and a catalytic center 
composed of a triad of acidic amino acids “DDE” that chelates divalent 
metal ions for DNA excision (50–52); 3) RSS, which the RAG 
recombinase recognizes, is analogous to the terminal inverted repeats 
(TIR), residing at the end of a mobile DNA elements (49, 53); 4) the similar 
biochemical reaction for cleavage, which proceeds through hydrolysis and 
transesterification (20, 54). Together, the similarity between the RAG 
recombinase and the transposase support the model that RAG may have 
originated from a transposase. Furthermore, RAG was thought to be a 
driving force for the evolution of the adaptive immune system in jawed 
vertebrate, presumably by horizontal transfer (55, 56). However, the high 
conservation of RAG1 to some trasib-like transposases present in several 
invertebrates suggests that the RAG1 acquisition appears much earlier 
than the stage of jawed vertebrates. Furthermore, the recent evidence for 
the existence of the adaptive system in the absence of V(D)J 
recombination implies that the origin of adaptive immunity might not be 
simply due to the emergence of the RAG-mediated recombination (47). 
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Clearly, more evidence will be required to further elucidate the origin and 
evolution of the RAG recombinase (2, 48, 57).  
Biochemistry and domain structure of RAG recombinase 
Despite the essential role of the RAG recombinase in V(D)J 
recombination as well as in lymphocyte development, most biochemical 
studies of the RAG 1/2 proteins have relied on the core RAG1 and core 
RAG2 proteins (cRAG1 and cRAG2, see table for nomenclature) because 
they have higher expression level and better solubility  than full-length 
RAG, which makes it possible to isolate and purify a large quantity of RAG 
proteins for their biochemical characterization. cRAG1 and cRAG2 are the 
smallest functional truncation mutants that are sufficient for enzymatic 
activity in the reconstituted cell free system (58–61). However, it is 
important to note that, although very active in the in vitro cell-free 
recombination system, core RAG displays much less efficiency on V(D)J 
recombination taking place in cells (through rearrangement of extra-
chromosomal recombination substrates) (62) or in core RAG knock-in 
mice (rearrangement made at the endogenous gene loci). In addition, core 
RAG mediated V(D)J recombination is frequently associated with the 
elevated aberrant recombination. Therefore, replacement of full length 
RAG with core RAG in cRAG2 knock-in mice can severely impairs T and 
B cell development, and increases genome instability and 
lymphomagenesis (63–66). These studies imply that non-core regions are 
indispensible to retain the efficiency and fidelity of physiological V(D)J 
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recombination. Although extensive mutagenesis and foot-printing assays 
help delineates structural domains and residues important for the 
cleavage reaction, (10, 45), see Figure 4 for details, the role of non-core 
regions of RAG1 and RAG2 have not completely defined. 
Core region of RAG1  
The RAG1 core region (residues 384-1008) includes three separate 
domains: 1) A nonamer binding domain (NBD, residues 389-442), which 
primarily recognize and interacts with the RSS nonamer region. 2) A 
central domain (residues 528-760), which interacts with RAG2 and 
mediates heptamer contact after initial nicking. 3) A C-terminal domain 
(residues 761-979) which binds to the RSS-flanking coding sequence non-
specifically (10). In addition to the aforementioned distinct regions, a 
feature structure that is essential for the enzymatic activity of RAG1, the 
catalytic center, also resides in core region. The catalytic center is 
comprised of three discretely distributed acidic amino acids, D600, D708, 
E962 (51, 52, 67, 68). The “DDE” triad is highly conserved in the 
transpose family and functions to chelates divalent metal ions through 
non-covalent bonds (50, 69). The definitive role of the divalent metal ions 
in RAG-mediated reactions remains elusive. However, a two-metal ion 
principle for phosphor-transfer was proposed in the study of 3’-5’ 
exonuclease activity of DNA polymerase and further extended in the study 
of Tn5 and Tn10 transposases (70, 71), and these proteins share similar 
phenotypes and mechanisms with the RAG recombinase. Specifically, two 
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metal ions are recruited to the catalytic center through non-covalent 
bonds, both of which lie within bonding distance with the non-bridging 
oxygen of the scissile phosphate. One metal ion activates an oxygen of 
water molecule and promotes the formation of hydroxide ion that then 
executes a nucleophilic attack of the non-esterified oxygen of the scissile 
phosphate at the cleavage site of DNA. The other metal ion serves to 
stabilize the intermediate covalent species and activate the nucleophilic 3’ 
OH to attack the 5’ phosphate on the opposite strand of DNA at the 
cleavage site (70, 71). The active site acidic amino acids “DDE” serve to 
orient and coordinate the metal ions and the hydroxyl ion through salt 
bridges, and are the key for appropriate and sequential generation of 
various intermediate species that lead to the ultimate DSB formation (70–
72).  
Mg2+ is believed to be a physiological metal ion important for RAG-
catalyzed cleavage, although other divalent cations can also function as a 
cofactor in the in vitro cell-free recombination system, such as Mn2+ or 
Ca2+ (14, 58). The detailed influence of metal ions on RAG-mediated 
reaction will be discussed and studied in the later chapter.  
Non-core region of RAG1 
Although dispensable for the in vitro catalysis reaction, N-terminal 
RAG1 is evolutionarily conserved and critical to the efficiency and fidelity 
of physiological V(D)J recombination (62, 63, 73–75). Even though several 
distinct domain structures have been identified, their function remains 
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poorly defined, such as cysteine-containing elements (residues 1-250), 
central non-core domain (CND, interacting with two zinc ions, residues 87-
217), Lysine/Arginine-rich basic motifs (residues 218-264), zinc 
dimerization domain (ZDD, residues 265-380, dimerization of RAG) and a 
RINE domain located within the classic C2H2 zinc finger domain (within 
ZDD, residues 287-351).  These structures have been implicated to be 
involved in the regulation of catalysis activity, nucleus localization, 
interaction with other proteins, protein stability, and ultimately the 
efficiency of V(D)J recombination (62, 73, 75–78). Among all N-terminal 
domains, the C3HC4 RING domain, which possesses some characteristics 
of a family of E3 ubiquitin ligase, has become an area of interest because 
of the implication of RAG1 as a self-regulator of the recombinase, besides 
its direct action as a recombinase (79, 80). This notion was supported in 
several reconstituted cell-free ubiquitination systems, where the tentative 
targets of RAG1 E3 ligase included KPNA1, RAG1 itself, histone H3, and 
RAG2, etc. (76, 81–83). However, it still remains elusive as to whether 
RAG1 functions in vivo as a single subunit E3 ligase or by collaborating 
with other partners to form a multi-component E3 ligase. A recent study by 
Swanson’s group demonstrated that full-length RAG1 interact with a cullin 
RINE E3 ligase complex, VprBP/DDB1/Cul4A/Roc1 in vivo, possibly 
through the interaction between VprBP and the N-terminus of RAG1. 
Together, this complex assembled in vitro supports cell-free ubiquitination 
activity and may be accountable for the RAG1 E3 ligase activity previously 
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ascribed to the RAG1 (76, 82). More importantly, VprBP is required for 
both the high fidelity of physiological V(D)J recombination events and the 
normal development of B cells, since disruption of VprBP results in 
impairment of VH-DJH and VΚ-JΚ rearrangement and arrest of B cell 
development at the pro- to pre- transition (84). This study was a big step 
forward towards the elucidation of RAG1 or its interaction with others to 
mediate ubiquitination reaction in vivo. 
Core region of RAG2 
Murine RAG2 contains an N-terminal six bladed β-propeller-like 
structure (residues 1-350), a middle acidic hinge region (residues360-408) 
and a C-terminal plant homeodomain (PHD, residues 414-487), among 
which the N terminal has proved to be essential for assisting the catalytic 
activity of RAG1, and thus is termed the core RAG2 region (62, 64–66, 
85). Although there is scarce evidence for the direct binding of RAG2 to 
RSS, the presence of RAG2 greatly increases the binding affinity and the 
specificity of RAG1–RSS interactions, possibly by changing the 
conformation of RAG1 for better and extensive binding to the RSS, as a 
result of direct association between RAG1 and RAG2 (78, 86, 87). 
Non-core region of RAG2 
Similar to the non-core region of RAG1, the non-core region of 
RAG2 is also indispensable for physiological V(D)J recombination (62, 
64–66).  The non-core RAG2 is composed of a portion of flexible “hinge” 
region (residues 360-408) and a non-canonical C-terminal PHD domain 
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(residues 414-487) (88). The presence of an intact PHD domain is 
required for normal V(D)J recombination and development of the 
functional adaptive immune system (89). Mutations at this region are 
found in patients with various types of immunodeficiency, e.g. Severe 
combined immunodeficiency (SCID), Omenn Syndrome (OS) (78). The 
PHD domain interacts robustly and specifically with the modified 
chromatin histone H3 tri-methylated on Lys4 (H3K4me3) (89, 90), which is 
known associated with transcriptionally active or open chromatin regions. 
Disruption of the interaction between the PHD domain and H3K4me3, 
such as mutation of a critical residue, W453A, in the PHD domain, or 
reduced tri-methylation level on H3K4, can lead to severe impairment of 
V(D)J recombination in vivo (90).  Therefore, the interaction between the 
RAG PHD domain and H3K4me3 renders chromosomal accessibility to 
the recombinase, which is a key regulatory mechanism to ensure lineage 
specificity and allelic exclusion of V(D)J recombination in developing 
lymphocytes (see detailed discussion in section 3). In addition, H3K4me3 
can also alleviate the RAG1/2 C-terminus mediated intrinsic inhibitory 
effect on hairpin formation, and therefore enhance the enzymatic activity 
of the RAG recombinase (91). Based on the crystal structure of RAG2-
PHD domain alone or the structure composed of PHD domain and H3 
peptide, it was found that RAG2 PHD can recognize both tri-methylated 
lysine 4 and di-methylated Arginine 2, a feature that is different from the 
traditional PHD domain. The double recognition mechanism probably 
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accounts for the enhanced binding affinity of the RAG2-chromatin 
interactions at the transcriptional active gene loci (85). Another activity of 
the PHD domain is phosphatidylinositol phosphate (PIP) binding (92), 
although the exact function of this interaction remains unknown. Together, 
the interaction between RAG2 PHD domain and H3K4me3 of the 
chromatin can modulate the V(D)J recombination reaction in a cell. On the 
other hand, the flexible hinge region that contains several acidic amino 
acids (residues 360-408, which flanks the C-terminal core region and N-
terminal non-core region) can bind to either modified or non-modified core 
histone. The interaction of this hinge region to core histone is of particular 
importance during V to DJ rearrangement on the IgH locus, although the 
underlying mechanism is not yet clear (93).  
The non-core region is also responsible for the cell-cycle 
dependent degradation of RAG2 at the G1/S boundary, which is mediated 
through the T490 residue at the far end of the C-terminus (94). T490 is 
phosphorylated by the cyclin-dependent kinase Cdk2 (95). The 
phosphorylated RAG2 is then ubiquitination by Skp2-SCF complexes, 
which leads to its ultimate degradation by the 26S proteasome (96). The 
temporal degradation of RAG2 restricts V(D)J recombination at the G0/G1 
phase of the cell cycle, thus greatly minimizes uncontrolled cleavage 
during the S phase and reduces genome instability (97). 
V(D)J recombination is a great genetic mechanism for generating 
and sustaining the enormous diversity that is highly advantageous for our 
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adaptive immune response.  However, the great diversity created by 
V(D)J recombination events is at the expense of genomic instability, and 
propensity for lymphoid malignancy. To reduce the risk of genome 
abnormalities, the V(D)J recombination process is tightly regulated at  
multiple levels, which is discussed in detail in the subsequent sections. 
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Figure 4. Schematic illustration of RAG1 and RAG2 structure.  
(A) RAG1 structure, ★represent the far N-terminus region that is rich in 
cysteines and basic amino acids. Pink boxes represent non core region of 
RAG1, blue box represent core RAG1. 
(B) RAG2 structure, which contains N-terminal core region (green) ,middle 
Hinge domain and C-terminal PHD domain (purple). 
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V(D)J recombination is tightly regulated at multiple levels 
RAG expression is controlled at both transcriptional and post-
translational level 
RAG-generated DSBs are essential intermediates in the course of 
creating an enormous antigen receptor gene pool. Given the lethality of 
DSBs to a cell in the absence of appropriate and prompt repair (98), the 
activity of the RAG recombinase has to be stringently controlled in 
developing lymphocytes, which is mainly mediated via regulation of RAG 
expression, including both transcriptional and post-translational regulation 
(99). The RAG proteins are primarily found in B and T cells, known as 
lineage specificity. The expression of RAG mRNA displays two distinct 
waves during lymphocyte development, showing a peak at the pro-B/pro-T 
cell stage, followed by a decline during the expansion of pre-B/pre-T cells 
and then a resurge after the expansion of pre-B/pre-T cells. The first wave 
results in the rearrangement of immunoglobulin heavy chain (IgH) and 
TCRβ gene, and the second wave activates the assembly of 
immunoglobulin light chain (IgL) and TCRα gene (100). The transcription 
of RAG 1 and RAG2 is regulated by a network of transcriptional factors, 
such as E2A, PAX5, Foxo1 and FoxP1 (101–106). These factors act on 
some cis-elements to exert lineage-dependent expression,  such as Erag 
and Ep in B cells and ASE in T cells, where these cis-elements cooperate 
with the promoter region to enhance transcription (107). Most studies so 
far have been focusing on how RAG transcription is activated by 
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transcriptional factors and cis-elements while the mechanisms of RAG 
down-regulation at the transcriptional level during the expansion of pre-B/-
pre-T stages remain elusive. A recent study by Schlissel’s group identified 
a new transcriptional repressor Gfi1b that functions as a negative 
regulator of RAG expression (108), opening a new avenue in the study of 
RAG expression regulation. In addition, signals transduced from cytokine 
receptors or pre-B/pre-T cell receptors can also influence the RAG 
expression. It has been shown that IL-7, an essential cytokine for the 
survival and proliferation of developing lymphocytes, plays an important 
role in repressing the RAG expression during the proliferating stages of 
pre- B or pre-T cells before IgL or TCRα locus rearrangement (103, 109, 
110). Together, these factors establish a developmental specific and 
lineage-specific pattern of RAG expression. Recently, the PI3K/AKT 
signaling pathway has been implicated in relaying the signals received 
from B cell receptor (BCR) or IL7R in B cells, and the corresponding 
pathway in T cells is Abl/Erk pathway (111). For example, the B cell 
receptor (BCR) in immature B cells represses RAG expression through 
PI3K and AKT pathway. Loss of BCR signal, upon BCR internalization, 
causes an inhibition of the PI3K and AKT pathways and thereby results in 
a reduction of phosphorylation at Foxo1 and Foxo3A, which ultimately 
leads to elevated RAG expression, as non- or low phosphorylated Foxo1 
and Foxo3A function as positive regulators of the RAG gene (107). On the 
other hand, the cell cycle progression promoted by IL-7 exerts another 
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level of controls on RAG expression. Oscillation of RAG2 expression level 
in dividing lymphoid cells was first observed by Desiderio’s group and the 
corresponding change was not observed in its steady-state transcript 
level, implying a post-transcriptional regulation (94). Subsequent studies 
further defined the underlying mechanism of this cell-cycle dependent 
RAG2 regulation at the post-translational level, i.e., RAG2 protein 
degradation targeted at S/G2/M phases. Mutagenesis revealed that the 
major determinant of RAG2 instability is Threonine 490, which is a 
phosphorylation site by the cyclin-dependent kinase 2, cdk2. The 
phosphorylated T490 residue serves as a signal for RAG2 degradation. 
Indeed, cyclin/cdk2 has been proved to be a positive regulator of RAG2 
degradation through both genetic approaches and biochemical 
approaches (95). On the other hand, an inhibitor of cyclin-dependent 
kinase, p21, was considered a negative regulator of RAG2 degradation, 
because of its ability to induce cdk2 down-regulation. (95) Mutation of 
Thr490 disrupts the cdk2-mediated phosphorylation, thus completely 
abolishing cell cycle dependent RAG2 degradation (94). Furthermore, cell 
extracts isolated at different cell cycle stages recapitulated the in vivo 
feature of cell-cycle dependent appearance of RAG2. The biochemical 
characterization in these cell-free systems demonstrated that the RAG2 
degradation is induced by the ubiquitin-mediated proteasomal degradation 
pathway. In particular, an E3 ligase SCF-Skp2, that is well known to 
promote cell cycle progression through the ubiquitination-mediated 
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disruption of p27, was found to also ubiquitinate T490-phosphorylated 
RAG2 proteins, leading to their degradation (96). Thus, cell cycle 
dependent RAG2 degradation couples the V(D)J recombination reaction 
to the cell cycle control, restricting V(D)J recombination to G0/G1 phase. 
This restriction not only minimizes the potential genomic instability caused 
by DSB in the cycling cell but also limits the repair of RAG-mediated DSB 
solely to NHEJ, which is a DNA repair pathway prevalent in the G1 phase 
(97). In addition to the cell cycle dependent post-translational regulation, 
as well as the transcriptional regulation, other mechanisms may also exist 
to account for the delicate control of RAG protein level, which will be 
discussed in more detail in chapter 5. 
Target specificity determined by RSS 
The recombination signal sequence (RSS) is an essential 
component for RAG-mediated site-specific recombination and it 
determines the specific recognition, binding, and cleavage of RAG at the 
variable region gene segments of Ig and TCR loci (58). This notion has 
been further substantiated by an in vivo ChIP-seq (chromatin 
immunoprecipitation-sequence) study, proving that RSS is the main 
determinant for RAG1 binding (112). The RSS is composed of a heptamer 
and a nonamer, separated by a spacer region of either 12 or 23 base 
pairs, based on which 12 RSS and 23RSs are defined. The RSS nonamer 
is the main binding surface for the RAG1 NBD domain, which mediates 
the initial binding of RAG to RSS. Heptamer region mediates the initial 
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recognition of RAG-RSS and provides the binding surface for RAG after 
the cleavage step (113, 114). The heptamer region is the most conserved 
component of the RSS, with the first three nucleotides “CAC” having more 
than 99% conservation among all RSSs. A mutation of any one of these 
nucleotides will completely abolish the RAG-mediated reaction. The last 
four nucleotides of the heptamer (77-91% conservation) and the nonamer 
(some positions less than 75% conservation) are less conserved. The 
spacer region is conserved in length, with either 12±1 or 23±1 base pairs, 
and bears a relatively variable sequence when compared to the heptamer 
and nonamer regions (115). However, some positions of the spacer are 
not completely subjected to random exchanges because they show a 
certain level of conservation among all the available RSS (40-60%) (115). 
Moreover, using experimental approaches, another group showed that the 
spacer sequence plays a determinant role in the frequency of 
recombination in the reconstitute cell free system and the in vitro effect 
correlates very nicely with the efficiency of rearrangement in vivo (116). 
Notably, despite a certain level of variation, RSSs adjoining V, D, J gene 
segments are still readily recognized and bound by RAG recombinase, 
indicating that RAG bares a wide-range of tolerance to recognize variable 
RSSs, which is advantageous in generating the diversified repertoire of 
antibodies and TCRs that is essential for the adaptive immune system 
(117). However, the intrinsic flexibility of the recognition between RAG and 
RSS increases the risk of potential mis-targeting of non-RSSs at the sites 
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other than legitimate Ig or TCR loci, invoking genome instability. Indeed, 
RAG was found to recognize and cleave cryptic RSS sites, causing 
aberrant DSB and aberrant repair, and at times, oncogenic chromosome 
translocationss, which have been a major cause of lymphoid neoplasm 
(118). Taken together, the relative conservation of the RSS, especially the 
heptamer and the nonamer, allows the direct recognition and specific 
interaction between RAG and the target gene segments, thereby 
establishing the site specificity of V(D)J recombination. On the other hand, 
the variation of RSS sequence, especially at the spacer region, seems to 
modulate the efficiency of RAG mediated reaction which in turn might 
account for the unequally usage of different gene segments during V(D)J 
recombination (119, 120). Therefore, an appropriate balance between 
conservation and variation of the RSS seem to play an important role in 
retaining the diversity and fidelity of V(D)J recombination as well as 
genome stability.  
In addition to regulating the fidelity and efficiency of V(D)J 
recombination, the RSS also enforces an appropriate order of 
rearrangement that involves different V, D and J segments, the “12/23” 
rule, i.e. only gene segments that are flanked with different RSS can be 
joined together (14, 15, 121). One significant example of “12/23”rule is that 
it prevents the direct joining of VH to JH segment during the generation of 
the variable region of the heavy chain because they are both flanked with 
the 23RSS. Rather, 12/23 rule ensures that DH is placed in between VH 
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and JH, since DH has 12RSS on both sides and thus is eligible to be linked 
with both VH and JH. The detailed mechanism of how the 12RSS and the 
23RSS are brought together to form a synaptic complex remains unclear. 
Previously, it was hypothesized that the synaptic complex was formed 
through the capture of a 23RSS gene segment by a pre-formed 12RSS-
RAG complex (15, 16, 122). However, a recent in vivo study by CHIP-Seq 
(Chromatin immunoprecipitation-sequence) demonstrates that the initial 
RSS engagement is not restricted to the 12RSS, rather it occurs with 
whichever RSS is found within the recombination centers followed by 
recruiting the partner RSS, which argues against the sequential capture of 
the 12RSS and the 23RSS (112). Nevertheless, 12/23 rule ensures the 
correct order of rearrangement and thus the fidelity of V(D)J 
recombination.  
Despite the importance of “12/23 rule”, the RSS seems to impose 
additional constraints on variable region gene assembly beyond the scope 
of the “12/23” rule. For example, during rearrangement of β chain of the 
TCR, Vβ does not directly link to Jβ although they are flanked with different 
RSS and thus is compatible with “12/23” rule. This phenomenon is 
referred as “beyond 12/23”, the detailed mechanism has not been clearly 
defined, but it has been suggested that the restriction may be imposed 
during the DNA cleavage step of TCR beta rearrangement. Specifically, a 
low level and slow nicking made at the Jβ region and inefficient Vβ-Jβ 
synapses have been speculated to hinder the Vβ to Jβ rearranging process 
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(123). Subsequent analyses suggest that the poor Vβ-to-Jβ recombination 
activity is attributed to the coding flank and RSS sequence at the Jβ locus, 
further substantiating the importance of the RSS in regulating V(D)J 
recombination at various levels (124).  
Control of V(D)J recombination at chromosomal level 
Although the highly controlled RAG expression and the composition 
of the RSS sequence dictates the site-specific V(D)J recombination in cell-
cycle dependent and developmental stage-ordered fashion, some aspects 
of the regulation of V(D)J recombination are incompletely defined. For 
example, V(D)J recombination is restricted to the Ig locus or the TCR 
locus in developing B or T cells, respectively, despite the availability of 
RAG recombinase in both cell types (125, 126). Meanwhile, it was 
consistently found that rearrangement is preceded by the transcription 
activation and changes of chromatin modifications, such as the 
appearance of RNA transcripts that define the boundary of rearrangement 
domain, nucleosome remodeling, and activating histone modifications 
such as acetylation (127, 128).The tight link between transcription and 
rearrangement suggests the possibility that chromosomal accessibility 
underlines the distinct pattern of V(D)J recombination observed in different 
cell types. Previously, it was thought that an open (enriched with activating 
histone modifications, such as acetylation) or a closed state (primaryly 
with repressing histone modifications, such as H3K9me3) of chromatin 
alone determined the accessibility (129). Recent finding that the RAG2 
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PHD domain interacting specifically with H3K4me3 (histone 3 tri-
methylated at Lysine 4, reviewed in previous section) suggested that the 
RAG recombinase not only passively obeys the chromatin code (i.e., RSS 
in the context of chromosome), but also actively participates in recognizing 
the chromosomal modification that reflects the accessibility of the locus. 
The chromatin accessibility is likely created through interactions between 
local cis-elements, e.g. enhancers or promoters, and trans-acting factors, 
e.g. transcriptional factors that can recruit nucleosome remodeling 
machinery and chromatin modifying enzymes and RNA polymerase II, 
increasing transcription activity through the region. In addition to histone 
modification, other epigenetic modulations, such as de novo 
demethylation of DNA at the Ig or TCR loci, have also been shown to 
occur prior to the rearrangement. Together, chromatin modifications at 
both histone and DNA contribute to the chromatin accessibility (130, 131). 
Furthermore, the important role of chromatin accessibility in regulating 
V(D)J recombination was further substantiated by Schatz’s group in a 
whole genome-wide ChIP analysis (112). They demonstrated that RAG1 
and RAG2 each have distinct in vivo binding patterns to the genome that 
are independent of each other, with RAG1 binding more tightly to the RSS 
regions whereas RAG2 binding more broadly at sites with substantial 
levels of H3K4me3. Each of these small RAG-bound regions that contain 
both RAG1 and RAG2 is referred to a “recombination center” and the 
formation of these “recombination centers” is highly dynamic, displaying a 
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developmental stage-specificity and lineage specificity. The more 
restricted RAG1 binding contrasts with the loose binding of RAG2, which 
prevents the RAG-1 mediated non-specific targeting and cleavage , 
thereby minimizing genome instability. However, the broad RAG2 binding 
to the whole genome may introduce an additional regulatory function of 
V(D)J recombination, e.g., by increasing recombination activity at the 
accessible gene loci (112). Together, these studies show that 
chromosomal accessibility play an important role in regulating and 
maintaining the specificity and fidelity of V(D)J recombination. 
Regulation of V(D)J recombination at the cleavage reaction step 
The RAG-mediated cleavage reaction is the first phase of V(D)J 
recombination, which involves a collaboration of multiple factors, such as 
the RAG recombinase, RSS, HMG and a metal ion cofactor, as well as 
epigenetic modifications on the chromatin as discussed above.. The 
importance of the RAG recombinase and the RSS has been summarized 
in the previous sections. Briefly, RAG is the major machinery of V(D)J 
recombination and mutations of RAG can cause loss of recombination 
activity and block of lymphocyte development in varying degrees of 
seriousness (12–14). The RSS is the major target site of RAG and 
depending on how closely it resembles the consensus RSS, it can 
determine cleavage efficiency and the usage frequency of the adjoining 
coding gene segment. Illegitimate RAG activity has been implicated in 
chromosomal translocations, through recognition and cleavage made by 
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RAG at cryptic RSS or distorted DNA structure, consequence of which is 
devastating and is a major cause for lymphoid malignancy (132). 
Although not as essential as RAG, the HMG protein also plays a 
role in regulating the efficiency and fidelity of V(D)J recombination by 
promoting synaptic complex formation and stimulating coupled cleavage 
involving both 12RSS and 23RSS. The probable function of HMG is to 
facilitate DNA bending, which become more accommodative to the RAG 
binding and DNA excision (19, 133). On the other hand, HMG by itself can 
recognize and stabilize distorted DNA structures and damaged DNA. This 
activity may also induce the mis-targeting and cleavage of RAG at a 
region that does not have an authentic RSS, thereby increasing the 
chances of illegitimate RAG-mediated cleavage and potential genome 
instability (132). Last but not least, a metal ion cofactor is essential for the 
RAG-mediated cleavage reaction (14, 21). A detailed mechanism of how 
the metal ion modulates physiological V(D)J recombination remains 
elusive, which is primarily due to the complexity of in vivo metal ion 
condition in terms of their composition and concentration. The complicated 
background of metal ion makes it impossible to definitively determine the 
metal ion condition prerequisite for V(D)J recombination in vivo. Hence 
most knowledge of metal ion participation in V(D)J recombination has 
been obtained from in vitro reconstituted cell free systems. The essential 
role of divalent metal ions in V(D)J recombination was first suggested 
based on the finding that addition of EDTA to the nuclear extracts resulted 
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in complete abolishment of the RAG-mediated cleavage activity (14). Mg2+ 
was later found to be the physiological metal ion cofactor because the 
RAG-mediated cleavage reaction in Mg2+ requires two RSSs bearing 
different spacer lengths for efficient cleavage and hairpin formation, which 
was consistent with the physiological “12/23”rule, while a single RSS is 
only nicked by RAG at the coding-signal junction in the presence of Mg2+ 
(14, 134). Besides Mg2+, other metal ions have also been tested in the in 
vitro recombination system although their roles in physiological V(D)J 
recombination remain unclear. Mn2+ uncouples the requirement of the 
“12/23” rule and promotes the nicking and hairpin formation on single 
RSS, thus Mn2+ is considered a permissive cation (15). On the contrary, 
Ca2+only allows the specific interaction between RAG and RSS but does 
not support RAG enzymatic activities (15). The various outcomes in the 
presence of different cations (as shown in Figure 5) have been attributed 
to the ability of the cations to induce different RAG conformations that 
allow different RAG-RSS interactions (135). For example, Mn2+ confers 
RAG to form a structure that is more amiable to cleavage on RSS 
substrates and has a very loose requirement in terms of temperature, pH, 
HMG intactness and RSS fidelity, in stark contrast to the more demanding 
requirement when Mg2+ is present, which induces a less poised RAG 
architecture and thus is forced to coordinate multiple factors to achieve the 
catalysis stage (21, 72, 136). However, the stringent requirement and 
relative inert nature of RAG-mediated cleavage in the presence of Mg2+ 
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ensures the rigorous and elegant multi-layered regulations during 
physiological V(D)J recombination, which helps to minimize the genome 
instability caused by aberrant activity of RAG. In conclusion, metal ion 
cofactors seem to participate not only in the catalysis step, but also in 
determining RAG conformation, RAG-RSS recognition and binding, and 
the structure of the pre-cleavage complex. Along this line, it is intriguing to 
think that metal ions may also affect the post-cleavage complex, which will 
be discussed in more detail in chapter 2. 
End joining process mediated by Classic-NHEJ pathway 
The RAG-cleaved DSB is primarily resolved by the non-
homologous end joining (NHEJ) pathway, which is considered the second 
phase of V(D)J recombination (137). Selection of NHEJ in V(D)J 
recombination is very significant, because it not only mediates the joining 
of broken ends, the error-prone nature of NHEJ also promotes the  
introduction of additional variation at the junction (junctional diversity) 
during the joining process (138) which is one of the major sources 
accounting for the diversity of V(D)J recombination (2). Four 
recombination ends are generated during the first phase of V(D)J 
recombination, two hairpin coding ends (HP-CEs) and two blunt signal 
ends (SEs). HP-CEs need to be opened before joining, which can occur 
asymmetrically (35, 38). The opening of HP-CEs made away from the 
apex site, which is catalyzed by the concerted action of Artemis and DNA-
PKcs, can give rise to palindromic nucleotide addition, known as P 
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nucleotides (27). In addition, opened coding ends can also be subjected to 
nucleotide deletion by exonuclease, and non-templated nucleotide 
addition mediated by terminal deoxynucleotidyl Transferase (TdT) (28). 
The deletion and addition of nucleotides during this process is somewhat 
random in terms of the sequence and number (usually less than 10), 
therefore introduces an additional level of variations at the coding joints. 
Furthermore, NHEJ occurs throughout the cell cycle and is the 
major DSB repair pathway in the cells at the G1 stage, unlike the 
homologous recombination (HR), which is restricted to the late S and G2 
phases (25). Thus, NHEJ is the most suitable pathway in repairing the 
RAG-generated DSB, as it coincides with the RAG activity that is also 
limited to the G1 phase (94, 139). The timely resolving of RAG-generated 
DSB in the G1 phase is essential to efficiently avoid the deleterious effect 
of unresolved DSBs to a cycling cell.  
Although the V(D)J recombination reaction relies on the NHEJ 
machinery for the generation of a functional repertoire of antigen 
receptors, alterations of this machinery does not completely abolish repair 
of RAG-generated DSBs,  suggesting the existence of other DSB repair 
pathways for resolving the recombination ends (140–142). One possible 
candidate of the substitute repair is alternative-NHEJ, known as a-NHEJ, 
which is characterized by frequent usage of micro-homology that relies on 
excessive deletions (142). The process of a-NHEJ results in aberrant 
joining products with extensive nucleotide deletions and even 
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chromosomal translocations, which are rarely observed in the junction 
made by the classic NHEJ (c-NHEJ). Alternative-NHEJ occurs at an 
extremely low level in wild type cells but shows significantly elevated 
activity in cells defective in c-NHEJ and thereby provides a back-up repair 
system to the c-NHEJ-deficient cells. However, due to its error-prone 
nature in DSB repair, a-NHEJ is frequently implicated in the 
tumorigenesis, presumably by distablizing genome stability, e.g., in human 
bladder tumors (118, 143). Therefore, increased repair by this pathway in 
V(D)J recombination may cause chromosome translocations, and 
oncogenic transformation, leading to development of lymphoid 
malignancy. Thus, in the absence of functional c-NHEJ, RAG 
recombinase has to collaborate with the a-NHEJ machinery for end 
joining. In addition, the defective recombinase, due to mutations in RAG1 
and RAG2, has also been speculated to be “forced” into this error-prone a-
NHEJ for rejoining the ends. Indeed, a recent study showed that the core 
form of RAG2 (cRAG2) lacking C-terminus tends to channel DNA ends to 
the alternative-NHEJ pathway for DNA ends resolution, As a result, 
severely disruptive genome stability and robust thymic lymphoma was 
observed in the cRAG2-knock in-mice that were also p53 deficient (64). 
Fortunately, in wild-type cells, a-NHEJ is greatly suppressed by classic-
NHEJ, which is mainly mediated by the core classic-NHEJ components, 
such as Ku, DNA-PK, and XRCC4-LigIV (144–146). In summary, NHEJ-
mediated RAG DSB repair plays an essential role in regulating V(D)J 
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recombination, 1) It introduces further variations to the antigen receptor 
gene repertoire, which is pivotal to the adaptive immune system. 2) It 
retains genome stability by inhibiting the detrimental effects caused by 
unattended RAG DSB. 3) It suppresses other undesired DNA repair 
pathways, thereby minimizing the chances of genomic instability.  
Regulation of the transition between phase I and phase II during 
V(D)J recombination 
Although V(D)J recombination has two seemingly distinctive 
phases, i.e., RAG-catalyzed cleavage and NHEJ-mediated joining, more 
and more evidence shows that RAG machinery and NHEJ machinery 
collaborate closely in order for the proper function of V(D)J recombination.  
Most evidences have been derived from in vitro recombination studies, 
such as: (1) the presence of Ku and DNA-PKcs proteins in the RAG-
mediated reactions seemed to modulate the cleavage activity and to 
increase the fidelity of 12/23 rule by inhibiting 12/12 and 23/23 DNA 
cleavage (147); (2) Ku was found to directly interact with the non-core 
region of full length RAG1 (148); (3) Intentionally linking the non-RAG-
mediated-DSB to the RAG recombinase complexes directed the DSB to 
the NHEJ pathway, suggesting the active role of RAG in selecting an 
appropriate DNA repair pathway (149). However, the most convincing 
evidence for the tight interactions between phase I and phase II is the 
revelation of several RAG2 mutants that have normal cleavage activity but 
display a severe defects in joining, either by impairing the recruitment of 
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the NHEJ component or by blocking the hairpin opening process (41). 
More importantly, RAG was believed to continuously retain the newly 
cleaved DSBs in a stable post-cleavage complex (PCC), and shepherd 
them to the NHEJ machinery. The failure to maintain PCC stability as 
observed in certain RAG mutations has been implicated in causing an 
increased tendency of aberrant DNA repair pathways, such as HR or 
alternative-NHEJ (39, 150, 151). These findings significantly substantiate 
the importance of RAG throughout V(D)J recombination, both cleavage 
and resolution phases, and further prove the tight collaboration between 
the two. By far, the importance of RAG in the joining step has been mostly 
attributed to the stability of the post-cleavage complex (PCC, see 
nomenclature), which seems vital for appropriate and efficient repair 
during V(D)J recombination and a major causal factor for aberrant joining 
of RAG DSB and potential genomic instability if the PCC stability is 
compromised in any way (64, 151, 152). Therefore, it is of great 
importance to identify and characterize the factors that influence the PCC 
stability. In addition to RAG mutations, the sequence alteration of the 
heptamer in a RSS and mutations in a checkpoint protein, ATM, has also 
been found to reduce PCC stability. These genetic alterations result in 
higher levels of recombination ends being directed to the HR and 
alternative-NHEJ, leading to genome instability like chromosomal 
translocations, and a high frequency of lymphoid malignancies (118, 153).  
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It has been noted that, after cleavage, RAG retains all four DNA 
ends in the PCC, including two signal ends and two hairpin coding ends 
(40, 154), which differ in the strength of retention, the end processing 
steps, the requirement of NHEJ factors, as well as the rate and precision 
of resolution (9, 23). Thus, depending on the composittion of the DNA 
ends, the PCC has evolved into two sub-complexes, the signal end 
complex (SEC) and the coding end complex (CEC). As a matter of fact, all 
of the aforementioned studies on PCC stability were focused on the SEC 
stability because it is intrinsically stable, thus any changes in signal ends 
retention can be readily detected. HP-CEs, on the other hand, were 
believed to be only transiently associated with the RAG complex. And the 
weak binding makes it relatively difficult to characterize these complexes, 
except for some indirect evidences (38, 58). Since the fate of coding ends 
are more significantly important than signale ends in generating antigen 
receptor diversity as well as preserving genome integrity, it is important to 
study the interaction and retention of coding ends within the CEC and the 
factors that might influence CEC stability. However, the effort to address 
these issues has yielded little progress, because of technical difficulties in 
revealing very weak interactions. Here I explore two complementary 
fluorescence-based techniques, steady-state fluorescence anisotropy and 
fluorescence resonance energy transfer (FRET), to 1) monitor the RAG-
mediated recombination reaction in real time and measure the stability of 
PCC in terms of HP-CEs retention, 2) assess many parameters that might 
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affect the HP-CEs retention, such as metal ion cofactors, non-core regions 
of the RAG recombinase, and various forms of RAG mutations, 3) 
compare the retention of HP-CEs and SEs in the same monitoring system 
under various conditions, allowing for examination in depth the 
mechanism of retaining HP-CEs and SEs. Our study introduces a powerful 
tool to study the biochemistry of the RAG recombination and may shed 
some light on the mechanism of physiological V(D)J recombination. 
Furthermore, the PCC could also be regulated by targeted destruction, 
i.e., RAG1-mediated degradation of RAG complex. By comparing 
expression of core and full-length RAG1 and RAG2 in transient 
transfection assays, I provided evidence for a rapid regulatory mechanism, 
which could promptly eliminate the RAG-mediated pre-cleavage and post-
cleavage complexes. 
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Figure 5. In vitro RAG-mediated cleavage reaction under three cations. 
Mg2+ requires the formation of synaptic complex that is composed of both 
12RSS and 23RSS in order to generate double strand breaks. Mg2+ only 
allows nicking with a single RSS. 
Mn2+ induces cleavage on a single RSS without synapsis. 
Ca2+ supports specific binding but is inhibitory of cleavage. 
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Ca2+ Mg2+ Mn
2+ 
HMG 
23RSS 
Mg2+      or Mn2+ 
HMG 
23RSS 
Ca2+ 
RSS 
OH 
Coupled-reaction 
Single reaction 
  40 
Reference 
1.  Cooper MD, Alder MN (2006) The Evolution of Adaptive Immune 
Systems. Cell 124:815–822. 
2.  Murphy KM, Travers P, Walport M (2007) Janeway’s Immunobiology 
(Immunobiology: The Immune System (Garland Science). 7th Ed. 
3.  Hozumi N, Tonegawa S (1976) Evidence for somatic rearrangement 
of immunoglobulin genes coding for variable and constant regions. Proc. 
Natl. Acad. Sci. U.S.A. 73:3628–3632. 
4.  Alt FW, Baltimore D (1982) Joining of Immunoglobulin Heavy Chain 
Gene Segments: Implications from a Chromosome with Evidence of Three 
D-JH Fusions. PNAS 79:4118–4122. 
5.  Lewis S, Gellert M (1989) The mechanism of antigen receptor gene 
assembly. Cell 59:585–588. 
6.  Brack C, Hirama M, Lenhard-Schuller R, Tonegawa S (1978) A 
complete immunoglobulin gene is created by somatic recombination. Cell 
15:1–14. 
7.  Early P, Huang H, Davis M, Calame K, Hood L (1980) An 
immunoglobulin heavy chain variable region gene is generated from three 
segments of DNA: VH, D and JH. Cell 19:981–992. 
8.  Lieber MR (2010) The Mechanism of Double-Strand DNA Break 
Repair by the Nonhomologous DNA End-Joining Pathway. Annual Review 
of Biochemistry 79:181–211. 
9.  Rooney S, Chaudhuri J, Alt FW (2004) The role of the non-
homologous end-joining pathway in lymphocyte development. Immunol. 
Rev. 200:115–131. 
10.  Schatz DG, Swanson PC (2011) V(D)J recombination: mechanisms 
of initiation. Annu. Rev. Genet. 45:167–202. 
11.  Gellert M (2002) V(D)J RECOMBINATION: RAG PROTEINS, 
REPAIR FACTORS, AND REGULATION*. Annual Review of Biochemistry 
71:101–132. 
  41 
12.  Oettinger MA, Schatz DG, Gorka C, Baltimore D (1990) RAG-1 and 
RAG-2, Adjacent Genes That Synergistically Activate V(D)J 
Recombination. Science 248:1517–1523. 
13.  Schatz DG, Oettinger MA, Baltimore D (1989) The V(D)J 
recombination activating gene, RAG-1. Cell 59:1035–1048. 
14.  van Gent DC et al. (1995) Initiation of V(D)J recombination in a cell-
free system. Cell 81:925–934. 
15.  Hiom K, Gellert M (1997) A stable RAG1-RAG2-DNA complex that is 
active in V(D)J cleavage. Cell 88:65–72. 
16.  Mundy CL, Patenge N, Matthews AGW, Oettinger MA (2002) 
Assembly of the RAG1/RAG2 Synaptic Complex. Mol Cell Biol 22:69–77. 
17.  McBlane JF et al. (1995) Cleavage at a V(D)J recombination signal 
requires only RAG1 and RAG2 proteins and occurs in two steps. Cell 
83:387–395. 
18.  van Gent DC, Mizuuchi K, Gellert M (1996) Similarities between 
initiation of V(D)J recombination and retroviral integration. Science 
271:1592–1594. 
19.  van Gent DC, Hiom K, Paull TT, Gellert M (1997) Stimulation of V(D)J 
cleavage by high mobility group proteins. EMBO J 16:2665–2670. 
20.  Sawchuk DJ et al. (1997) V(D)J Recombination: Modulation of RAG1 
and RAG2 Cleavage Activity on 12/23 Substrates by Whole Cell Extract 
and DNA-bending Proteins. The Journal of Experimental Medicine 
185:2025 –2032. 
21.  Santagata S, Aidinis V, Spanopoulou E (1998) The effect of Me2+ 
cofactors at the initial stages of V(D)J recombination. J. Biol. Chem 
273:16325–16331. 
22.  Bassing CH, Swat W, Alt FW (2002) The mechanism and regulation 
of chromosomal V(D)J recombination. Cell 109 Suppl:S45–55. 
23.  Lieber MR (2010) The Mechanism of Double-Strand DNA Break 
Repair by the Nonhomologous DNA End-Joining Pathway. Annu. Rev. 
Biochem. 79:181–211. 
  42 
24.  Helmink BA, Sleckman BP (2011) The Response to and Repair of 
RAG-Mediated DNA Double-Strand Breaks. Annual Review of 
Immunology. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22224778 
[Accessed March 24, 2012]. 
25.  Mao Z, Bozzella M, Seluanov A, Gorbunova V (2008) Comparison of 
nonhomologous end joining and homologous recombination in human 
cells. DNA Repair (Amst.) 7:1765–1771. 
26.  Mao Z, Bozzella M, Seluanov A, Gorbunova V (2008) DNA repair by 
nonhomologous end joining and homologous recombination during cell 
cycle in human cells. Cell Cycle 7:2902–2906. 
27.  Lewis SM (1994) P nucleotides, hairpin DNA and V(D)J joining: 
making the connection. Semin. Immunol. 6:131–141. 
28.  Gilfillan S, Dierich A, Lemeur M, Benoist C, Mathis D (1993) Mice 
lacking TdT: mature animals with an immature lymphocyte repertoire. 
Science 261:1175–1178. 
29.  Downs JA, Jackson SP (2004) A means to a DNA end: the many 
roles of Ku. Nat Rev Mol Cell Biol 5:367–378. 
30.  Mari P-O et al. (2006) Dynamic assembly of end-joining complexes 
requires interaction between Ku70/80 and XRCC4. Proceedings of the 
National Academy of Sciences 103:18597 –18602. 
31.  Gottlieb TM, Jackson SP (1993) The DNA-dependent protein kinase: 
requirement for DNA ends and association with Ku antigen. Cell 72:131–
142. 
32.  Yaneva M (1997) Interaction of DNA-dependent protein kinase with 
DNA and with Ku: biochemical and atomic-force microscopy studies. The 
EMBO Journal 16:5098–5112. 
33.  Meek K, Douglas P, Cui X, Ding Q, Lees-Miller SP (2007) trans 
Autophosphorylation at DNA-dependent protein kinase’s two major 
autophosphorylation site clusters facilitates end processing but not end 
joining. Mol. Cell. Biol 27:3881–3890. 
  43 
34.  Mahaney BL, Meek K, Lees-Miller SP (2009) Repair of ionizing 
radiation-induced DNA double strand breaks by non-homologous end-
joining. Biochem J 417:639–650. 
35.  Moshous D et al. (2001) Artemis, a Novel DNA Double-Strand Break 
Repair/V(D)J Recombination Protein, Is Mutated in Human Severe 
Combined Immune Deficiency. Cell 105:177–186. 
36.  Ma Y, Pannicke U, Schwarz K, Lieber MR (2002) Hairpin opening and 
overhang processing by an Artemis/DNA-dependent protein kinase 
complex in nonhomologous end joining and V(D)J recombination. Cell 
108:781–794. 
37.  Lieber MR (2008) The mechanism of human nonhomologous DNA 
end joining. J. Biol. Chem 283:1–5. 
38.  Lu H et al. (2008) A Biochemically Defined System for Coding Joint 
Formation in V(D)J Recombination. Mol Cell 31:485–497. 
39.  Tsai C-L, Drejer AH, Schatz DG (2002) Evidence of a critical 
architectural function for the RAG proteins in end processing, protection, 
and joining in V(D)J recombination. Genes & Development 16:1934 –
1949. 
40.  Agrawal A, Schatz DG (1997) RAG1 and RAG2 Form a Stable 
Postcleavage Synaptic Complex with DNA Containing Signal Ends in 
V(D)J Recombination. Cell 89:43–53. 
41.  Qiu JX, Kale SB, Yarnell Schultz H, Roth DB (2001) Separation-of-
function mutants reveal critical roles for RAG2 in both the cleavage and 
joining steps of V(D)J recombination. Mol. Cell 7:77–87. 
42.  Sekiguchi J, Whitlow S, Alt FW (2001) Increased Accumulation of 
Hybrid V(D)J Joins in Cells Expressing Truncated versus Full-Length 
RAGs. Molecular Cell 8:1383–1390. 
43.  Elkin SK, Matthews AG, Oettinger MA (2003) The C-terminal portion 
of RAG2 protects against transposition in vitro. EMBO J 22:1931–1938. 
44.  Neiditch MB, Lee GS, Landree MA, Roth DB (2001) RAG 
Transposase Can Capture and Commit to Target DNA before or after 
Donor Cleavage. Mol Cell Biol 21:4302–4310. 
  44 
45.  Swanson PC (2004) The bounty of RAGs: recombination signal 
complexes and reaction outcomes. Immunol. Rev. 200:90–114. 
46.  Posey JE, Pytlos MJ, Sinden RR, Roth DB (2006) Target DNA 
Structure Plays a Critical Role in RAG Transposition. PLoS Biol 4:e350. 
47.  Fugmann SD, Messier C, Novack LA, Cameron RA, Rast JP (2006) 
An ancient evolutionary origin of the Rag1/2 gene locus. Proc. Natl. Acad. 
Sci. U.S.A. 103:3728–3733. 
48.  Sebastian D. F (2010) The origins of the Rag genes—From 
transposition to V(D)J recombination. Seminars in Immunology 22:10–16. 
49.  Sakano H, H|[uuml]|ppi K, Heinrich G, Tonegawa S (1979) 
Sequences at the somatic recombination sites of immunoglobulin light-
chain genes. , Published online: 26 July 1979; | doi:10.1038/280288a0 
280:288–294. 
50.  Dreyfus DH, Jones JF, Gelfand EW (1999) Asymmetric DDE (D35E)-
like sequences in the RAG proteins: implications for V(D)J recombination 
and retroviral pathogenesis. Med. Hypotheses 52:545–549. 
51.  Landree MA, Wibbenmeyer JA, Roth DB (1999) Mutational analysis 
of RAG1 and RAG2 identifies three catalytic amino acids in RAG1 critical 
for both cleavage steps of V(D)J recombination. Genes Dev 13:3059–
3069. 
52.  Kim DR, Dai Y, Mundy CL, Yang W, Oettinger MA (1999) Mutations 
of acidic residues in RAG1 define the active site of the V(D)J 
recombinase. Genes Dev 13:3070–3080. 
53.  Max EE, Seidman JG, Leder P (1979) Sequences of Five Potential 
Recombination Sites Encoded Close to an Immunoglobulin Kappa 
Constant Region Gene. PNAS 76:3450–3454. 
54.  Ferrier P ed. V(D)J Recombination Available at: 
http://www.springerlink.com/content/978-1-4419-0296-
2#section=641426&page=1 [Accessed March 23, 2012]. 
55.  Schatz DG (2004) Antigen receptor genes and the evolution of a 
recombinase. Semin. Immunol. 16:245–256. 
  45 
56.  Jones JM, Gellert M (2004) The taming of a transposon: V(D)J 
recombination and the immune system. Immunol. Rev. 200:233–248. 
57.  Litman GW, Rast JP, Fugmann SD (2010) The origins of vertebrate 
adaptive immunity. Nat. Rev. Immunol. 10:543–553. 
58.  Fugmann SD, Lee AI, Shockett PE, Villey IJ, Schatz DG (2000) The 
RAG proteins and V(D)J recombination: complexes, ends, and 
transposition. Annu. Rev. Immunol 18:495–527. 
59.  Cuomo CA, Oettinger MA (1994) Analysis of regions of RAG-2 
important for V(D)J recombination. Nucleic Acids Res. 22:1810–1814. 
60.  Silver DP, Spanopoulou E, Mulligan RC, Baltimore D (1993) 
Dispensable sequence motifs in the RAG-1 and RAG-2 genes for plasmid 
V(D)J recombination. Proc. Natl. Acad. Sci. U.S.A. 90:6100–6104. 
61.  Kirch SA, Sudarsanam P, Oettinger MA (1996) Regions of RAG1 
protein critical for V(D)J recombination. European Journal of Immunology 
26:886–891. 
62.  Steen SB, Han J-O, Mundy C, Oettinger MA, Roth DB (1999) Roles 
of the “Dispensable” Portions of RAG-1 and RAG-2 in V(D)J 
Recombination. Molecular and Cellular Biology 19:3010 –3017. 
63.  Dudley DD et al. (2003) Impaired V(D)J Recombination and 
Lymphocyte Development in Core RAG1-Expressing Mice. J Exp Med 
198:1439–1450. 
64.  Deriano L et al. (2011) The RAG2 C terminus suppresses genomic 
instability and lymphomagenesis. Nature 471:119–123. 
65.  Akamatsu Y et al. (2003) Deletion of the RAG2 C Terminus Leads to 
Impaired Lymphoid Development in Mice. PNAS 100:1209–1214. 
66.  Liang H-E et al. (2002) The “dispensable” portion of RAG2 is 
necessary for efficient V-to-DJ rearrangement during B and T cell 
development. Immunity 17:639–651. 
67.  Huye LE, Purugganan MM, Jiang M-M, Roth DB (2002) Mutational 
analysis of all conserved basic amino acids in RAG-1 reveals catalytic, 
  46 
step arrest, and joining-deficient mutants in the V(D)J recombinase. Mol. 
Cell. Biol 22:3460–3473. 
68.  Fugmann SD, Villey IJ, Ptaszek LM, Schatz DG (2000) Identification 
of two catalytic residues in RAG1 that define a single active site within the 
RAG1/RAG2 protein complex. Mol. Cell 5:97–107. 
69.  Dreyfus DH (2006) The DDE recombinases: diverse roles in acquired 
and innate immunity. Ann. Allergy Asthma Immunol 97:567–576; quiz 
576–578, 602. 
70.  Beese LS, Steitz TA (1991) Structural basis for the 3’-5’ exonuclease 
activity of Escherichia coli DNA polymerase I: a two metal ion mechanism. 
EMBO J. 10:25–33. 
71.  Lovell S, Goryshin IY, Reznikoff WR, Rayment I (2002) Two-metal 
active site binding of a Tn5 transposase synaptic complex. Nat Struct Mol 
Biol 9:278–281. 
72.  Allingham JS, Pribil PA, Haniford DB (1999) All three residues of the 
Tn10 transposase DDE catalytic triad function in divalent metal ion 
binding. Journal of Molecular Biology 289:1195–1206. 
73.  McMahan CJ, Difilippantonio MJ, Rao N, Spanopoulou E, Schatz DG 
(1997) A basic motif in the N-terminal region of RAG1 enhances V(D)J 
recombination activity. Mol Cell Biol 17:4544–4552. 
74.  Noordzij JG et al. (2000) N-Terminal Truncated Human RAG1 
Proteins Can Direct T-Cell Receptor but Not Immunoglobulin Gene 
Rearrangements. Blood 96:203–209. 
75.  Santagata S et al. (2000) N-Terminal RAG1 Frameshift Mutations in 
Omenn’s Syndrome: Internal Methionine Usage Leads to Partial V(D)J 
Recombination Activity and Reveals a Fundamental Role in Vivo for the N-
Terminal Domains. PNAS 97:14572–14577. 
76.  Simkus C, Makiya M, Jones JM (2009) Karyopherin alpha 1 is a 
putative substrate of the RAG1 ubiquitin ligase. Molecular Immunology 
46:1319–1325. 
77.  Arbuckle JL, Rahman NS, Zhao S, Rodgers W, Rodgers KK (2011) 
Elucidating the domain architecture and functions of non-core RAG1: The 
  47 
capacity of a non-core zinc-binding domain to function in nuclear import 
and nucleic acid binding. BMC Biochem 12:23. 
78.  Schatz DG, Swanson PC (2011) V(D)J recombination: mechanisms 
of initiation. Annu. Rev. Genet. 45:167–202. 
79.  Jackson PK et al. (2000) The lore of the RINGs: substrate recognition 
and catalysis by ubiquitin ligases. Trends Cell Biol. 10:429–439. 
80.  Yurchenko V, Xue Z, Sadofsky M (2003) The RAG1 N-Terminal 
Domain Is an E3 Ubiquitin Ligase. Genes Dev. 17:581–585. 
81.  Grazini U et al. (2010) The RING Domain of RAG1 Ubiquitylates 
Histone H3: A Novel Activity in Chromatin-Mediated Regulation of V(D)J 
Joining. Molecular Cell 37:282–293. 
82.  Jones JM, Gellert M (2003) Autoubiquitylation of the V(D)J 
Recombinase Protein RAG1. PNAS 100:15446–15451. 
83.  Jones JM, Simkus C (2009) The roles of the RAG1 and RAG2 “non-
core” regions in V(D)J recombination and lymphocyte development. Arch. 
Immunol. Ther. Exp. (Warsz.) 57:105–116. 
84.  Kassmeier MD et al. (2011) VprBP binds full-length RAG1 and is 
required for B-cell development and V(D)J recombination fidelity. EMBO J 
advance online publication. Available at: 
http://dx.doi.org/10.1038/emboj.2011.455 [Accessed January 29, 2012]. 
85.  Ramón-Maiques S et al. (2007) The plant homeodomain finger of 
RAG2 recognizes histone H3 methylated at both lysine-4 and arginine-2. 
Proceedings of the National Academy of Sciences 104:18993 –18998. 
86.  Zhao S, Gwyn LM, De P, Rodgers KK (2009) A non-sequence 
specific DNA binding mode of RAG1 is inhibited by RAG2. J Mol Biol 
387:744–758. 
87.  Akamatsu Y, Oettinger MA (1998) Distinct roles of RAG1 and RAG2 
in binding the V(D)J recombination signal sequences. Mol. Cell. Biol 
18:4670–4678. 
88.  Callebaut I, Mornon J-P (1998) The V(D)J recombination activating 
protein RAG2 consists of a six-bladed propeller and a PHD fingerlike 
  48 
domain, as revealed by sequence analysis. Cellular and Molecular Life 
Sciences 54:880–891. 
89.  Liu Y, Subrahmanyam R, Chakraborty T, Sen R, Desiderio S (2007) 
A plant homeodomain in RAG-2 that binds Hypermethylated lysine 4 of 
histone H3 is necessary for efficient antigen-receptor-gene 
rearrangement. Immunity 27:561–571. 
90.  Matthews AGW et al. (2007) RAG2 PHD finger couples histone H3 
lysine 4 trimethylation with V(D)J recombination. Nature 450:1106–1110. 
91.  Grundy GJ, Yang W, Gellert M (2010) Autoinhibition of DNA cleavage 
mediated by RAG1 and RAG2 is overcome by an epigenetic signal in 
V(D)J recombination. Proceedings of the National Academy of Sciences 
107:22487 –22492. 
92.  Elkin SK et al. (2005) A PHD Finger Motif in the C Terminus of RAG2 
Modulates Recombination Activity. J. Biol. Chem. 280:28701–28710. 
93.  West KL et al. (2005) A Direct Interaction between the RAG2 C 
Terminus and the Core Histones Is Required for Efficient V(D)J 
Recombination. Immunity 23:203–212. 
94.  Li Z, Dordai DI, Lee J, Desiderio S (1996) A conserved degradation 
signal regulates RAG-2 accumulation during cell division and links V(D)J 
recombination to the cell cycle. Immunity 5:575–589. 
95.  Lee J, Desiderio S (1999) Cyclin A/CDK2 regulates V(D)J 
recombination by coordinating RAG-2 accumulation and DNA repair. 
Immunity 11:771–781. 
96.  Jiang H et al. (2005) Ubiquitylation of RAG-2 by Skp2-SCF links 
destruction of the V(D)J recombinase to the cell cycle. Mol. Cell 18:699–
709. 
97.  Zhang L, Reynolds TL, Shan X, Desiderio S (2011) Coupling of V(D)J 
recombination to the cell cycle suppresses genomic instability and 
lymphoid tumorigenesis. Immunity 34:163–174. 
98.  Jackson SP (2002) Sensing and Repairing DNA Double-Strand 
Breaks. Carcinogenesis 23:687–696. 
  49 
99.  Grawunder U et al. (1995) Down-regulation of RAG1 and RAG2 gene 
expression in PreB cells after functional immunoglobulin heavy chain 
rearrangement. Immunity 3:601–608. 
100.  Wilson A, Held W, MacDonald HR (1994) Two Waves of 
Recombinase Gene Expression in Developing Thymocytes. J Exp Med 
179:1355–1360. 
101.  Chen Z et al. (2011) Transcription factors E2A, FOXO1 and FOXP1 
regulate recombination activating gene expression in cancer cells. PLoS 
ONE 6:e20475. 
102.  Amin RH, Schlissel MS (2008) Foxo1 directly regulates the 
transcription of recombination-activating genes during B cell development. 
Nat. Immunol. 9:613–622. 
103.  Lazorchak AS et al. (2010) Sin1-mTORC2 suppresses rag and il7r 
gene expression through Akt2 in B cells. Mol. Cell 39:433–443. 
104.  Hsu L-Y, Liang H-E, Johnson K, Kang C, Schlissel MS (2004) Pax5 
activates immunoglobulin heavy chain V to DJ rearrangement in 
transgenic thymocytes. J. Exp. Med. 199:825–830. 
105.  Zhang Z et al. (2006) Transcription factor Pax5 (BSAP) 
transactivates the RAG-mediated V(H)-to-DJ(H) rearrangement of 
immunoglobulin genes. Nat. Immunol. 7:616–624. 
106.  Hu H et al. (2006) Foxp1 is an essential transcriptional regulator of B 
cell development. Nature Immunology 7:819–826. 
107.  Kuo TC, Schlissel MS (2009) Mechanisms controlling expression of 
the RAG locus during lymphocyte development. Curr. Opin. Immunol. 
21:173–178. 
108.  Schulz D et al. (2012) Gfi1b negatively regulates Rag expression 
directly and via the repression of FoxO1. The Journal of Experimental 
Medicine 209:187 –199. 
109.  Bednarski JJ et al. (2012) RAG-induced DNA double-strand breaks 
signal through Pim2 to promote pre–B cell survival and limit proliferation. 
The Journal of Experimental Medicine 209:11 –17. 
  50 
110.  Hikida M et al. (1998) Expression of Recombination Activating 
Genes in Germinal Center B Cells: Involvement of Interleukin 7 (IL-7) and 
the IL-7 Receptor. J Exp Med 188:365–372. 
111.  Liu Y, Zhang L, Desiderio S (2009) Temporal and spatial regulation 
of V(D)J recombination: interactions of extrinsic factors with the RAG 
complex. Adv. Exp. Med. Biol. 650:157–165. 
112.  Ji Y et al. (2010) The In Vivo Pattern of Binding of RAG1 and RAG2 
to Antigen Receptor Loci. Cell 141:419–431. 
113.  Ramsden DA, McBlane JF, van Gent DC, Gellert M (1996) Distinct 
DNA sequence and structure requirements for the two steps of V(D)J 
recombination signal cleavage. EMBO J 15:3197–3206. 
114.  Akamatsu Y et al. (1994) Essential Residues in V(D)J 
Recombination Signals. J Immunol 153:4520–4529. 
115.  Ramsden DA, Baetz K, Wu GE (1994) Conservation of sequence in 
recombination signal sequence spacers. Nucleic Acids Res 22:1785–
1796. 
116.  Nadel B, Tang A, Escuro G, Lugo G, Feeney AJ (1998) Sequence of 
the Spacer in the Recombination Signal Sequence Affects V(D)J 
Rearrangement Frequency and Correlates with Nonrandom Vκ Usage In 
Vivo. The Journal of Experimental Medicine 187:1495–1503. 
117.  Cuomo CA, Mundy CL, Oettinger MA (1996) DNA sequence and 
structure requirements for cleavage of V(D)J recombination signal 
sequences. Mol Cell Biol 16:5683–5690. 
118.  Arnal SM, Holub AJ, Salus SS, Roth DB (2010) Non-consensus 
heptamer sequences destabilize the RAG post-cleavage complex, making 
ends available to alternative DNA repair pathways. Nucleic Acids Res 
38:2944–2954. 
119.  Montalbano A et al. (2003) V(D)J recombination frequencies can be 
profoundly affected by changes in the spacer sequence. J. Immunol. 
171:5296–5304. 
  51 
120.  Feeney AJ, Tang A, Ogwaro KM (2000) B-cell repertoire formation: 
role of the recombination signal sequence in non-random V segment 
utilization. Immunol. Rev. 175:59–69. 
121.  Eastman QM, Leu TMJ, Schatz DG (1996) Initiation of V(D)J 
recombination in vitro obeying the 12/23 rule. , Published online: 07 March 
1996; | doi:10.1038/380085a0 380:85–88. 
122.  Jones JM, Gellert M (2002) Ordered assembly of the V(D)J synaptic 
complex ensures accurate recombination. The EMBO Journal 21:4162–
4171. 
123.  Jung D et al. (2003) Extrachromosomal recombination substrates 
recapitulate beyond 12/23 restricted VDJ recombination in nonlymphoid 
cells. Immunity 18:65–74. 
124.  Drejer-Teel AH, Fugmann SD, Schatz DG (2007) The beyond 12/23 
restriction is imposed at the nicking and pairing steps of DNA cleavage 
during V(D)J recombination. Mol. Cell. Biol. 27:6288–6299. 
125.  Cobb RM, Oestreich KJ, Osipovich OA, Oltz EM (2006) in Advances 
in Immunology (Academic Press), pp 45–109. Available at: 
http://www.sciencedirect.com/science/article/pii/S0065277606910025 
[Accessed March 25, 2012]. 
126.  Schatz DG, Oettinger MA, Schlissel MS (1992) V(D)J 
Recombination: Molecular Biology and Regulation. Annual Review of 
Immunology 10:359–383. 
127.  Feeney A (2010) Epigenetic regulation of V(D)J recombination. 
Seminars in Immunology 22:311–312. 
128.  Bergman Y, Cedar H (2010) Epigenetic control of recombination in 
the immune system. Seminars in Immunology 22:323–329. 
129.  del Blanco B, García V, García-Mariscal A, Hernández-Munain C 
(2011) Control of V(D)J Recombination through Transcriptional Elongation 
and Changes in Locus Chromatin Structure and Nuclear Organization. 
Genetics Research International 2011:1–10. 
  52 
130.  Cherry SR, Baltimore D (1999) Chromatin remodeling directly 
activates V(D)J recombination. Proc. Natl. Acad. Sci. U.S.A. 96:10788–
10793. 
131.  Bergman Y, Cedar H (2010) Epigenetic control of recombination in 
the immune system. Seminars in Immunology 22:323–329. 
132.  Zhang M, Swanson PC (2009) HMGB1/2 can target DNA for 
illegitimate cleavage by the RAG1/2 complex. BMC Molecular Biology 
10:24. 
133.  Rodgers KK et al. (1999) A dimer of the lymphoid protein RAG1 
recognizes the recombination signal sequence and the complex stably 
incorporates the high mobility group protein HMG2. Nucleic Acids Res 
27:2938–2946. 
134.  van Gent DC, Ramsden DA, Gellert M (1996) The RAG1 and RAG2 
proteins establish the 12/23 rule in V(D)J recombination. Cell 85:107–113. 
135.  Shlyakhtenko LS et al. (2009) Molecular mechanism underlying 
RAG1/RAG2 synaptic complex formation. J. Biol. Chem 284:20956–
20965. 
136.  Kriatchko AN, Bergeron S, Swanson PC (2008) HMG-box domain 
stimulation of RAG1/2 cleavage activity is metal ion dependent. BMC Mol. 
Biol 9:32. 
137.  Taccioli GE et al. (1993) Impairment of V(D)J Recombination in 
Double-Strand Break Repair Mutants. Science 260:207–210. 
138.  Gong C et al. (2005) Mechanism of nonhomologous end-joining in 
mycobacteria: a low-fidelity repair system driven by Ku, ligase D and 
ligase C. Nature Structural & Molecular Biology 12:304–312. 
139.  Lin WC, Desiderio S (1994) Cell Cycle Regulation of V(D)J 
Recombination-Activating Protein RAG-2. PNAS 91:2733–2737. 
140.  Weinstock DM, Jasin M (2006) Alternative pathways for the repair of 
RAG-induced DNA breaks. Mol. Cell. Biol 26:131–139. 
  53 
141.  Bennardo N, Cheng A, Huang N, Stark JM (2008) Alternative-NHEJ 
is a mechanistically distinct pathway of mammalian chromosome break 
repair. PLoS Genet 4:e1000110. 
142.  Iliakis G (2009) Backup pathways of NHEJ in cells of higher 
eukaryotes: Cell cycle dependence. Radiotherapy and Oncology 92:310–
315. 
143.  Bentley J, Diggle CP, Harnden P, Knowles MA, Kiltie AE (2004) 
DNA Double Strand Break Repair in Human Bladder Cancer Is Error 
Prone and Involves Microhomology-Associated End-Joining. Nucl. Acids 
Res. 32:5249–5259. 
144.  Bennardo N, Cheng A, Huang N, Stark JM (2008) Alternative-NHEJ 
Is a Mechanistically Distinct Pathway of Mammalian Chromosome Break 
Repair. PLoS Genet 4. 
145.  Perrault R, Wang H, Wang M, Rosidi B, Iliakis G (2004) Backup 
pathways of NHEJ are suppressed by DNA-PK. J. Cell. Biochem 92:781–
794. 
146.  Simsek D, Jasin M (2010) Alternative end-joining is suppressed by 
the canonical NHEJ component Xrcc4-ligase IV during chromosomal 
translocation formation. Nat. Struct. Mol. Biol 17:410–416. 
147.  Sawchuk DJ et al. (2004) Ku70/Ku80 and DNA-dependent Protein 
Kinase Catalytic Subunit Modulate RAG-mediated Cleavage. Journal of 
Biological Chemistry 279:29821 –29831. 
148.  Raval P, Kriatchko AN, Kumar S, Swanson PC (2008) Evidence for 
Ku70/Ku80 association with full-length RAG1. Nucleic Acids Research 
36:2060 –2072. 
149.  Cui X, Meek K (2007) Linking double-stranded DNA breaks to the 
recombination activating gene complex directs repair to the 
nonhomologous end-joining pathway. Proc. Natl. Acad. Sci. U.S.A 
104:17046–17051. 
150.  Lee GS, Neiditch MB, Salus SS, Roth DB (2004) RAG proteins 
shepherd double-strand breaks to a specific pathway, suppressing error-
prone repair, but RAG nicking initiates homologous recombination. Cell 
117:171–184. 
  54 
151.  Corneo B et al. (2007) Rag mutations reveal robust alternative end 
joining. Nature 449:483–486. 
152.  Deriano L, Stracker TH, Baker A, Petrini JHJ, Roth DB (2009) Roles 
for NBS1 in alternative nonhomologous end-joining of V(D)J 
recombination intermediates. Mol. Cell 34:13–25. 
153.  Bredemeyer AL et al. (2006) ATM stabilizes DNA double-strand-
break complexes during V(D)J recombination. Nature 442:466–470. 
154.  Jones JM, Gellert M (2001) Intermediates in V(D)J recombination: A 
stable RAG1/2 complex sequesters cleaved RSS ends. Proceedings of 
the National Academy of Sciences 98:12926 –12931. 
 
 
  55 
CHAPTER 2 
REGULATION OF RAG-MEDIATED REACTION BY METAL ION 
COFACTOR - REAL TIME MONITORING OF RAG-MEDIATED 
CLEAVAGE REACTION REVEALS THAT CEC IS MORE STABLE IN 
MAGNESUIM 
Introduction 
The principles and applications of fluorescence anisotropy and FRET 
Fluorescence anisotropy is a frequently used fluorescence-based 
technique, which measures the rotational mobility of a fluorophore (1, 2). 
The relative comparison of a fluorophore between its tumbling time in 
solution and its intrinsic fluorescent lifetime (nano-seconds scale) 
determines its anisotropy value (ranging from 0 to 0.4), i.e. if a fluorophore 
rotates very slowly in solution, a large anisotropy value will be generated; 
if a fluorophore tumbles very rapidly in solution, anisotropy value will be 
smaller. The nature of fluorescence anisotropy measurement makes it 
applicable to reveal the interaction between two molecules, and it is more 
accurate if the fluorophore is labeled at a small molecule. Binding of the 
fluorophore-labeled small molecule to a larger molecule will significantly 
decrease the rotational mobility of the fluorophore, resulting in increased 
anisotropy. Thus, fluorescence anisotropy is very suitable to measure the 
protein-DNA interaction, where a relatively small DNA molecule is labeled 
with fluorophore and interaction with a protein can be readily revealed by 
increase in anisotropy (3). In addition, the degree of anisotropy changes 
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upon protein binding may reflect three aspects of protein-DNA interaction: 
1) strength of the interaction between two molecules, from which the 
binding constant of the interaction can be derived; 2) size of DNA-protein 
complex; 3) property of the binding pocket if the fluorophore is labeled 
close to the binding site. Nevertheless, the most advantageous aspect of 
anisotropy measurement is that it can directly measure the protein-DNA 
interaction in solution without perturbations arising from the separating 
steps that are required in other assays, such as electrophoresis or 
filtration. To summarize, the solution-based fluorescence anisotropy 
measurement is adopted in this study because it can determine very weak 
binding, which is otherwise very difficult to reveal by conventional 
methods. In addition, it measures the protein-DNA interaction in the most 
natural environment, in terms of salt concentration, pH range, 
temperature, etc., rather than changing into a complete different condition 
that is required for the separation of the DNA-protein complexes. Last but 
not least, It allows continuous collection of data points without interruption, 
which makes possible the kinetics measurement over the course of a 
reaction (2, 3).  
Another fluorescence-based technique, Fluorescence Resonance 
Energy Transfer (FRET), is the most widely used technique in many 
diverse disciplines such as physics, chemistry and biology. FRET reflects 
the energy transfer between the excited states of two fluorophores in the 
distance-dependent manner. The energy transfer is inversely proportional 
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to the six power of the distance between donor and acceptor, and thus is 
extremely sensitive to the distance changes (within 1-10nm range) (4). In 
addition to distance, several other parameters can also influence FRET 
efficiency, such as the relative orientation of the emission and absorption 
dipole moment, the refractive index of the medium, and the overlap 
between the donor emission spectrum and the acceptor excitation 
spectrum (4). Because of its well-established principle and relatively easy 
access, FRET is universally used in many fields and it is referred to as 
“spectroscopic ruler” to measure behaviors at the molecular level, such as 
interaction of two molecules, conformation change, folding and the 
dynamics of these behaviors. Similar to fluorescence anisotropy, FRET is 
also amenable to solution-based measurement, but has been extended to 
other types of measurements, such as FRET microscopy (5), which 
makes FRET technique even more powerful.  
However, disadvantages of anisotropy and FRET measurements 
are also apparent, e.g. the sensitivity of fluorescence is much less than 
that of radioactivity and thus higher concentration of labeled molecule is 
required in order to obtain sufficient signal. Therefore, it is very important 
to combine these fluorescence-based techniques with other 
measurements to provide a comprehensive understanding on protein-DNA 
interaction, which will be discussed in detail in the result section.  
Application of fluorescence techniques in RAG-mediated reactions 
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V(D)J recombination is essential to generate a diverse repertoire of 
antibodies and T cell receptors. Physiological V(D)J recombination is 
divided into two-phases, lymphocyte specific cleavage phase mediated by 
the RAG recombinase (RAG1/2) and the joining phase mediated by the 
ubiquitous non-homologous end joining (NHEJ) pathway (6, 7) The 
processes of physiological V(D)J recombination has been reviewed in 
detail in chapter 1. Briefly, the RAG1/2 mediated cleavage results in the 
generation of two hairpin-coding ends (HP-CEs) and blunt signal ends 
(SEs), which are then primarily resolved by NHEJ pathway to form coding 
joints and signal joints (8), (9). The RAG-mediated catalysis reaction has 
been recapitulated in the cell-free system, where recombinant RAG1 and 
RAG2 proteins are both necessary and sufficient to catalyze the site-
specific cleavage on an extrochromosomal DNA substrate that contains 
RSS. The biochemistry of RAG-mediated reaction has been extensively 
investigated, including the RAG-RSS interaction, enzymatic details, 
stoichiometry of RAG proteins during cleavage or after cleavage (10–12). 
Even more so, the whole process of V(D)J recombination has been 
successfully reconstituted in the in vitro cell free system using thirteen 
highly purified proteins, such as RAG1, RAG2, HMGB1, DNA-PKcs, 
Artemis, DNA ligase IV:XRCC4, etc. (13). However, few studies can 
reveal th Note that the ratioe dynamic changes of the reaction in the time-
dependent manner, instead, most of them have been relying on the 
detection of the end results, such as the production of CEs, SEs, or coding 
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joints (CJs) and signal joints (SJs), which precludes the revelation of many 
important aspects in the course of the reaction.  
Here in this study, I took advantage of two complementary 
fluorescence-based techniques, fluorescent anisotropy and FRET, to 
monitor the RAG-mediated recombination cleavage reaction in real time. 
The real-time monitoring system, for the first time, enables us to record 
the kinetics of the interaction between RAG and RSS or between RAG 
and the reaction intermediates, i.e. HP-CEs and blunt-SEs, which will 
provide important insights on 1) the initial binding properties, including 
possible conformational changes and the binding affinity measurement, 2) 
the stability of post-cleavage complex, i.e. HP-CEs retention and SEs 
retention. These studies will allow us to characterize the role and function 
of each participating factor in the course of RAG-mediated reactions, and 
to identify parameters that could potentially affect any of the above-
mentioned processes.  
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Materials and Methods 
Protein purification 
Maltose binding protein (MBP) tagged core RAG1 (residues 384-
1008) and core RAG2 (residues 1-387) proteins were co-expressed in 
293T cells using the Plus/Lipofectamine reagent (Invitrogen, Carlsbad, 
CA). Other MBP-fused RAG proteins were also prepared, including a 
catalytically inactive RAG1 mutant D600A (dRAG1, 384-1008) (14), a 
gain-of-function RAG1 mutant E649A (eRAG1, 384-1008) (15), Various 
combinations of wild type or mutant RAG1 and RAG2 were co-expressed 
in 293T cells, which are listed in Table 1, along with the nomenclatures of 
these proteins and various PCCs. The expressed proteins were purified 
following the procedure described by Bergeron et al. (16). The protein 
concentration was measured with the Nanodrop Spectrophotometer 
(Thermo SCIENTIFIC, Wilmington, DE) and verified by SDS-PAGE, in 
which no bands other than RAG1 and RAG2 were visible, as shown in 
Figure 1. The same amount of RAG proteins was used in the binding or 
cleavage reactions unless described otherwise. 
DNA substrates 
The sequence of the DNA substrate used in this study are shown 
below: 12RSS Top: 5’-TATCAGCTGATAGCTAACACAGTGCTACAGA-
CTGGAACAAAAACCCTGCT-3’; 12RSS bottom: 5'-AGCAGGGTTTTTG-
T-TC-CAGTCTGTAGCACTGTGTTAGCTATCAGCTGATC-3'; 23RSS top: 
5’-ATCGAAGTACCAGTAGCACAGTGGTAGTACGCGTCTGTCTGGCTG-
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TACAAAAACCATGGATCCT-3’; 23RSS bottom: 5’-AGGATCCATGGTT-
TTTGTACAGCCAGACAGACGCGTACTACCACTGTGCTACTGGTACTT-
CGAT-3’. The 12RSS top strand was labeled with TAMRA, either at 5’-
end, or internally at the 3rd nucleotides (T) 5’ to the heptamer. The 12RSS 
bottom strand was labeled with ATTO647N (hereafter referred to as 
ATTO) at the spacer region, 6th nucleotides (T) 3’ to the nonamer. The 
fluorescence labeled-DNA nucleotides were obtained from IBA 
BioTAGnology (Göttingen, Germany) and the unlabeled ones from 
Integrated DNA Technologies Inc. (Coralville, IA). 12RSS top strand with 
the internal labeled TAMRA was annealed to the ATTO-labeled bottom 
strand and were purified by native polyacrylamide gel electrophoresis to 
remove any residual single-stranded DNA. The dually labeled 12RSS 
oligonucleotide substrates were examined in the FRET experiments while 
the 5’ end-TAMRA-labeled 12RSS substrates were analyzed by the 
fluorescence anisotropy. As controls for analyzing fluorescence quenching 
effect, the singly labeled substrates were obtained by annealing the 
internal labeled TAMRA strand to the unlabeled bottom strand or the 
unlabeled top strand to the ATTO labeled bottom strand.  
In vitro cleavage assay 
The cleavage reaction of the fluorescence-labeled 12RSS (20 nM) 
was catalyzed by RAG proteins (65 nM) in 10 ml reaction containing 10 
mM Tris-HCl [pH 7.5], 50 mM NaCl and 100 µg/µl BSA in Mn2+ (0.2 mM) 
and Mg2+ (2.5 mM). The reaction inactive for cleavage was also included 
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as a control, i.e., the same probe incubated in the same reaction buffer, 
except with Ca2+ (2.5 mM) or using the catalysis-defective RAG1 mutant 
(dRAG1) paired with cRAG2. For the coupled cleavage reactions, HMGB1 
protein (30 ng/µl, Sigma-Aldrich) and 23RSS (150 nM) were included. The 
reaction mixture was incubated at 37°C for various times as indicated in 
the figures, and stopped by adding 10 ml denaturing loading dye 
containing 90% formamide for denaturation at 95°C and quick chill on ice 
before being loaded onto a 16% Tris-Borate-EDTA-7 M urea-
polyacrylamide gel. After electrophoresis, the gel was imaged on a 
Typhoon scanner (GE Healthcare) with laser excitation at 532 nm and 
emission filter of 580 nm to detect TAMRA fluorescence. 
Electrophoretic Mobility Shift Assay (EMSA) 
EMSA was performed to analyze the interactions between RAG 
proteins and RSS. Samples were prepared as described for the in vitro 
cleavage assay. The reaction was stopped by adding 5 µl 100% glycerol 
for every 10 µl reaction, and the sample was immediately loaded onto a 
discontinuous native polyacrylamide gel (top half 4% and bottom half 16%, 
with 19:1 acrylamide: bisacrylamide). Samples were subjected to 
electrophoresis at 200 V, 4°C for 2.5 hours. The resulting gel was imaged 
on the Typhoon scanner (GE Healthcare). 
Fluorescence anisotropy. 
A Photon Technology International QuantaMaster-4/2005SE 
Spectrofluorometer was used for all fluorescence experiments. A 3 mm × 
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3 mm quartz micro-cuvette with a 50 µl-sample chamber was used in all 
measurements, and temperature was controlled by a circulating water 
bath and set at 37°C except where noted. The fluorophore-labeled sample 
is excited by a polarized beam light, which allows photo-selection of a 
fraction of fluorophores that are properly oriented relative to the incoming 
light. The anisotropy is defined as〈r〉= (IVV − GIVH)/(IVV+2GIVH), where I 
is the fluorescent intensity, V and H reflects the vertical and horizontal 
orientation by which the emission and excitation polarizer is mounted,. 
The factor G is defined as, IHV/IHH, the intensity ratio of the vertical 
emission to horizontal emission when the sample is excited with horizontal 
polarized light. G factor is dependent on the monochromator wavelength 
and slit width and is used to correct for polarization-dependent effects in 
detection sensitivity. The excitation and the emission wavelengths were 
set at 510 nm and 580 nm, and data was acquired every 10 seconds. 
Background correction was applied to all the measurements. The 
anisotropy of the 5’-TAMRA-labeled 12RSS in the appropriate buffer (with 
cations indicated in the figures) was measured before and after the 
addition of RAG proteins. The temperature was maintained at 37°C for the 
duration of the experiment (~3 hours). The final concentration of all the 
components was the same as used in the in vitro cleavage reactions. At 
the end of cleavage reactions, SDS and proteinase K was added to 
disrupt the protein-DNA complex, resulting a complete release of HP-CEs, 
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where the anisotropy of free HP-CEs is lower than the free probe or DNA 
with a nick.  
Fluorescence Resonance Energy Transfer (FRET) 
The same instrument and setting are used for FRET experiment as 
those in fluorescence anisotropy measurement. Samples were excited at 
510 nm, except in the control experiments with ATTO-only RSS, where 
the excitation wavelength was set at 600 nm. Sample reactions were 
assembled as described for the in vitro cleavage assay, except that 
sample components were scaled up five-fold so that the final 
concentration of all the components was the same as used in the in vitro 
cleavage reaction. The FRET efficiency of the TAMRA-ATTO-labeled 
12RSS probe was measured before and after adding the purified RAG 
proteins. Emission scans were recorded every 10 min during the first hour 
and then every 20 min for another 2 hours. The ratio Iacceptor /Idonor was 
calculated from the peak intensities of the acceptor and donor, and used 
as a measure of the FRET efficiency. Note that the ratio, Iacceptor /Idonor, 
does not represent the actual FRET efficiency.  Because I do not attempt 
to obtain the distance information between donor-acceptor, rather I would 
like to have a relative comparison of the FRET efficiency changes, and 
thus the ratio Iacceptor /Idonor was used instead for its simplicity. 
For the experiment involving the step-wise addition of cations, the 
cleavage reaction was initiated by e/cRAG in Mg2+ for 2 hrs and then 
continued after the addition of different cations to the desired final 
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concentrations (Mn2+ = 0.2mM, Mg2+ = 2.5 mM and Ca2+ = 2.5 mM). A 
mock treatment without the cation addition was also included as a control. 
These reactions were monitored by FRET and analyzed by denaturing gel 
electrophroresis for the production of HP-CEs. The experiment involving a 
temperature ramp was conducted on the cleavage reaction initiated by 
e/cRAG or e/fsRAG in Mg2+ at 37°C for 1 hour followed by a temperature 
increase to 55°C over 15 min. The emission intensities of TAMRA and 
ATTO were monitored over the temperature-ramp every 2°C, and then 
every 20 min over the next 1 hour.  
Data fitting. 
Kinetic traces of FRET and fluorescence anisotropy experiment 
were fitted using the program embedded in OriginPro8, to either a mono-
exponential decay (Iacceptor /Idonor = Aexp(-t/τ)+A∞),  or to a sum of two 
mono-exponential decays (Iacceptor /Idonor = A1 exp(-t/τ1)+ A2 exp(-t/τ2)+ A∞). 
The latter was used if the former failed to generate a satisfactory fit, which 
reflects the non-random residues during fitting. In these equations, t 
represents time, τ represents the dissociation lifetime, and A∞ represents 
the Iacceptor /Idonor ratio where all generated HP-CEs is liberated from the 
RAG complex. Because in some reactions, HP-CEs was not completely 
released by the end of 3 hours acquisition time, meaning the lifetime is 
longer than 3 hours, the parameter A∞ was determined by either adding a 
denaturing agent (SDS/Proteinase K) at the end of the experiment, or by 
increasing the temperature to 55 °C to dissociate all hairpins. Both 
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methods yield the same value, which was used as a fixed parameter in the 
fitting procedures.  
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Result 
Proof of concept demonstration in the RAG-mediated reaction 
system with Mn2+ 
The probe for fluorescence anisotropy measurement is a 50 base 
pair 12RSS substrate that is labeled with TAMRA at the 5’end of coding 
flank, hereafter referred to TAMRA-12RSS. Fluorescence anisotropy can 
reflect RAG-RSS interaction in both the pre-cleavage complex and post-
cleavage complex, the scenarios of which are illustrated in Figure 2A. 
Free probe displays a relatively low anisotropy 〈r〉. Upon RAG addition, the 
specific interaction between RAG and TAMRA-12RSS causes a slower 
rotational mobility of TAMRA, therefore increased 〈r〉. Excision of TAMRA-
12RSS by RAG to generate TAMRA-labeled hairpin-coding ends (HP-
CEs) and the subsequent release of the smaller-sized TAMRA-HP-CEs 
from CEC will cause a decrease in 〈r〉, On the other hand, 〈r〉 stays 
constant if the cleaved HP-CE is retained in CEC.  
To test these scenarios, I first need to make sure fluorescence 
anisotropy is applicable and sensitive enough to reveal the changes of 
interaction between RAG and the RSS or the cleavage intermediate, e.g. 
HP-CEs. As a proof of concept demonstration, I compared the c/cRAG 
(RAG recombinase containing coreRAG1 and core RAG2, see Table 1 for 
nomenclature) mediated-cleavage reactions on single TAMRA-12RSS, in 
the presence of various cations, i.e. Mg2+, Ca2+, Mn2+, which results in 
different cleavage outcomes and thus is suitable for testing different 
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scenarios. Among these cations, Mn2+ is of particular interest, because it 
supports uncoupled cleavage on a single RSS, and thus is considered a 
permissive cation, which was speculated to allow rapid HP-CEs 
dissociation from the CEC. Indeed, as shown in Figure 2B, Mn2+ induced 
an initial higher increase of 〈r〉 upon c/cRAG addition (which will be 
discussed in more detail in the later section), followed by a continuous 〈r〉 
decrease during the incubation time, most likely due to the release of 
generated HP-CEs from CEC. On the other hand, RAG-mediated binding 
alone in Ca2+ and nicking alone in Mg2+ both displayed initial anisotropy 
increase over the free probe upon RAG addition and 〈r〉 remained rather 
constant afterwards, consistent with their lack of HP-CEs generation and 
release from CEC.  
The demonstration of fluorescence anisotropy in revealing various 
recombination outcomes was very encouraging. However, we could not 
exclude the possibility that the 〈r〉 reduction observed only in Mn2+ was due 
to dissociation of intact TAMRA-12RSS from the RAG complex, instead of 
premature release of HP-CEs from the CEC. To delineate whether the 〈r〉 
reduction is due to release of intact RSS or HP-CEs and to definitively 
measure HP-CEs release, we applied another fluorescence detection 
system, FRET, to monitor the same cleavage reaction. The 12RSS probe 
for the FRET study was labeled with TAMRA (donor) at the coding flank 
next to heptamer of the top strand and with ATTO 647N (acceptor, 
henceforth referred to as ATTO) at the spacer region of the bottom strand. 
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The distance between donor and acceptor fluorophore in intact 12RSS is 
5.4nm (16 bp apart), such that  an excitation of TAMRA is expected to 
result in the appearance of an additional fluorescence band corresponding 
to the ATTO emission spectrum and meanwhile a reduction in TAMRA 
emission, since within such short distance, a fraction of energy absorbed 
by TAMRA can be transferred to ATTO, as shown in Figure 3A. The 
possible scenarios of RAG-mediated cleavage reaction on TAMRA-ATTO 
12RSS are illustrated in Figure 3B, RAG binding or nicking alone is not 
supposed to change FRET efficiency, as donor-acceptor distance remains 
the same. However, in some cases, if RAG-RSS interactions distort DNA 
so that the orientation (less likely distance) between donor-acceptor dipole 
is affected, FRET efficiency may fluctuate without an actual excision of the 
12RSS. For example, due to DNA bending, a decreased distance between 
TAMRA-ATTO, possibly is likely to increase of ATTO and decrease of 
TAMRA.  On the other hand, reduction in FRET has also been observed in 
the absence of recombination cleavage, which will be discussed in more 
detail in chapter 4. Nevertheless, the more apparent change in FRET 
efficiency is caused by physical change in distance, e.g. increased 
distance due to hairpin dissociation from CEC will lead to reduction of 
ATTO emission (Idonor) and corresponding increase of TAMRA emission 
(Idonor). Thus, the ratio Iacceptor/Idonor is a direct measure of the relative 
distance between TAMRA and ATTO, and is used here to model changes 
of FRET efficiency corresponding to the interaction of 12RSS or the 
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cleaved HP-CEs with RAG in both single cleavage reactions or coupled 
cleavage reactions.  
Indeed, RAG mediated reactions containing Mg2+ (only causes 
nicking) or Ca2+ (only induces specific binding) have very stable FRET 
efficiency over the incubation time, as shown in Figure 3C. While in the 
presence of Mn2+, the ratio Iacceptor/Idonor decays significantly, a result of 
reduced ATTO emission and enhanced TAMRA emission caused by 
distance increase between donor and acceptor molecule. Changes of 
FRET efficiency represented by Iacceptor/Idonor is consistent with the 
anisotropy decrease, denoted as 〈r〉, under the same condition and is a 
definitive proof of HP-CEs release from CEC. Furthermore, changes of 
Iacceptor/Idonor and 〈r〉 can be fitted into a single exponential decay, and both 
of them generate a lifetime around 120min, reflecting the dissociation 
kinetics of newly generated HP-CEs (TARMA) away from the CEC and 
cleaved signal ends (ATTO), as well. The excellent agreement of lifetime 
generated from anisotropy and FRET further indicates that both methods 
monitor the same kinetics of the cleavage process. Thus, the combination 
of fluorescence anisotropy and FRET techniques provide us with great 
tools to real time monitor kinetics of RAG-mediated reaction and most 
importantly, for the first time, enable us to measure the HP-CEs retention 
in CEC.  
Reveal the distinct interaction between RAG and RSS in the 
presence of different cations 
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Noted that in the anisotropy measurements of c/cRAG mediated 
reaction under various cations, Mn2+ renders the highest 〈r〉 upon RAG 
addition, which either reflect c/cRAG binding to 12RSS with higher affinity 
or c/cRAG and 12RSS forms a larger complex in the presence of Mn2+. 
This observation was very interesting, because among all the studies that 
compared Mg2+ and Mn2+ under various conditions (summarized in 
introduction), where Mn2+ in general relaxes the specificity of RAG-
mediated reaction while Mg2+ ensures the specificity stringently, no direct 
biochemical evidence has been reported to distinguish the binding 
affinities of RAG and RSS under different metal ions. On the contrary, 
EMSA studies from several labs showed no obvious variations of c/cRAG 
binding to RSS under various cations (17–19). However, as indicated in 
the first section of this chapter, EMSA is relatively insensitive in 
determining the true binding affinity and especially too harsh to reveal the 
weak binding, thus the real effect of cation on RAG-RSS binding has not 
been thoroughly investigated. Here the sensitive and non-disruptive 
fluorescence anisotropy revealed a significant difference on the initial RAG 
interaction with 12RSS among different metal ions, allowing us to have 
more detailed comparison on their roles in RAG-RSS interactions. First, I 
applied fluorescence anisotropy in dose-dependent RAG-RSS interactions 
to measure affinities of initial binding at 37°C between c/cRAG and 12RSS 
in the presence of Ca2+, Mn2+ and Mg2+, from which the binding constants 
could be derived. As shown in Figure 4A, the binding constant is 13.5 ± 
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2.3 nM in Ca2+, 3.9 ± 3 nM in Mn2+, and 14.5 ± 2.4 nM in Mg2+, 
respectively, which provides clear evidence that Mn2+ induce stronger 
binding of c/cRAG to the 12RSS substrates than the other cations. I then 
made a direct comparison on the c/cRAG-RSS complex formation at 37°C 
over a period of time in the presence of different cations based on EMSA 
experiment, which is different from the previous EMSA studies where the 
complexes were assembled at a much lower temperature to avoid actual 
cleavage, e.g. 4°C or 15°C. As shown in Figure 4B, the complexes formed 
at the beginning of the reaction in three cations are indistinguishable, 
however, the complex formed under Mn2+ is most stable despite the 
continuous generation of hairpin, as it is still retained after 3 h incubation. 
So the combination of fluorescence anisotropy and a modified EMSA 
measurement revealed the stronger binding of c/cRAG and RSS in the 
presence of Mn2+, which may partly explain the excessive cleavage 
activity rendered by Mn2+ in RAG-mediated cleavage.  
Mg2+ induces RAG to form more stable PCC in both single and 
coupled reactions in comparison to Mn2+  
Given that the assembly of pre-cleavage c/cRAG-RSS complex is 
significantly affected by the metal ion cofactor, it is conceivable that the 
metal ion might also affect the stability of post-cleavage complex. I 
investigated this possibility using both fluorescence anisotropy and FRET 
measurement. However, the direct comparison between Mg2+ and Mn2+ is 
impossible in the single cleavage reaction, since Mg2+ doesn’t support the 
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generation of HP-CEs on single 12RSS but rather requires synaptic 
complex (12RSS and 23RSS, coupled reaction) formation in order for 
efficient cleavage, while Mn2+ allows cleavage on a single RSS in the 
absence of synapsis. Then, it is not clear whether the previous 
observation of rapid HP-CEs dissociation from CEC in the presence of 
Mn2+ is due to an uncoupled reaction or an intrinsic property of Mn2+ in 
destabilizing CEC. To address this issue, I took advantage of a gain-of 
function E649A core RAG1 (eRAG1) mutant, which has been reported to 
permit site-specific excision in the single cleavage reaction even in the 
presence of Mg2+ (15). This mutant was found to closely resemble its wild-
type counterpart (cRAG1) in their DNA binding activity, transposition 
activity (catalysis of other DNA strand transfer), and most important, in 
end resolution of both SEs and CEs on a plasmids substrates containing 
12/23RSS pair. The similarity in end resolution suggested that cRAG1 and 
eRAG1 exhibits a comparable level of post-cleavage complex stability, 
which allows us to determine the effect of Mg2+ or Mn2+ on HP-CEs 
retention from CEC. 
First, I performed the time-course analysis of in vitro cleavage 
reaction under various conditions, e/cRAG (eRAG1 paired with cRAG2, 
see Table 1 for nomenclature) together with Mn2+, c/cRAG with Mn2+ and 
e/cRAG with Mg2+, as shown in the left panels of Figure 5A, B and C. 
Reaction containing e/cRAG and Mn2+ displayed a very fast kinetics of 
hairpin generation, with a calculated life time of 10 min (τHP-P  = 10 min), 
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compared to 60 min (τHP-P  = 60 min) for both c/cRAG in Mn2+ and e/cRAG 
in Mg2+. However, besides the expected nicked and HP-CEs products, an 
unknown band at the position above the HP-CEs also appeared only in 
the reaction mediated by e/cRAG in Mn2+ (denoted with *). The nature of 
this band remains unidentified, but it was most likely related to the ATTO 
labeling at the spacer region, possibly reflecting an excision product made 
near the ATTO site, since no such band was observed when the 12RSS 
labeled only with TAMRA was tested under the same reaction condition. 
Nevertheless, once the above three reaction conditions were compared by 
FRET measurement, I found that despite the different kinetics of hairpin 
production, the reactions mediated by e/cRAG in Mn2+ and c/cRAG in 
Mn2+ displayed similar patterns of FRET changes, in which a rapid 
increase in the TAMRA intensity coincided with a decrease in the ATTO 
intensity, as shown in right panel of Figure 5A, indicating a significant 
FRET decrease, the Iacceptor/Idonor ratio changes of which are summarized 
in Figure 5E. On the other hand, in the reaction containing e/cRAG and 
Mg2+, the emission intensity of TAMRA and ATTO changed at a much 
slower rate compared to the reactions containing Mn2+, as shown in the 
right panel of Figure 5C. Specifically, the Iacceptor/Idonor ratio remained fairly 
constant during the first 50 min of the reaction, and showed a much slower 
decay afterwards, with a lifetime τHP-R of 400 ± 14 min (Figure 5E). 
Although the level and kinetics of HP-CEs generation is similar between 
the reactions mediated by e/cRAG in Mg2+ and c/cRAG in Mn2+, their HP-
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CEs release rate differs significantly, suggesting that hairpin-CEs are 
retained much better in CEC in the presence of Mg2+ than that in the 
presence of Mn2+. As negative controls, in reactions that is lack of 
cleavage, such as the catalytic-inactive mutant d/cRAG (dRAG1 paired 
with cRAG2) with Mn2+ or e/cRAG with Ca2+, FRET efficiency is not 
changed in both cases, as shown in Figure 5D. 
The significant difference between Mn2+ and Mg2+ in HP-CEs 
retention was very intriguing, but I noticed that FRET decrease in e/cRAG 
with Mn2+ seemed to be a bi-phasic process, with an early faster phase (τ1 
= 12 min) and a later slower phase (τ2 = 370 min), different from that of 
c/cRAG in Mn2+. The slower phase at the later stage greatly bothered us 
because it suggested the possibility that e/cRAG also played a role in 
holding HP-CEs. On the other hand, I cannot rule out the possibility that 
the slower FRET decrease at the later stage might be attributed to the 
unknown band exist only under this condition, which was indeed 
generated in a delayed manner compared to HP-CEs product (left panel of 
Figure 5A) and may interfere with the rapid hairpin release. To delineate 
these two possibilities, I performed the cleavage reaction with step-wise 
addition of cations in both FRET experiment and in vitro cleavage 
experiment. The reactions were initiated with e/cRAG in the presence of 
Mg2+ for 2 hours, a time long enough for the reaction to occur and to 
generate a significant amount of hairpin, and then additional Mg2+, Mn2+, 
or Ca2+ was dispensed into the pre-incubated reaction. A mock treatment 
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of simply disturbing the incubation by repetitive pipetting was also included 
to control for the possible artifact arising from the pipetting procedure. It is 
important to note that the step-wise addition of any cation induced no 
further HP-CEs production, and it also prevented the generation of the 
unknown band associated with e/cRAG in Mn2+, as revealed by the in vitro 
cleavage reaction in Figure 6B. However, in FRET measurement, addition 
of Mn2+ resulted in significant decrease in FRET efficiency, possibly due to 
the dissociation of HP-CEs that would otherwise be bound to CEC in the 
presence of Mg2+, since no additional hairpin were generated. On the 
other hand, addition of Mg2+ and Ca2+ triggers no apparent HP-CEs 
release since they displayed similar FRET decrease with that of mock 
treatment, as shown in Figure 6A. Therefore, by sequentially adding 
cations to a pre-incubated reaction, I alleviate the complexity associated 
with the unknown band as well as the bi-phasic FRET decrease, and 
substantiate our previous finding that CEC formed in the presence of Mg2+ 
is more stable than the one in Mn2+, and adding Mn2+ disrupts this 
complex and causes the premature release of that the PCC formed in 
Mg2+.  
I then extended my FRET analysis to assess the influence of metal 
ions on the stability of CEC formed during coupled reaction. Both c/cRAG 
and e/cRAG mediated coupled reaction were tested, with the addition of 
HMG and unlabeled 23RSS, in the presence of Mn2+ or Mg2+, as shown in 
Figure 7. The initial increase in Iacceptor/Idonor present in three conditions, 
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c/cRAG with Mn2+, c/cRAG with Mg2+, and e/cRAG with Mg2+, may reflect 
the DNA bending effect caused by HMG and RAG together (20, 21), 
because DNA bending shortens the distance between donor-TAMRA and 
acceptor-ATTO and therefore causes increase in FRET efficiency. On the 
other hand, the lack of the initial Iacceptor/Idonor increase observed in e/c 
RAG with Mn2+ could be because that DNA bending-induced FRET 
increase was overcome by the rapid FRET reduction due to hairpin 
release under this condition. Nevertheless, the initial increase was also 
observed in e/cRAG mediated reaction in the presence of Ca2+ Figure 8A 
and B, suggesting that it is not associated with actual cleavage but rather 
reflect a structural change of DNA. However, the change of Iacceptor/Idonor 
ratio could also be due to differential quenching of TAMRA or ATTO by 
RAG/HMG in the coupled reaction. To test this scenario, I performed the 
same reactions using single labeled probe, i.e. TAMRA-top strand paired 
with unlabeled bottom strand and unlabeled top strand paired with ATTO-
bottom strand, and monitor the fluorescence intensity changes in e/cRAG 
mediated coupled reaction. As shown in Figure 8C and D, the 
fluorescence intensity of the single probe stays rather constant over the 
course of incubation, which proves that the changes seen using doubly-
labeled probe is indeed due to FRET change.  
Regardless of the initial FRET increase, the dissociation of hairpin 
is much slower in the presence of Mg2+ than that with Mn2+, which is 
consistent with the finding in single reactions. Specifically, in coupled 
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reaction containing e/cRAG and Mn2+, HP-CEs dissociated at a rate of τHP-
R  = 12 min, which is identical to the rate observed in the single reaction 
(Compare Figure 5E to Figure 7B). The faster HP-CEs release rate was 
again observed in coupled reactions catalyzed by c/cRAG together with 
Mn2+, τHP-R = 186 min, which is within the same range of that in single 
reaction, where τHP-R = 120 min (summarized in Table 2). These data 
indicated that, in the presence of Mn2+, CEC fails to effectively retain HP-
CEs to its close proximity, regardless of whether they are in the context of 
synaptic complex produced during a coupled reaction or single complex 
formed in a single reaction. On the other hand, in coupled reaction 
catalyzed by c/cRAG or e/cRAG in Mg2+, except for the initial increase, 
FRET efficiency stayed fairly constant, indicating the strong retention of 
HP-CEs in CEC formed with a pair of RSS. Furthermore, Iacceptor/Idonor 
signal remains higher at all time points in coupled reactions than those 
observed in the single reactions over the course of incubation, indicating 
that HP-CEs are retained better in paired-CEC than in single-CEC, which 
is consistent with the previous notion on this matter (comparing Figure 7A 
and Figure 5E). Overall, for the first time, I demonstrated the importance 
of Mg2+ in modulating the stability of post-cleavage complex in HP-CEs 
retention. Our study reinforces the irreplaceable role of Mg2+ serving as a 
physiological cofactor for V(D)J recombination, because of its ability to 
exerts stringent regulations at various stages during recombination, from 
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pre-cleavage assembly to cleavage reaction, now even extended to the 
control of CEC stability.   
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Discussion 
As reviewed in chapter1, PCC stability is a very important aspect 
that can potentially interfere with the ability of RAG recombinase to 
choose the appropriate repair pathway for resolving the RAG mediated 
DSB. Between the two types of PCC, SEC is relatively easy to study due 
to its intrinsic high stability, and abnormalities associated with a less stable 
SEC has been reported by several groups (22, 23). CEC, on the other 
hand, has long been recognized to only transiently retain the HP-CEs, so 
the effect of CEC stability on V(D)J recombination and genome stability 
remains elusive, largely due to the technique difficulties to reveal very 
weak binding. By combining fluorescence anisotropy and FRET 
techniques, I build a very elegant system that allows real-time monitoring 
of the RAG-mediated cleavage reaction. For the first time, I can directly 
assess the interaction between HP-CEs and CEC after cleavage. My 
quantitative and real time monitoring system empowers us to evaluate 
various factors that might influence the RAG mediated cleavage and most 
importantly, the HP-CEs retention in CEC. Indeed, I found that the metal 
ion cofactor, which was previously thought to only affect pre-cleavage 
complex formation as well as the catalysis step, also exert significant 
influence on HP-CEs retention in CEC.  
Real-time monitoring of the RAG-catalyzed cleavage reaction and the 
kinetics of HP-CE release. 
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Fluorescence anisotropy and FRET techniques provide us great 
tools to real time monitor the HP-CEs release dissociation from the CEC, 
but noted that the dissociation kinetic derived from these two methods are 
actually influenced by the rate of two events, HP-CEs generation (τHP-p) 
and HP-CEs release (τHP-R). 
To interpret the kinetic data of these two events, I considered the 
following simplified mechanism, in which the first step represents the 
production of HP-CE and the second step represents its release from the 
CEC, leaving SEC.  
          
The rate of the first step (k1) can be easily calculated based on a 
time-course in vitro cleavage reaction revealed by a denaturing gel 
electrophoresis (Figure 5A, B, C right pannel). The rate of the second step 
(k2) is primarily determined by FRET measurement. Specifically, FRET 
efficiency is only changed proportionally to the released HP-CEs, 
however, in the reaction mixture at certain moment, a fraction of HP-CEs 
may still be retained in CEC which does not change FRET efficiency, so 
the rate determined in this experiment is in principle a combination of k1 
and k2. Based on the relative values of k1 and k2, three situations can be 
distinguished, reflecting different dissociation kinetics. (1) If k2 >> k1, i.e. 
the rate limiting step is hairpin production, the rates measured by FRET 
and denaturing electrophoresis will be the same, as the hairpin is released 
12 RSS + RAG HP-CE/CEC HP-CE + SEC 
k1 k2 
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as soon as it is formed (τHP-p = τHP-R). This seems to be the situation 
observed in DNA cleavage reactions catalyzed by several restriction 
endonucleases, where the cleaved products quickly dissociate from the 
enzyme (56). The rapid FRET reduction in the initial phase of the cleavage 
reaction catalyzed by e/cRAG in Mn2+ seems to fit into this category, 
where τHP-R approaches τHP-P (12 min vs 10 min; see Table 2). Thus, 
e/cRAG fails to hold HP-CEs in the presence of Mn2+. (2) On the other 
hand, if k1 = k2, i.e., the two rates are comparable, the observed tHP-R 
should be somewhat slower than tHP-p, but the two lifetimes should be of 
the same order of magnitude. Clearly, the c/cRAG-catalyzed excision in 
Mn2+ fits into this profile (Table 2). (3) If k2  << k1, the rate-limiting step is 
the release of the hairpin, the lifetime measured by FRET is expected to 
be much slower than the one measured by electrophoresis (τHP-p << τHP-R). 
This appears to be the case in the cleavage reactions catalyzed by 
e/cRAG in Mg2+, where tHP-R is at least 6 times slower than τHP-P (Table 2).  
The role of metal ion cofactor in RAG-mediated cleavage reaction 
has been studied extensively (summarized in chapter 1) and has been 
implicated in affecting the RAG structure, RAG-RSS interaction, most 
importantly, the catalysis step of RAG-mediated cleavage on RSS site. 
Here in this study, by comparing the dissociation kinetics of HP-CEs in the 
presence of Mg2+ and Mn2+, and their behavior in the context of other 
parameters, such as different forms of RAG proteins, single or coupled 
reaction, I provide unequivocal evidence that Mg2+ also function to 
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maintain CEC stability and promote HP-CEs retention. Our study further 
substantiated the important role of Mg2+ as a physiological cation in 
regulating V(D)J recombination throughout the process, from enforcing 
coupled cleavage of a synaptic complex by following 12/23 rule, to 
maintain post-cleavage complex stability in terms of HP-CEs retention. 
However, our observation contrasts with the previous finding that SEs are 
retained in SEC synaptic complex, regardless of the cation used. (28, 49) 
(31). The possible reason underneath these two seemingly controversial 
findings is that, the intrinsically high stability of SEC makes it less 
influenced by the type of cation present than that of the much labile CEC. 
Nevertheless, the sensitive nature of our fluorescence-based 
measurement allows us to assess a very broad dynamic range and to 
distinguish different levels of association between the RAGs and 
recombination intermediates under various conditions, which will then help 
to evaluate the effect of various factors on the stability of these 
associations in situ. 
Besides our successful attempt to reveal the weak binding between 
HP-CEs with CEC, I also observed variation of binding affinities in the 
presence of different cations, by the fluorescence anisotropy 
measurement (Figure 4A). Mn2+ was found to induce the highest binding 
affinity of RAG and RSS (Kd = 3.9 nM), while Mg2+ and Ca2+ show 
comparable but much lower binding (Kd =13.5 nM or 14.5 nM, 
respectively). This is the first demonstration that Mn2+ induces stronger 
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binding and may partially explain the very aggressive nature of Mn2+. 
Noted that the calculated Kd here of c/c RAG binding to 12RSS were 
somewhat different (much lower) from the Kd in two different anisotropy 
analyses, i.e., 41 nM and 28 nM reported by Ciubotaru et al and Zhao et 
al. Noted that the Kd in those two studies were determined for the 
interaction between cRAG1 and RSS, rather than cRAG1/cRAG2 as in our 
study, substantiating the notion that the presence of cRAG2 can 
significantly promote cRAG1 interaction with RSS. (Shuying Zhao, 2009, 
JMB) On the other hand, Kd  for RAG-RSS binding was also determined 
by EMSA, where the Kd for cRAR1 binding is 123 nM, and the Kd for 
cRAR1/cRAG2 binding is 25nM. The Kd generated based on EMSA are 
slightly higher than the Kd  obtained by anisotropy, which is likely attribute 
to the overestimation of binding affinity by EMSA, resulting from the 
separation of the bound complex from the free probe during the relatively 
harsh electrophoresis step. So the anisotropy measurement in our study 
seems to generate the most reliable Kd for c/cRAG-RSS interaction, and 
provide strong evidence that this interaction is metal ion dependent. 
Although the physiological role of metal ion on V(D)J recombination 
remains elusive, our in vitro biochemical studies on this issue definitely put 
forward a new potential regulatory mechanism of V(D)J recombination in 
vivo, where metal ion, depending on its content or concentration, may 
modulate the fidelity and efficiency of V(D)J recombination.  
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Table 1. Protein nomenclature 
 
Category Name Protein Description 
RAG1 cRAG1 core RAG1 (384-1008) 
 eRAG1 E649A core RAG1 mutant (384-1008) 
 dRAG1 D600A core RAG1 mutant (384-1008) 
   
RAG2 cRAG2 core RAG2 (1-387) 
   
RAG1-RAG2 c/cRAG cRAG1/cRAG2 
 e/cRAG eRAG1/cRAG2 
 d/cRAG dRAG1/cRAG2 
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Table 2 Kinetics of the production and release of HP-CEs 
Cleavage RAG Cation τHP-pa (min) τHP-Rb (min) 
 c/cRAG Mn2+ 60 ± 5 120 ± 6 
Single e/cRAG Mn2+ 10 ± 2 τ1 12 ± 3; τ2=370 ± 30c 
 e/cRAG Mg2+ 60 ± 4 400 ± 14 
     
 c/cRAG Mn2+ NDd 186 ±10 
 c/cRAG Mg2+ ND >600 
Coupled e/cRAG Mn2+ ND τ1 12 ± 2; τ2=380 ± 25c 
 e/cRAG Mg2+ ND >600 
 
a: Lifetime of HP-CE production, a measure of the rate of HP-CE 
production. The number given was calculated from the kinetic analysis of 
HP-CE production, as exemplified in Fig. 5A. 
b: Lifetime obtained from FRET or anisotropy, a measure of the rate of HP-
CE release, as exemplified in Fig. 5A. 
c: Bi-phasic kinetics, in which ττ1 is relevant to HP-CE release whereas τ2 
may be caused by the generation of additional band as it is not correlated 
with τHP-p, i.e., HP-CE production rate (see Fig. 5A).  
d: Not determined. 
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Figure 1. Visualization of c/cRAG and e/cRAG on SDS-PAGE, revealed by 
Coomassie blue staining.  
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Figure 2. Real-time analysis of RAG-RSS interactions using fluorescence-
Anisotropy.   
(A) Schematic illustration of the expected changes in fluorescence 
anisotropy due to interactions between RAG and the 5’-TAMRA labeled 
12RSS. The anisotropy signal increases once the RAG protein binds to 
the 12RSS. The elevated anisotropy signals are maintained after RAG-
mediated nicking or excision, as long as the HP-CEs remain in the CEC. 
The release of HP-CEs from the CEC results in the reduction of the 
anisotropy signal.  
(B) Cation-dependent changes in FRET experiment during RAG-RSS 
interactions. The anisotropy profiles of c/cRAG interactions with the 
TAMRA-labeled 12RSS are affected by the cation present in the cleavage 
reaction, i.e., Ca2+ (blue), Mg2+ (black) or Mn2+ (red).  
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Figure 3. Real-time analysis of RAG-RSS interactions using FRET 
techniques  
(A) Emission spectral of TAMRA-12RSS and TAMRA-ATTO-12RSS, the 
presence of ATTO results in a reduction of TAMRA intensity and the 
appearance of ATTO emission peak. 
(B) Schematic representation of the FRET changes that result from RAG-
mediated interactions with the TAMRA-ATTO doubly labeled 12RSS. The 
FRET signal remains unchanged during nicking (left) and hairpin formation 
(middle), as long as the HP-CEs are kept within the coding end complex 
(CEC) at close proximity with signal ends (SEs). The release of the HP-
CEs from the CEC (right) results in an increase in donor (TAMRA), and a 
reduction in acceptor (ATTO), producing a reduction in FRET efficiency.  
(B) c/cRAG mediated single cleavage reactions in the presence of 
different cations revealed by FRET. The ratio of acceptor to donor (Iacceptor 
/ Idonor) is compared among the cleavage reactions in the presence of Ca2+ 
(blue), which does not support cleavage, Mg2+ (black), which causes 
nicking only, or Mn2+ (red), which allows the uncoupled cleavage. The 
results are presented as an average of three replicates with the standard 
deviation (SD).  
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Figure 4. Comparison of the binding affinity of RAG and RSS in the 
presence of three cations 
(A) Determination of the binding affinity (Kd) between c/cRAG and 12RSS 
in the presence of Ca2+ (left), Mn2+ (middle), and Mg2+ (right). The fraction 
of bound 12RSS (fB) was calculated from fluorescence anisotropy data 
obtained with 5’-labeled TAMRA 12RSS as described in the supplemental 
information. The red lines represent the fit to a model that assumes a 1:2 
binding stoichiometry, from which I obtained the dissociation constant of 
the complex (see supplemental information).  
(B) RAG-RSS interactions analyzed by Electrophoretic Mobility Shift 
Assay (EMSA). c/cRAG was incubated with TAMRA-12RSS at 4 °C or 37 
°C for the time indicated in the figure, in the presence of either Ca2+ or 
Mn2+ or Mg2+. The first lane in each gel shows the intact 12RSS without 
RAG. The arrows point to the bands corresponding to the DNA-protein 
complexes (SC1 and SC2), the free 12RSS probe (RSS) and the hairpin 
(HP). Note the presence of DNA-protein complexes at 37°C after 3 hrs of 
incubation in the presence of Mn2+. 
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Figure 5. Time-course assessment of cleavage reactions with different 
cations by both denaturing gel electrophoresis and FRET analysis. Left: 
Examination of the recombination intermediates, nicked ends and HP-CEs 
by denaturing gel electrophoresis, which are generated by (A) e/cRAG in 
Mn2+, (B) c/cRAG in Mn2+, (C) e/cRAG in Mg2+. * denotes a non-specific 
band. Right: Results of FRET experiments under the same conditions as 
in the Left, showing the emission intensities of TAMRA (red) and ATTO 
(green) as a function of time. (D) FRET signals (Iacceptor / Idonor ) in reactions 
containing the catalytic inactive d/cRAG mutant in Mn2+ (gray line) or the 
gain-of-function e/cRAG in Ca2+ (red line). (E) FRET signals (Iacceptor / Idonor 
) obtained from the cleavage reactions shown in (A-C): e/cRAG in Mn2+ 
(magenta), c/cRAG in Mn2+ (black) and e/cRAG in Mg2+ (blue).  
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Figure 6. The influence of HP-CE release by different cations.  
(A) FRET changes over the course of cation addition. The reaction was 
initiated with e/cRAG in Mg2+ and incubated for 2 hours, after which Mg2+ 
(black), Ca2+ (magenta), or Mn2+ (blue) were added. A mock treatment is 
shown in cyan.  
(B) Denaturing gel electrophroresis analysis of HP-CE production after the 
step-wise addition of different cations. The different bands (from top to 
bottom) represent the intact RSS, hairpin, and nicked DNA. All reactions 
were initiated by e/cRAG in Mg2+ and incubated for 2 hrs, after which the 
different cations described in the figure were added to the reaction. The 
times represent the incubation time after cation addition.  
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Figure 7. FRET profiles of coupled cleavage reactions catalyzed by (A) 
c/cRAG or (B) e/cRAG in the presence of HMGB1 and unlabeled 23RSS 
under Mg2+ (blue) or Mn2+ (red). 
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Figure 8. Confirmation of the initial increase of the ratio, Iacceptor/Idonor, as 
FRET change in coupled reaction 
(A) Change of Iacceptor/Idonor in the reaction mediated by e/cRAG in the 
presence of Ca2+ using TAMRA-ATO RSS. 
(B) The corresponding changes of the emission intensities of TAMRA 
(black) and ATTO (red) observed in the above reaction.  
(C) The fluorescence intensity was monitored for the single labeled 
12RSS, TAMRA-12RSS (green), under the same reaction condition for 
TAMRA-ATTO 12RSS, and was compared to the TAMRA (black in C) 
intensity changes of the dual labeled 12RSS. The emission intensities 
TAMRA-12RSS stay quite constant, in contrast to the changes observed 
in the dual-labeled 12RSS, such as the gradual decrease observed in dual 
probe. 
(D) The fluorescence intensity was monitored for the single labeled 
12RSS, ATTO-12RSS (magenta), under the same reaction condition for 
TAMRA-ATTO 12RSS, and was compared to the ATTO (red in D) 
intensities of the dual labeled 12RSS, respectively. The intensity of single 
ATTO-12RSS also stays quite constant, in contrast to the changes 
observed in the dual-labeled 12RSS.  
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CHAPTER 3 
REGULATION OF V(D)J RECOMBINATION BY RAG 
RECOMBINASE - CHARACTERIZATION OF THE FRAME-SHIFT RAG2 
MUTANT USING FLUORESCENCE-BASED MEASUREMENTS 
Introduction 
PCC (Post-cleavage complex) stability is thought to be directly 
related to the selection of appropriate repair pathway in V(D)J 
recombination, for its ability to properly retain and transfer the RAG-
induced double strand breaks (DSBs) to the repair machinery. (1, 2). 
Various factors have been postulated to alter PCC stability, such as 
mutations in RAG, alteration in RSS heptamer and coding flanks, or 
mutations of DSB sensor or repair proteins, such as Ataxia telangiectasia 
mutated (ATM) and NHEJ factors etc. (3–5). Given the feasibility of using 
fluorescence-based detection techniques to quantify PCC stability 
(detailed in the Chapter 2), I decided to directly investigate a long-standing 
unresolved question on a RAG2 mutant, frame shift core RAG2 mutant 
(hereafter referred to as fsRAG2). 
fsRAG2 is implicated in causing increased end resolution by 
aberrant repair pathways, such as alternative-NHEJ and homologous 
repair (HR) (1, 4). Notably, the aberrant end joining in the presence of 
fsRAG2 happens to both signal ends (SEs) and HP-CEs, which suggests 
that CEC and SEC both may be affected by this mutant. On the other 
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hand, in the NHEJ-deficient background, signal joints are more robustly 
rescued by the alternative-NHEJ than the rescue of coding joints, 100% to 
50%, indicating that fsRAG2 mutant may affect CEC and SEC at different 
levels or with different regulatory systems (1, 4), which seems paradoxical 
to the fact that CEC and SEC actually refers to the same RAG complex 
and only differs in their retained ends, which in theory should handle HP-
CEs and SEs similarly. Nevertheless, the exact molecular mechanism of 
fsRAG2-induced aberrant V(D)J recombination remains undefined, and a 
less stable PCC  associated with fsRAG2 was blamed to be the underlying 
culprit, however, no direct biochemical evidence was reported. Here I took 
advantage of the fluorescence-based system to monitor in real time the 
RAG-mediated cleavage reaction in the presence of fsRAG2. Our highly 
sensitive and non-disruptive system allows us to characterize the 
molecular mechanism of the reaction containing fsRAG2, e.g., through 
direct comparison of fsRAG2 and cRAG2, I can reveal any abnormalities 
associated with this mutant, and I can determine whether or how fsRAG2 
affects the PCC stability. In addition, to entertain the possibility that CEC 
and SEC might be influenced differently by fsRAG2, I sought to investigate 
the stability of both CEC and SEC in the same cleavage reaction 
conditions using the fluorescence-based monitoring system. My analyses 
will shed light on the mechanistic basis of fsRAG2-associated aberrant 
V(D)J recombination. Furthermore, such analysis also provides us with 
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more confidence to examine many other factors that might influence the 
efficiency and fidelity of V(D)J recombination. 
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Materials and Methods 
Protein purification 
Maltose binding protein (MBP) tagged core RAG1 (residues 384-
1008) and core RAG2 (residues 1-387) proteins were co-expressed in 
293T cells using the Plus/Lipofectamine reagent (Invitrogen, Carlsbad, 
CA). Other MBP-fused RAG proteins were also prepared, a gain-of-
function RAG1 mutant E649A (eRAG1, 384-1008) (6), and a frame shift 
RAG2 mutant (fsRAG2) (1), in which the C-terminus 22 amino acids of 
core RAG2 is replaced by another 27 novel amino acids. Four 
combinations of wild type or mutant RAG1 and RAG2 were co-expressed 
in 293T cells, which are listed in Table I, along with the nomenclatures of 
these proteins. The expressed proteins were purified following the 
procedure described by Bergeron et al. (7). The protein concentration was 
measured with the Nanodrop Spectrophotometer (Thermo SCIENTIFIC, 
Wilmington, DE) and verified by SDS-PAGE, in which no bands other than 
RAG1 and RAG2 were visible, as shown in Figure 1. The same amount of 
RAG proteins was used in the binding or cleavage reactions unless 
descried otherwise. 
DNA The sequence of the DNA substrate used in this study are shown 
below: 12RSS Top: 5’-TATCAGCTGATAGCTAACACAGTGCTACAGA-
CTGGAACAAAAACCCTGCT-3’; 12RSS bottom: 5'-AGCAGGGTTTTTG-
T-TC-CAGTCTGTAGCACTGTGTTAGCTATCAGCTGATC-3'; 23RSS top: 
5’-ATCGAAGTACCAGTAGCACAGTGGTAGTACGCGTCTGTCTGGCTG-
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TACAAAAACCATGGATCCT-3’; 23RSS bottom: 5’-AGGATCCATGGTT-
TTTGTACAGCCAGACAGACGCGTACTACCACTGTGCTACTGGTACTT-
CGAT-3’. The 12RSS top strand was labeled with TAMRA, either at 5’-
end, or internally at the 3rd nucleotides (T) 5’ to the heptamer. The 12RSS 
bottom strand used in the FRET experiment was labeled with ATTO647N 
(hereafter referred to as ATTO) at the spacer region, 6th nucleotides (T) 3’ 
to the nonamer. And the 12RSS probe used for signal end complex (SEC) 
study is labeled with TAMRA at 5’end of the bottom strand. The 
fluorescence labeled-DNA nucleotides were obtained from IBA 
BioTAGnology (Göttingen, Germany) and the unlabeled ones from 
Integrated DNA Technologies Inc. (Coralville, IA). 12RSS top strand with 
the internal labeled TAMRA was annealed to the ATTO-labeled bottom 
strand and were purified by native polyacrylamide gel electrophoresis to 
remove any residual single-stranded DNA. The dually labeled 12RSS 
oligonucleotide substrates were examined in the FRET experiments while 
the 5’ end-TAMRA-labeled (both top and bottom) 12RSS substrates were 
analyzed by the fluorescence anisotropy. As controls for analyzing 
fluorescence quenching effect, the singly labeled substrates were 
obtained by annealing the internal labeled TAMRA strand to the unlabeled 
bottom strand or the unlabeled top strand to the ATTO labeled bottom 
strand.  
In vitro cleavage assay 
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The cleavage reaction of the fluorescence-labeled 12RSS (20 nM) 
was catalyzed by RAG proteins (65 nM) in 10 ml reaction containing 10 
mM Tris-HCl [pH 7.5], 50 mM NaCl and 100 µg/µl BSA in Mn2+ (0.2 mM) 
and Mg2+ (2.5 mM). The reaction inactive for cleavage was also included 
as a control, i.e., the same probe incubated in the same reaction buffer, 
except with Ca2+ (2.5 mM) or using the catalysis-defective RAG1 mutant 
(dRAG1) paired with cRAG2. For the coupled cleavage reactions, HMGB1 
protein (30 ng/µl, Sigma-Aldrich) and 23RSS (150 nM) were included. The 
reaction mixture was incubated at 37°C for various times as indicated in 
the figures, and stopped by adding 10 ml denaturing loading dye 
containing 90% formamide for denaturation at 95°C and quick chill on ice 
before being loaded onto a 16% Tris-Borate-EDTA-7 M urea-
polyacrylamide gel. After electrophoresis, the gel was imaged on a 
Typhoon scanner (GE Healthcare) with laser excitation at 532 nm and 
emission filter of 580 nm to detect TAMRA fluorescence or use laser 
excitation at 633 nm and emission filter of 670 nm to detect ATTO 
fluorescence. 
Electrophoretic Mobility Shift Assay (EMSA) 
EMSA was performed to analyze the interactions between RAG 
proteins and RSS. Samples were prepared as described for the in vitro 
cleavage assay. The reaction was stopped by adding 5 µl 100% glycerol 
for every 10 µl reaction, and the sample was immediately loaded onto 4% 
native gel (with 19:1 acrylamide: bisacrylamide). Samples were subjected 
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to electrophoresis at 200 V, 4°C for 2.5 hours. The resulting gel was 
imaged on the Typhoon scanner (GE Healthcare) to detect either TAMRA 
or ATTO fluorescence. 
Fluorescence anisotropy. 
A Photon Technology International QuantaMaster-4/2005SE 
Spectrofluorometer was used for all fluorescence experiments. A 3 mm × 
3 mm quartz micro-cuvette with a 50 ml-sample chamber was used in all 
measurements, and temperature was controlled by a circulating water 
bath and set at 37°C except where noted. The fluorophore-labeled sample 
is excited by a polarized beam light, which allows photo-selection of a 
fraction of fluorophores that are properly oriented relative to the incoming 
light. The anisotropy is defined as〈r〉= (IVV − GIVH)/(IVV+2GIVH), where I 
is the fluorescent intensity, V and H reflects the vertical and horizontal 
orientation by which the emission and excitation polarizer is mounted. The 
factor G is defined as, IHV/IHH, the intensity ratio of the vertical emission to 
horizontal emission when the sample is excited with horizontal polarized 
light. G factor is dependent on the monochromator wavelength and slit 
width and is used to correct for polarization-dependent effects in detection 
sensitivity. The excitation and the emission wavelengths were set at 510 
nm and 580 nm, and data was acquired every 10 seconds. Background 
correction was applied to all the measurements. The anisotropy of the 5’-
TAMRA-labeled 12RSS in the appropriate buffer (with cations indicated in 
the figures) was measured before and after the addition of RAG proteins. 
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The temperature was maintained at 37°C for the duration of the 
experiment (~3 hours). The final concentration of all the components was 
the same as used in the in vitro cleavage reactions. At the end of cleavage 
reactions, SDS was added to liberate DNA from protein association, 
where the anisotropy of free HP-CEs is lower than the free probe or DNA 
with a nick.  
Fluorescence Resonance Energy Transfer (FRET) 
The same instrument and setting are used for FRET experiment as 
those in fluorescence anisotropy measurement. Samples were excited at 
510 nm, except in the control experiments with ATTO-only RSS, where 
the excitation wavelength was set at 600 nm. Sample reactions were 
assembled as described for the in vitro cleavage assay, except that 
sample components were scaled up five-fold so that the final 
concentration of all the components was the same as used in the in vitro 
cleavage reaction. The FRET efficiency of the TAMRA-ATTO-labeled 
12RSS probe was measured before and after adding the purified RAG 
proteins. Emission scans were recorded every 10 min during the first hour 
and then every 20 min for another 2 hours. The ratio Iacceptor /Idonor was 
calculated from the peak intensities of the acceptor and donor, and used 
as a measure of the FRET efficiency. Note that the ratio, Iacceptor /Idonor, 
does not represent the actual FRET efficiency, which should be Iacceptor 
/(Idonor + Iacceptor ), where the FRET efficiency is highly sensitive to donor-
acceptor distance. Because I did not attempt to obtain the distance 
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information between donor-acceptor, rather we focused on the relative 
comparison of the FRET efficiency changes, and thus the ratio Iacceptor 
/Idonor was used instead as a measure of FRET efficiency for its simplicity. 
The experiment involving a temperature ramp was conducted on 
the cleavage reaction initiated by e/cRAG or e/fsRAG in Mg2+ at 37°C for 1 
hour followed by a temperature increase to 55°C over 15 min. The 
emission intensities of TAMRA and ATTO were monitored over the 
temperature-ramp once every 2°C, and then every 20 min over the next 1 
hour.  
Data fitting. 
Kinetic traces of FRET and fluorescence anisotropy experiment 
were fitted using the program embedded in OriginPro8, to either a mono-
exponential decay (Iacceptor /Idonor = Aexp(-t/τ)+A∞), In these equations, t 
represents time, τ represents the dissociation lifetime, and A∞ represents 
the Iacceptor /Idonor ratio where all generated HP-CEs is liberated from the 
RAG complex. Because in some reactions, HP-CEs was not completely 
released by the end of 3 hours acquisition time, meaning the lifetime is 
longer than 3 hours, the parameter A∞ was determined by either adding a 
denaturing agent (0.5% SDS) at the end of the experiment, or by 
increasing the temperature to 55 °C to dissociate all hairpins. Both 
methods yield the same value, which was used as a fixed parameter in the 
fitting procedures.  
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Result 
Comparison of CEC stability between cRAG2 and fsRAG2 
As I discussed in chapter 2, RAG1 E649A mutant (eRAG1) as a 
gain-of-function mutant, allows single cleavage in the presence of Mg2+. 
So I paired eRAG1 with fsRAG2 together (e/fsRAG), and compared the 
HP-CEs retention pattern in single reaction catalyzed by either e/cRAG or 
e/fsRAG in the presence of Mg2+ using FRET technique. As shown in 
Figure 2A, except for the initial drastic drop of the ratio Iacceptor/Idonor (which 
will be discussed in detail in next section), FRET signal decreased at the 
same rate for cRAG2 and fsRAG2, suggesting that the stability of CEC 
formed with a single 12RSS is not significantly affected by the fsRAG2 
mutant. The fsRAG2 does not seem to affect the cleavage activity either, 
as c/cRAG and c/fsRAG display comparable rate and level of HP-CEs 
formation, as shown in Figure 2B. Thus, this finding indicates fsRAG2 and 
cRAG2 display comparable degree of PCC stability.  
To rule out the possibility that the lack of apparent differences 
between fsRAG2 and cRAG2 in our PCC stability analysis might have 
been attributed to the insensitivity of our detection system, I attempted to 
amplify the difference by applying a temperature-challenging release 
assay, which was described by Roth’s group in their attempt to assess the 
SEC stability (3). Specifically, I first incubated the single cleavage reaction 
mediated by either e/cRAG or e/fsRAG at 37°C for one hour, a period of 
time sufficient to generate a significant amount of HP-CEs for subsequent 
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analysis. Then, the temperature was ramped to 55°C over a period of 15 
min, and the reaction was maintained at 55°C for another 2 hours. FRET 
signal was continuously recorded during and after the temperature 
increase. As shown in Figure 2C, the rapid FRET drop upon temperature 
increase reflected the total release of newly generated HP-CEs and it 
happened almost simultaneously and at a similar temperature range for 
both reactions. This finding argues against the scenario of a less stable 
CEC that is formed in the presence of fsRAG2, where the FRET drop 
would happen earlier and at a lower temperature. Notably, there is a slight 
rise in the Iacceptor /Idonor ratio during the temperature increase occurring in 
both RAG-containing reaction as well as in the probe only reaction, 
possibly due to the temperature-induced differential change in the 
quantum yield of TAMRA and ATTO fluorophores. This data further 
substantiates our earlier finding that in the single cleavage reaction, the 
CEC composed of the fsRAG2 displays a similar level of stability as 
compared to the one containing cRAG2.  
To test the influence of fsRAG2 on HP-CEs retention under a more 
physiological condition, coupled reactions mediated by e/cRAG and 
e/fsRAG were also compared (Figure 3A, red and pink). Specifically, in 
coupled reaction containing e/cRAG, the FRET signal initially increases 
due to potential DNA bending (as discussed in chapter 2, Figure 7) and 
then gradually decays due to the release of HP-CEs. The above pattern of 
FRET changes was greatly altered in the presence of e/fsRAG, such that 
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an initial instant FRET drop occurred before the FRET increase caused by 
DNA bending. However, the FRET decay rate at later stage was 
indistinguishable between the two. The similar results were again 
observed when I tested coupled reactions that paired cRAG1 together with 
either cRAG2 or fsRAG2 (Figure 3A, black and blue). Notably, similar to 
c/cRAG, in the presence of the partner 23RSS and HMGB1, c/fsRAG can 
form a synaptic complex onto the labeled 12RSS, revealed by the upper 
shifted bands in EMSA as shown in Figure 3B, which indicates that 
fsRAG2 does not interfere with the synapsis formation. To summarize, 
regardless of the mysterious nature of the initial sharp FRET decrease 
and the content of partner RAG1, reactions containing cRAG2 or fsRAG2 
show similar HP-CEs release rate, indicating that fsRAG2 does not seem 
to destabilize the CEC formed with either single RSS or paired RSSs, 
although both our study and others have shown that the paired-CEC is 
intrinsically more stable than the single-CEC (compare Figure 3A to Figure 
2A) (8).  
Evidence for the unique FRET pattern in RAG-mediated reactions 
containing fsRAG2 mutant 
Although the PCC stability is not affected by fsRAG2, the initial 
rapid FRET drop associated only with fsRAG2 in both single reaction and 
coupled reaction raised great interest. To elucidate the role of fsRAG2 in 
mediating this unique FRET change pattern and to determine whether this 
change is assocated with actual hairpin formation, I replaced Mg2+ with 
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Ca2+ in e/fsRAG mediated single reaction to allow specific binding, or 
tested single reaction catalyzed by c/fs RAG protein together with Mg2+ to 
allow only nicking. In both cases, I observed the initial drastic signal 
reduction (Figure 4), together with the fact that this drop was observed at 
the very beginning of the reaction where no HP-CEs is formed yet, it 
implies that the FRET reduction was not caused by the actual cleavage, 
i.e., not due to HP-CEs formation and the subsequent release from CEC. 
However, the reduction of Iacceptor/Idonor is completely unexpected since the 
distance between donor and acceptor is not supposed to undergo such 
drastic increase upon RAG binding. To ensure that the observed reduction 
is a real change of FRET efficiency, rather than the result of RAG-induced 
differential quenching of the donor or acceptor fluorophores, I measured 
the fluorescence intensity changes of single-labeled probes (TAMRA-
labeled strand paired with an unlabeled strand or ATTO-labeled strand 
paired with an unlabeled strand) in a time-dependent manner under the 
same reaction condition as shown in Fig. 3A, Ca2+ and e/fsRAG. The 
result from single-labeled probe was compared with the intensity profile of 
the corresponding fluorophore in the doubly-labeled probe, as shown in 
Figure 5. The fluorescence intensity of the singly labeled probes displayed 
a rather constant profile over time, and did not exhibit the initial changes 
observed in the doubly-labeled probe (Figure 5). Thus, the reduction of 
ATTO in the doubly-labeled probe was indeed caused by a reduction in 
energy transfer efficiency, which could be either caused by orientation 
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alteration between donor and acceptor upon RAG interaction, or by actual 
distance increase between donor and acceptor. However, the latter 
scenario is less likely since the distance increase reflected by the drastic 
FRET reduction only happens when the two DNA strands that contain 
TAMRA and ATTO are significantly separated (melted), which requires a 
tremendous amount of energy and seems inconceivable to be induced by 
protein binding. Regardless of the actual cause, the FRET change seems 
unique to the presence of fsRAG2. It is known that RAG2 is the regulatory 
subunit of the RAG recombinase and can directly influence the recognition 
and interaction of RAG1 to a RSS thereby increase the specificity of 
RAG1 binding. Therefore, fsRAG2 mutant seems to modulate the RAG1 
and 12RSS interaction in such way that the structure of RAG-RSS 
complex containing fsRAG2 is strikingly different from the one formed by 
cRAG2. Meanwhile, the TAMRA-ATTO labeled 12RSS probe used in our 
study may be highly sensitive to this conformational change, either 
because of the labeling position (especially ATTO labeling at the spacer 
region) or because of the choice of fluorophores (ATTO is a relative large 
molecule and is probably more prone to sense any conformational 
change), or the combination of both. To test these scenarios, I designed a 
different FRET 12RSS probe (hereafter referred to as ATTO-TAMRA-
12RSS), where the choice of donor and acceptor is still the same but the 
labeling position is opposite to the previous one, with ATTO labeled at the 
coding flank 5’ of heptamer and TAMRA at the spacer region, since 
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TAMRA is a relatively small molecule and may not be as sensitive as 
ATTO. When I applied the new probe in reaction containing c/fsRAG and 
Mg2+, except that the FRET signal of free probe is considerably higher 
than the previous one, the initial drastic FRET reduction was again 
observed (Figure 6), which is identical to the previous findings, and further 
substantiate the unique feature of fsRAG2 in conferring this unusual 
structure. This finding indicates that the observed FRET drop is not unique 
to one particular fluorophore, but rather sensitive to the relative position of 
the two fluorophores upon interactions with fsRAG2 containing RAG. This 
finding suggests fsRAG2 may confer a structure of the RAG-pre-cleavage 
complex very different from the one formed by c/cRAG. Also, the labeling 
position, 3rd nucleotide 5’ to heptamer on the top strand and the 6th 
nucleotide 3’ to nonamer on the bottom strand, seems to be sensitive to 
the conformational change caused by fsRAG2, providing additional 
information on the contact site of RAG binding when fsRAG2 is present. 
Regardless of the detailed mechanism of FRET reduction, the unique 
structural change observed in fsRAG2 upon its interaction with RSS is of 
great interest for further investigation.  
Further examination of the unusual RAG-12RSS complex associated 
with fsRAG2 
Our FRET-based real time monitoring system reveals a unique 
structure of the pre-cleavage complex in the presence of fsRAG2. To 
further examine this structure, I applied both EMSA and fluorescence 
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anisotropy to characterize any possible distinct features associated with 
fsRAG2 in terms of the pre-cleavage complex formation and RAG-RSS 
interaction. In EMSA studies, with the same input of various RAG1/RAG2 
combinations (Figure 1), a higher intensity band at the position of SC1 
(Singe Complex 1, one of the complexes formed upon RAG binding to a 
single RSS, which is possibly composed of two RAG1 and one RAG2) 
was observed in reactions containing either e/fsRAG or c/fsRAG. 
Furthermore, a band migrating much slower than the conventional SC2 
(Single Complex 2, which is composed of two RAG1 and two RAG2) also 
appeared when fsRAG2 was present, as shown in Figure 7C. The above 
phenotype was observed similarly in either Mg2+ or Ca2+ containing 
reaction, suggesting that regardless of the metal ion cofactor, fsRAG2 
promotes more RAG-RSS complex formation, which is possibly due to 
stronger binding. In addition, fsRAG also renders the formation of larger 
RAG-RSS complex, which runs much slower than the conventional SC2 
complex and is probably composed of more RAG1 or fsRAG2 protein in 
the complex. Indeed, when I applied fluorescence anisotropy to monitor 
the aforementioned reactions, a significantly higher anisotropy signal was 
observed in e/fsRAG than that in e/cRAG, in the presence of Ca2+, as 
shown in Fig. 7B, in consistent with the EMSA study. Moreover, our 
binding affinity measurement performed by fluorescence anisotropy 
revealed that the binding constant for e/cRAG and e/fsRAG in Ca2+ is 14.7 
± 5.4 nM and 3.9 ± 3.5 nM, respectively. Thus, fsRAG2 paired with cRAG1 
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or eRAG1, can confer a larger and more stable pre-cleavage complex 
when assembled at the 12RSS. It is conceivable that such complex render 
a DNA structure significantly different from the one formed by the RAG-
12RSS containing cRAG2. Notably, the large amount of complex formed 
in the presence of fsRAG2 diminished in the time dependent manner 
(Figure 8), which is possibly due to the HP-CEs formation and subsequent 
release as well as the intact 12RSS release. Taken together, the unique 
pre-cleavage complex induced by fsRAG2 exerts no influence on the CEC 
stability.  
Comparison of SEC stability in the presence or absence of fsRAG2 
Our finding of lack alteration of the CEC stability by fsRAG2 does 
not support the previous speculation, which attributed the increased 
aberrant joining associated with fsRAG2 to its destabilizing action on the 
PCC. However, as we know, PCC is composed of two subunits, CEC and 
SEC, which may not behave in a similar way. Even though the CEC 
stability is not influenced by fsRAG2, the SEC may respond differently. To 
entertain this possibility, I decided to examine the stability of SEC using 
fluorescence anisotropy. The probe for SEC study is a 50 bp 12RSS 
substrate (12RSS-TAMRA-1) that has the identical sequence to the one 
used earlier in assessing HP-CEs retention (TAMRA-12RSS). This 12RSS 
probe, however, is now labeled with TAMRA at 5’ of bottom strand, which 
is five base pairs apart from the nonamer region. Possible scenarios are 
listed in Figure 9 for different outcomes, in which 12RSS-TAMRA-1 is 
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applied in RAG-mediated reactions, the free probe has a relatively low 〈r〉, 
binding to RAG proteins of various combinations will induce an elevated 
〈r〉. After the RAG-mediated production of HP-CEs and blunt-SEs, if SEs 
are stably retained in the RAG-PCC, 〈r〉 remains constant, on the other 
hand, if SEs is gradually released from SEC, 〈r〉 decays.  
I first compared SEs retention in the reactions catalyzed by either 
c/cRAG or c/fsRAG, and found that 〈r〉 presents a faster decay, i.e., 
shorter lifetime, in c/fsRAG than in c/cRAG, τSE-R=680±30 min vs τSE-
R=454±13 min, respectively, despite less SEs generation in c/fsRAG 
mediated reaction, as shown in Figure 10 A and B. Our finding support the 
idea that fsRAG2 renders the formation of a less stable SEC, which may 
account for its aberrant phenotype. Notably, the lifetime generated for SEs 
release is much longer than those generated in HP-CEs retention, 
substantiating the previous finding that the SEC is more stable than CEC.  
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Discussion 
Possible dual abnormalities associated with fsRAG2 
Our finding that fsRAG2 renders a less stable SEC is consistent 
with the previous speculation on this issue. But a compromised SEC 
stability is not the only abnormality related to fsRAG2. I provide strong 
evidence that fsRAG2 also promotes an unique pre-cleavage complex 
assembly featured with higher binding affinity and possible larger RAG-
RSS complexes, which is significantly different from the one formed by its 
non-mutated cRAG2 counterpart. As a matter of fact, the structural 
change of the pre-cleavage complex in the presence of fsRAG2 is so 
evident that it can be readily sensed by our FRET measurement, which is 
a highly powerful and sensitive technique and is capable of detecting such 
structural alteration, while no other assays by far can do so. Furthermore, 
the positions of donor-acceptor labeling on our FRET probe provide 
additional information on the binding surface of cRAG1 to a RSS when 
fsRAG2 is present, which differs from the one displayed by cRAG2. 
Therefore, for the first time, I raised the possibility that in addition to the 
decreased PCC stability, an unusual pre-cleavage complex, might also 
attributes to the aberrant end resolution associated with fsRAG2, which of 
course requires subsequent in-depth examination. Thus, the aberrant 
joining associated with fsRAG2 may be caused by either abnormal pre-
cleavage complex or less stable SEC, which however, are not mutually 
exclusive. Notably, in the presence of fsRAG2, both CEs and SEs are 
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prone to be repaired by aberrant pathways, although the rate of joining 
formation is much lower in CEs than that in SEs. Based on our study that 
no detectable impairment of CEC stability was observed in fsRAG2, so the 
aberrant CEs resolution is probably only caused by the abnormal pre-
cleavage complex. On the other hand, aberrant signal joint formation may 
be induced by both unusual pre-cleavage complex and less stable SEC, 
and the combination of the two induces higher tendency and much severe 
aberrant joining of SEs. The detailed mechanisms under these scenarios 
remain to be defined. However, the evidence of full length RAG1 
interaction with Ku (9) offers additional support for the role of RAG 
complex in collaborating and communicating with the NHEJ DNA repair 
machinery. Although core RAG1 was used in our study, the different 
partner RAG2, cRAG2 vs fsRAG2, may still affect the selection of DNA 
repair pathways, switching between the appropriate classic-NHEJ to the 
error-prone alternative pathways. The dissection of biochemical 
characteristic of fsRAG2 raises the possibility that abnormality associated 
with pre-cleavage complex may also affect the final end joining, and puts 
forward another parameter for future screening of the joining-deficient 
RAG mutant.  Also, it provide us with more confidence of the advantages 
and strength of our fluorescence based system, which paves the way for 
future examinations of any parameters that might affect the efficiency and 
fidelity of V(D)J recombination.  
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Comparison of CEC and SEC stability under the same detection 
system 
Our fluorescence-based measurements, for the first time, allow us 
to compare the stability of SEC and CEC in the same system, with 
accurate kinetic measurement. This opens a new possibility in the study of 
RAG biochemistry and enables detailed elucidation of the mechanism 
underlying the asymmetric nature of PCC in holding HP-CEs versus SEs. 
Three possible scenarios can be deprived based on the parallel 
comparison between SEC and CEC stability, which are listed below: 1) 
CEC and SEC stability is uniformly influenced by certain participating 
factor, e.g. RAG mutations, RSS mutations, metal ion cofactors etc., and 
such factor can simultaneously destabilize or stabilize CEC and SEC, 
which suggests that the RAG recombinase retains CEs and SEs in a 
highly orchestrated manner, despite of their intrinsically different stability 
(10). 2) CEC and SEC stability is differentially affected by a certain factor, 
which suggests that PCC retain CEs and SEs in completely unrelated 
manners. In another word, RAG may hold CEs and SEs with different 
mechanisms and a certain factor can cause the release of one end but 
have no influence on the other end. If this is indeed the case, it will shed 
light on the question why CEs and SEs have such different fate after they 
are generated. 3) How CEC and SEC stability is impacted under certain 
condition, uniformly or differentially, may also be dependent upon the 
individual factor that initiates the change, hypothetically, Mn2+ may induce 
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destabilization of both SEC and CEC, while a RSS mutant may only affect 
CEC stability without any disturbance on SEC stability. This will provide 
additional information on the role of each of these factors in retaining the 
SEC or CEC stability. 
By exploring the feature of fsRAG2-containing reactions using the 
fluorescence based techniques, I demonstrated that fsRAG2 shows no 
influence on CEC stability, rather it causes a less stable SEC, suggesting 
that HP-CEs and SEs are retained in the RAG complex in different 
manners when fsRAG2 is present, which is consistent with scenario 2). 
Whether the different influence on CEC and SEC stability is unique to 
fsRAG2 or it is intrinsic nature of this process is of considerate interest 
and requires more extensive future investigations. However, it is well 
known that, even in the physiological V(D)J recombination, HP-CEs and 
SEs have very different fate after RAG-mediated cleavage. HP-CEs are 
processed and modified extensively before prompt resolution, while the 
precise SEs joining happens after a significant delay (11, 12). Even more 
so, processing and joining of SEs and HP-CEs requires different DNA 
repair proteins (13). In addition, the notion of HP-CEs and SEs are 
handled differently was also implicated in the study of NBS1 (4), which is a 
component of alternative-NHEJ (14, 15). NBS1 was directly involved in the 
aberrant repair of HP-CEs by the alternative-NHEJ, meanwhile, it greatly 
suppressed the alternative-NHEJ mediated repair of SEs (4). Together, 
others and I demonstrate that SEC and CEC have distinct properties and 
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can differentially respond to certain factor, i.e. fsRAG2, NBS1, which 
provides important insights into the mechanistic basis for the different fate 
of HP-CEs and SEs. 
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Table 1. Protein nomenclature 
 
Category Name Protein Description 
RAG1 cRAG1 core RAG1 (384-1008) 
 eRAG1 E649A core RAG1 mutant (384-1008) 
   
RAG2 cRAG2 core RAG2 (1-387) 
 fsRAG2 Frame-shift core RAG2 mutant 
   
RAG1-RAG2 c/cRAG cRAG1/cRAG2 
 e/cRAG eRAG1/cRAG2 
 c/fsRAG  
 e/fsRAG eRAG1/fsRAG2 
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Figure 1. Visualization of various RAG preparations on SDS-PAGE, 
revealed by Coomassie blue staining. (A) Different core RAG 
combinations, including cRAG1, cRAG2, eRAG1, fsRAG2. 
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Figure 2. Unique FRET profiles conferred by the presence of fsRAG2.  
(A) FRET profiles of E-RAG (red) and e/fsRAG (black) in single cleavage 
reactions in the presence of Mg2+.  
(B) The retention of HP-CEs in CEC under different temperatures. e/cRAG 
(red) or e/fsRAG (black) was initially incubated in Mg2+ at 37°C for 1 hour. 
The temperature was then ramped up to 55°C over a period of 15 min, 
and then kept constant at 55°C for 1 hour. A control with 12RSS only 
(blue) was used to rule out possible temperature-dependent changes in 
FRET due to changes in the fluorescence efficiencies of the dyes. 
(C) Comparison between e/cRAG and e/fsRAG on the kinetics of 
recombination cleavage reaction made at the TAMRA-ATTO 12RSS. 
0 5 10 20 30 60 90 120 200 
e/cRAG+Mg2+ 
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OH 
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B
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Figure 3. Comparison of FRET pattern in coupled reactions in the presence 
or absence of fsRAG2 
 (A) FRET profiles of the coupled cleavage reactions initiated by c/cRAG 
(black), e/cRAG (red), c/fsRAG (blue) and e/fsRAG (magenta) in the 
presence of unlabeled 23RSS, HMGB1 and Mg2+.  
(B) EMSA analysis of RAG-12RSS interactions in single reaction or 
coupled reactions. The major shifted bands present in lanes 2 and 4 
(marked with bracket), are at the position higher than the SC1, reflecting 
paired complexes 
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Figure 4. Evidence for a unique FRET pattern associated with fsRAG2.  
(A) FRET profile of RAG-12RSS interactions induced by e/fsRAG in Ca2+. 
(B) Fluorescence anisotropy of TAMRA-12RSS before and after the 
addition of e/cRAG (red) or e/fsRAG. (black). (C) Gel mobility shift assay 
(EMSA) analysis of the TAMRA-12RSS with various RAG combinations in 
the presence of Ca2+ or Mg2+. The various reactions, after being 
assembled at 37°C for 0.5-1 min, were immediately analyzed by EMSA, in 
which only the shifted DNA-protein complexes, but not the free probe, are 
shown here. The arrows point to SC1 and SC2 RAG-RSS complexes, as 
well as some slower mobility complexes denoted by *.  
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Figure 5. Confirmation of the initial decrease of the ratio, Iacceptor/Idonor, as 
FRET change in the presence of fsRAG2 
(A) Emission intensity of TAMRA (black squares) and ATTO (red triangles) 
in the doubly-labeled 12RSS in the presence of e/fsRAG and Ca2+ 
showing an initial rapid decrease in FRET. (B) Fluorescence intensity of 
TAMRA in the doubly-labeled probe (black squares) and singly-labeled 
12RSS (green diamonds) in the presence of e/fsRAG and Ca2+. (C) 
Fluorescence intensity of ATTO in the doubly-labeled probe (red triangles) 
and singly-labeled 12RSS (magenta stars) in the same reaction 
conditions. The fluorescence intensities of TAMRA-12RSS and ATTO-
12RSS were rather constant throughout the incubation, indicating that the 
changes observed with the doubly-labeled RSS samples are due to FRET 
change. 
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Figure 6. Confirm the unique FRET change with a new ATTO-TAMRA-
12RSS probe, in the single reaction mediated by c/fsRAG in the presence 
of Mg2+ 
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Figure 7. Characterization of the unique phenotype associated with 
fsRAG2 
(A) Fluorescence anisotropy of TAMRA-12RSS before and after the 
addition of e/cRAG (red) or e/fsRAG. (black).  
(B) Gel mobility shift assay (EMSA) analysis of the TAMRA-12RSS with 
various RAG combinations in the presence of Ca2+ or Mg2+. The various 
reactions, after being assembled at 37°C for 0.5-1 min, were immediately 
analyzed by EMSA, in which only the shifted DNA-protein complexes, but 
not the free probe, are shown here. The arrows point to SC1 and SC2 
RAG-RSS complexes, as well as some slower mobility complexes 
denoted by *.  
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Figure 8. Time course RAG-RSS interactions analyzed by Electrophoretic 
Mobility Shift Assay (EMSA) , in the presence or absence of fsRAG2. 
c/cRAG or c/fsRAG was incubated with TAMRA-12RSS at 37 °C for the 
time indicated in the figure, in the presence of Mg2+. The arrows point to 
the bands corresponding to the DNA-protein complexes (SC1 and SC2), 
the free 12RSS probe (RSS) and the hairpin (HP).  
Two doses of e/fsRAG,10 µl and 20 µl, were tested and compared to 
e/cRAG, the amount of which is comparable with 10 µl of e/fsRAG. 
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Figure 9. Possible outcomes of SEC stability under various conditions. 
12RSS-TAMRA probe alone displays a lower anisotropy, binding of this 
probe to RAG increases anisotropy. Three conditions will retain a elevated 
〈r〉, i.e. intact 12RSS remain bound to the RAG, nicked-product remain 
bound to the RAG, cleaved SEs retained in SEC. Both intact 12RSS 
release and SEs release will result in a the reduction of 〈r〉. 
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Figure 10. SEC stability in the presence of fsRAG2 or cRAG2. 
(A) Anisotropy analysis of SEs retention in SEC in c/cRAG and c/fsRAG-
catalyzed reactions. The lifetimes of the SEs release are listed. 
(B) Electrophoresis analysis of the SEs generation. 
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CHAPTER 4 
REGULATION OF V(D)J RECOMBINATION BY RAG RECOMBINASE - 
THE IMPORTANCE OF FULL LENGTH RAG2 IN FORMING PRE-
CLEAVAGE AND IN STABILIZING POST-CLEAVAGE COMPLEX 
Introduction 
The RAG-mediated reaction has been recapitulated in the cell-free 
system, where recombinant RAG1 and RAG2 proteins are necessary and 
sufficient to catalyze the site-specific cleavage on the RSS containing 
DNA substrate (1). By far, most biochemical characterizations (including 
our previous studies) have been relying on the core RAG1 and core 
RAG2, the smallest functional truncated RAG mutants, because they are 
more easily purified as soluble and functional forms and their cleavage 
activity is generally more efficient (2). However, non-core regions of RAG 
proteins are indispensible for physiological V(D)J recombination. For 
example, replacing full length RAG2 (flRAG2, see table 1 for 
nomenclature) with core RAG2 (cRAG2), the cRAG2-knock in mice 
displayed severe genome instability and elevated tendency for lymphoid 
neoplasm (3). The underlying mechanism of this abnormality was 
attributed to an significantly increased level of aberrant repair of RAG DSB 
(3). Furthermore, mutations found in non-core region of both RAG1 and 
RAG2 have been implicated in various immune deficiency diseases, e.g. 
Severe Combined Immunodeficiency (SCID) and Omenn Syndrome (OS) 
(2). Because non-core regions of RAG recombinase play such an 
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essential role in physiological V(D)J recombination as well as in 
lymphocyte development, it is of great importance to explore the 
biochemical nature and function of flRAG1 and flRAG2. By far, the error-
prone outcome associated with core RAG has been speculated for their 
severe defect in forming a stable post cleavage complex (PCC), for 
example, compared to the core RAG1 and core RAG2 proteins, the full 
length RAG1 promotes the holding of hairpin coding ends in PCC (4) while 
the full length RAG2 helps retain signal ends in PCC (3). However, these 
studies relied mostly on gel electrophoresis or physical isolation of the 
PCC complex, which were narrowly focused and failed to reveal the real-
time interactions between RAG and intact RSS or the subsequent SEs 
and CEs. 
As detailed in the Chapter 2, I have successfully developed a 
system that monitors the RAG-mediated cleavage reaction in real time, 
which allows us to make quantitative comparisons among various 
parameters that might influence the reaction. As detailed in Chapter 3, the 
characterization of a well-known frame-shift RAG2 mutant (fsRAG2) in our 
real-time monitoring system revealed several unique features associated 
with this mutant, i.e. it promotes the assembly of an abnormal pre-
cleavage complex and the formation of a less stable SEC. However, the 
CEC stability was found indistinguishable between fsRAG2 and cRAG2, 
which may reflect an artifact due to the intrinsic instability of core forms 
RAG2.  
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The importance of RAG non-core regions in physiological V(D)J 
recombination and the concern of erroneous outcome associated with 
core RAG together prompted us to extend our study to full length RAG, 
under a more physiological condition such as in coupled reaction in the 
presence of Mg2+. I first focused on the flRAG2, which is expressed at a 
higher level than flRAG1 and thus is easier to purify. I then compared the 
cleavage activity, binding characteristics to RSS, as well as the CEC and 
SEC stability in coupled reactions containing either cRAG2 or flRAG2 
paired with cRAG1. Notably, during in vivo V(D)J recombination, instead 
of binding to a bare DNA which is frequently used in most in vitro 
biochemical studies, physiological RAG actually targets at the 
chromosome, where the DNA is tightly packaged in conjunction with 
histone proteins. As discussed in Chapter 1, flRAG2 has a plant 
homeodomain (PHD) at its C-terminus non-core region, which is known to 
directly interact with a modified chromatin that has high levels of tri-
methylation at Lysine 4 on histone 3 (H3K4me3). This interaction directs 
the recruitment of RAG2 to the chromosome, and determine the 
chromosome accessibility of in vivo V(D)J recombination (5).  So in order 
to make our study more physiological relevant, I also took into 
consideration a chromatin element. A synthesized H3K4me3 peptide was 
included in the RAG mediated reactions and was tested for its influence 
on the aforementioned parameters, i.e. binding characteristics, cleavage 
activity and the stability of CEC and SEC. Because our fluorescence 
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based monitoring system is highly sensitive, I can detect slight differences 
of RAG-RSS interaction mediated by full length RAG or core RAG in 
various situations. 
Through fluorescence based-biochemistry characterization, I will 
shed light on the essential role of full length RAG in the physiological 
V(D)J recombination and how non-core regions of RAG fine tune the RAG 
activity throughout the reaction. Our study will be a big step forward in 
unveiling the underlying mechanism of physiological V(D)J recombination. 
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Materials and Methods 
Protein purification 
Maltose binding protein (MBP) tagged core RAG1 (residues 384-
1008) and core RAG2 (residues 1-387) proteins were co-expressed in 
293T cells using the Plus/Lipofectamine reagent (Invitrogen, Carlsbad, 
CA). Core RAG1 is also co-expressed with full length RAG2 in 293T cells. 
The expressed proteins were purified following the procedure described 
by Bergeron et al. (6). The protein concentration was measured with the 
Nanodrop Spectrophotometer (Thermo SCIENTIFIC, Wilmington, DE) and 
verified by SDS-PAGE, in which no bands other than RAG1 and RAG2 
were visible, as shown in Figure 1. The same amount of RAG proteins 
was used in the binding or cleavage reactions unless descried otherwise. 
DNA substrates 
The sequence of the DNA substrate used in this study are shown 
below: 12RSS Top: 5’-TATCAGCTGATAGCTAACACAGTGCTACAGA-
CTGGAACAAAAACCCTGCT-3’; 12RSS bottom: 5'-AGCAGGGTTTTTG-
T-TC-CAGTCTGTAGCACTGTGTTAGCTATCAGCTGATC-3'; 23RSS top: 
5’-ATCGAAGTACCAGTAGCACAGTGGTAGTACGCGTCTGTCTGGCTG-
TACAAAAACCATGGATCCT-3’; 23RSS bottom: 5’-AGGATCCATGGTT-
TTTGTACAGCCAGACAGACGCGTACTACCACTGTGCTACTGGTACTT-
CGAT-3’. The 12RSS top strand was labeled with TAMRA at 5’-end and 
paired with unlabeled bottom strand, the purified double strand DNA were 
analyzed by the fluorescence anisotropy. The fluorescence labeled-DNA 
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nucleotides were obtained from IBA BioTAGnology (Göttingen, Germany) 
and the unlabeled ones from Integrated DNA Technologies Inc. (Coralville, 
IA).  
In vitro cleavage assay 
The coupled cleavage reaction of the fluorescence-labeled 12RSS 
(20 nM) was catalyzed by RAG proteins (65 nM) in 10 ml reaction 
containing 10 mM Tris-HCl [pH 7.5], 50 mM NaCl and 100 µg/µl BSA in 
Mn2+ (0.2 mM) and Mg2+ (2.5 mM), HMGB1 protein (30 ng/µl, Sigma-
Aldrich) and 23RSS (150 nM). To enhance the cleavage activity in the 
presence flRAG2, DMSO is supplemented to the reactions with a final 
concentration 5%.  The reaction mixture was incubated at 37°C for various 
times as indicated in the figures, and stopped by adding 10 ml denaturing 
loading dye containing 90% formamide for denaturation at 95°C and quick 
chill on ice before being loaded onto a 16% Tris-Borate-EDTA-7 M urea-
polyacrylamide gel. After electrophoresis, the gel was imaged on a 
Typhoon scanner (GE Healthcare) with laser excitation at 532 nm and 
emission filter of 580 nm to detect TAMRA fluorescence. 
Fluorescence anisotropy. 
A Photon Technology International QuantaMaster-4/2005SE 
Spectrofluorometer was used for all fluorescence experiments. A 3 mm × 
3 mm quartz micro-cuvette with a 50 ml-sample chamber was used in all 
measurements, and temperature was controlled by a circulating water 
bath and set at 37°C except where noted. The fluorophore-labeled sample 
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is excited by a polarized beam light, which allows photo-selection of a 
fraction of fluorophores that are properly oriented relative to the incoming 
light. The anisotropy is defined as〈r〉= (IVV − GIVH)/(IVV+2GIVH), where I 
is the fluorescent intensity, V and H reflects the vertical and horizontal 
orientation by which the emission and excitation polarizer is mounted. The 
factor G is defined as, IHV/IHH, the intensity ratio of the vertical emission to 
horizontal emission when the sample is excited with horizontal polarized 
light. G factor is dependent on the monochromator wavelength and slit 
width and is used to correct for polarization-dependent effects in detection 
sensitivity. The excitation and the emission wavelengths were set at 510 
nm and 580 nm, and data was acquired every 10 seconds. Background 
correction was applied to all the measurements. The anisotropy of the 5’-
TAMRA-labeled 12RSS in the appropriate buffer (with cations indicated in 
the figures) was measured before and after the addition of RAG proteins. 
The temperature was maintained at 37°C for the duration of the 
experiment (~3 hours). The final concentration of all the components was 
the same as used in the in vitro cleavage reactions. At the end of cleavage 
reactions, SDS and proteinase K were added to liberate DNA from protein 
association, where the anisotropy of free HP-CEs is lower than the free 
probe or DNA with a nick.  
Data fitting. 
Kinetic traces of FRET and fluorescence anisotropy experiment 
were fitted using the program embedded in OriginPro8, to a mono-
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exponential decay (Iacceptor /Idonor = Aexp(-t/τ)+A∞), In these equations, t 
represents time, τ represents the dissociation lifetime, and A∞ represents 
the Iacceptor /Idonor ratio where all generated HP-CEs is liberated from the 
RAG complex. Because in some reactions, HP-CEs was not completely 
released by the end of 3 hours acquisition time, meaning the lifetime is 
longer than 3 hours, the parameter A∞ was determined by adding a 
denaturing agent (0.5% SDS and proteinase K) at the end of the 
experiment. Both methods yield the same value, which was used as a 
fixed parameter in the fitting procedures.  
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Result 
Reveal the difference between flRAG2 and cRAG2 mediated reaction 
by anisotropy and FRET experiment  
Based on our previous studies in Chapter 2, that FRET experiment 
and anisotropy experiment measure the same kinetics of HP-CEs 
retention. Since SEs retention can only be monitored via anisotropy 
experiment, I then sought to record both CEC and SEC stability using 
fluorescence anisotropy. First, I performed a time-course in vitro cleavage 
reaction in c/cRAG or c/flRAG mediated coupled reactions in the presence 
of Mg2+. As shown in the left panel of Figure 2, the hairpin generation 
kinetics of the two reactions are similar, with the lifetime τHP-R  = 60 min. 
However, the overall activity was slightly higher in c/cRAG-induced 
cleavage than that of c/flRAG, because c/cRAG generates more HP-CEs 
after 3 hours incubation (Left panel of Figure 2A, B). The comparison of 
the cleavage activity between c/cRAG and c/flRAG has long been studied 
and the results were somewhat inconsistent, probably due to the use of 
different RAG constructs as well as the different purification procedure, 
and most importantly, due to the variations in the experimental condition of 
cleavage reactions, such as salt concentration, with or without BSA, with 
or without DMSO, etc (7, 8). So it is relatively difficult to make a cross 
comparison among all these studies. However, in our study, as long as the 
condition in in vitro cleavage reaction is consistent with the subsequent 
anisotropy measurements, I can normalize the difference of hairpin 
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generation when I determine the HP-CEs release rate, which is additional 
strength of my system. I then examined the HP-CEs association within 
CEC in coupled reaction by fluorescence anisotropy. To minimize any 
variations from different experiments, the changes in anisotropy during the 
cleavage reaction were expressed as Δ 〈r〉, which is defined by subtracting 
free probe 〈r〉 from the 〈r〉 upon RAG addition over the course of cleavage 
reaction. In this case, RAG binding to intact 12RSS can cause an increase 
in Δ 〈r〉 over the free probe, and thus Δ 〈r〉 after RAG binding is higher than 
0.  On the other hand, the generation and subsequent release of HP-CEs 
from CEC results in a decrease of Δ 〈r〉, and the complete release of all 
HP-CEs by SDS/proteinase K treatment in the end of the incubation is 
supposed to generate a negative Δ 〈r〉 over the control, because the size 
of HP-CEs are smaller than the non-cleaved or nicked 12RSS substrates, 
and thus the 〈r〉 is smaller. The changes of Δ 〈r〉 over the reaction course 
was fitted into a mono-exponential decay and the Δ 〈r〉 of free HP-CEs 
after SDS/ProK treatment was used as an “offset” (the critical points 
value) to calculate the τHP-R. As shown in the right panel of Figure 2, upon 
RAG addition, the initial Δ 〈r〉 in c/flRAG mediated reactions is significantly 
lower than the Δ 〈r〉 observed in the c/cRAG reactions, indicating c/flRAG 
confers a lower binding affinity to the RSS than that of c/cRAG. Our 
observation is consistent with the previous EMSA data, which shows that 
the combination of cRAG1 and flRAG2 resulted in a lower level of paired 
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complexes, and the underlying mechanism has been attributed to the 
RAG2 C-terminus mediated destabilizing of RAG-RSS interaction 
(especially with the coding flank) (9). Regardless of the different initial 
binding affinities, the decay of Δ 〈r〉 in c/flRAG is faster than that in 
c/cRAG, suggesting that the CEC containing flRAG2 is less stable and 
HP-CEs is more readily released from CEC than the reaction containing 
cRAG2. On one hand, the less stable CEC in the presence of flRAG2 
seems to match to the lower binding affinity under the same condition. 
This hypothesis, however, assumes that the interaction between RAG and 
RSS in the pre-cleavage complex is similar with the interaction of RAG 
and HP-CEs in the CEC. On the other hand, the finding that flRAG2 
confers a less stable CEC is in stark contrast with the previous SEC 
studies (3), which will be discussed in detail in the next section.  
The difference in CEC stability between c/cRAG and c/flRAG 
containing reaction will be verified in the FRET experiment under the 
same conditions. 
I then extended our study to a more physiological condition by 
including a chromatin element, H3K4me3 peptide. H3K4Me3 has been 
reported to promote RAG-mediated RSS cleavage at both nicking and 
hairpinning steps (8), and  it can also greatly increase the formation of 
RAG-RSS pre-cleavage complex (8, 9). Remarkably, the stimulation can 
be achieved both in cis (tethered to RSS or reconstitute a chromatin on 
RSS substrate) and in trans (free H3K4me3 peptide). However, the effect 
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of H3K4me3 on CEC stability has not been addressed. I reasoned that our 
system offers an excellent approach to examine the role of H3K4me3 
through out the RAG-mediated reaction in the presence or absence of 
flRAG2. Indeed, when H3K4Me3 peptide was present in the reaction 
catalyzed by c/flRAG on fluorophore-labeled RSS substrates, but not 
c/cRAG (Figure 2B and 2C, Figure 3B), I found a significant increase in 
the initial fluorescence anisotropy with an overall longer lifetime 
(compared τHP-R=255±5 min to τHP-R=198±8 min), as shown in Figure 2 
and Figure 3, which reflects the protein association at the probe. This 
finding clearly indicates that the PHD-binding H3K4Me3 can significantly 
enhance the HP-CE retention by the flRAG2-containing CEC-PR. Also in 
line with the previous reports (53, 54), the formation of more c/flRAG-
12RSS complexes was induced by H4K4me3 peptide as well, since an 
enhancement in the initial anisotropy was found upon addition of c/flRAG 
to the reaction containing the peptide (Figure 2C). Thus, I provide the 
direct evidence that the H3K4me3 peptide can stabilize both pre-cleavage 
and post-cleavage RAG complexes. The kinetics of HP-CEs production 
and release is summarized in Table 1. 
Comparison of the stability of SEC in the presence of cRAG2 and 
flRAG2 
I then sought to determine SEC stability in c/cRAG or c/flRAG 
mediated reactions. The 12RSS-TAMRA (probe for the SEC study) was 
incubated in coupled reactions catalyzed by either c/cRAG or c/flRAG, and 
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monitored by fluorescence anisotropy. Δ 〈r〉 was again used to reflect the 
RAG-12RSS interaction at the beginning of the reaction, and the changes 
of RAG-SEs/12RSS interaction during the reaction process. Consistent 
with our previous finding using TAMRA-12RSS (probe for the CEC study), 
c/flRAG mediated reaction again displays a lower Δ 〈r〉, which further 
proves that c/flRAG binds to RSS with a less affinity than that of c/cRAG. 
Despite the initial lower binding, Δ 〈r〉 remains barely unchanged over the 
reaction course in the presence of flRAG2, which is significantly different 
from the pattern observed in c/cRAG, where an initial higher Δ 〈r〉 rapidly 
decays, as shown in Figure 4A. Consistent with the previous finding, 
c/flRAG generate slightly less SEs compared to c/cRAG (Figure 4B). The 
decay of Δ 〈r〉 indicates the release of SEs from SEC in the presence of 
cRAG2, while a constant Δ 〈r〉 in flRAG2 represents a relatively stable 
SEC. Our finding using a more sensitive detection system substantiates 
the finding by the Roth’s group, that SEC composed of flRAG2 is more 
stable then the one with cRAG2, The kinetic of SE release is summarized 
in Table 1. 
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Discussion 
A more stable SEC in the presence of flRAG2 
Using the fluorescence anisotropy, I found that as compared to the 
cRAG2, the flRAG2 confers a somewhat unstable CEC, but a rather stable 
SEC. Although seemingly contradictory, this finding again highlights the 
asymmetric feature of the RAG in dealing with coding ends versus signal 
ends. This feature was also evident in our analysis of fsRAG2, as 
described in Chapter 2, where fsRAG2 exert no influence on CEC stability 
but renders a less stable SEC. Notably, unlike the flRAG2, both cRAG2 
and fsRAG2 are considered as mutant forms of RAG2, and these two 
mutants seem to share similar influence on the SEC stability, by conferring 
poor retention of SEs in SEC. Our findings substantiate the importance of 
non-core region of RAG2 in maintaining the SEC stability. Furthermore, I 
also provide the first parallel comparison of the two forms of RAG2 
mutants, cRAG2 and fsRAG2, in their influences on both CEC and SEC. 
The demonstration of less stable SECs of these RAG2 mutants provide 
mechanistic explanation of their abnormal phenotypes observed in vivo, 
such as elevated aberrant rearrangement (cRAG2 and fsRAG2), 
compromised genomic stability and high propensity for lymphoid 
neoplasm (cRAG2) in mice carrying these RAG2 mutants (3, 10, 11).   
Less stable CEC in the presence of RAG2? 
The appropriate time window and strength of HP-CE association 
with the CEC may be a key for optimal resolution of newly generated HP-
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CEs, although the structural basis of this association and its functional 
connection to ultimate end resolution pathways remains to be defined. I 
demonstrated that the flRAG2 causes faster HP-CEs release than that of 
the cRAG2, reflecting the weak binding between HP-CEs and CEC in the 
presence of the flRAG2. This finding draws a contrast with the SEC 
comparison and is also contradictory with the general idea that flRAG2 
should function to stabilize post-cleavage complex, as compared to 
cRAG2.  
Notably, the physiological target for RAG2 recognition is the 
modified chromatin DNA that has high level of tri-methylation on H3K4, 
and the binding is through the C-terminal PHD domain of flRAG2 (7, 8). 
The cross talk between the RAG2-PHD domain with a epigenetic signal at 
chromosomal loci ensures the correct targeting of RAG2, i.e., according to 
the presence of appropriate chromosomal modifications. Furthermore, it 
was suggested that the PHD-dependent inhibition of RAG-mediated 
cleavage is a check-point to minimize the illegitimate RAG activity (9). On 
the other hand, most in vitro RAG-mediated cleavage reaction has been 
relying on the RSS substrate without a chromatin component, including 
ours. Thus, the use of bare DNA substrate in the reactions containing 
flRAG2 fail to establish the correct interaction with the PHD domain and 
therefore may not reflect the genuine influence or function of flRAG2 in 
these reactions. If this were indeed the case, we should not be surprised 
by our demonstration of a labile CEC conferred by flRAG2. In another 
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word, without an appropriate form of target DNA, the c/flRAG displays no 
advantage over c/cRAG in preserving the CEC stability. Moreover, a 
further reduced CEC stability in the flRAG2 compared to the cRAG2, 
might reflect an abnormal in vitro artifact of RAG-RSS when the PHD 
domain fails to target the appropriate partner, H3K4me3. Therefore, it is 
important to take into consideration the chromatin component when we 
characterize the role of flRAG2 in their interaction with recombination 
substrates or recombination ends. 
 Indeed, the addition of H3K4me3 peptide into c/flRAG mediated 
reactions significantly increases the binding affinity between RAG and 
RSS, and more importantly, induces a better HP-CEs retention in CEC. 
Although flRAG2 seems to render a less stable CEC in vitro, we would still 
expect it to develop a very stable CEC in the physiological conditions, 
when it is surrounded by H3K4me3 and is able to exerts more stringent 
regulation over the RAG-mediated cleavage reaction as well as the 
subsequent end joining, through the interaction with chromatin. Therefore, 
a stable CEC and a stable SEC are both essential in vivo for the transfer 
of the ends to an appropriate repair pathway, which ultimately ensure the 
efficiency and fidelity of V(D)J recombination and also minimize the 
genome instability.  
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Table 1. Protein nomenclature 
 
Category Name Protein Description 
RAG1 cRAG1 core RAG1 (384-1008) 
   
RAG2 cRAG2 core RAG2 (1-387) 
 flRAG2 full length RAG2 (1-528) 
   
RAG1-RAG2 c/cRAG cRAG1/cRAG2 
 c/flRAG eRAG1/cRAG2 
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Table 2 Kinetics of the production and release of HP-CEs 
Labeled ends RAG Cation τHP-pa (min) τHP-Rb (min) 
 c/cRAG Mg2+ 60 ± 4 231 ± 5 
HP-CEsc  c/flRAG Mg2+ 62 ± 3 198 ± 8 
 c/flRAG+peptide Mg2+ 52 ± 4 255 ± 5 
     
SEsd c/cRAG Mg2+ 60 ± 4 680 ± 30 
 c/flRAG Mg2+ 62 ± 3 454 ± 13 
 
a: Lifetime of HP-CE production determined by electrophoresis. The 
number given was calculated from the kinetic analysis of HP-CE 
production, as exemplified in Figure 2. 
b: Lifetime obtained from anisotropy, a measure of the rate of HP-CE 
release, as shown in Figure 2 and 4. 
c: Determine the HP-CEs production and release rate, TAMRA is labeled 
at the coding flanks. 
d: Determine the SEs production and release rate, TAMRA is labeled at 
the signal ends.  
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Figure 1. Visualization of RAG proteins on SDS-PAGE, revealed by 
coomassie blue staining, shown here is cRAG1 paired with either cRAG2 
or flRAG2. 
 
 
 
 
 
!"#$%&
'"#$(&
!"#$(&
!)!
"#
$&
!)'
"#
$&
*&
(+,&-.&
%+,&-.&
%,,&-.&
/+&-.&
+,&-.&
  160 
 
 
  
  161 
Figure 2. 
Assessment of HP-CE production and association with CEC-PR 
composed of c/c RAG or c/flRAG in the coupled cleavage reactions with 
Mg2+ and HMGB1.   
(A) Cleavage reactions catalyzed by c/cRAG; (B) Cleavage reactions 
catalyzed by c/flRAG; and (C) Coupled reaction mediated by c/flRAG in 
the presence of H3K4me4. Left panel: time-course analysis of cleavage 
intermediates, including nicked and hairpin products, revealed by 
denaturing gel electrophoresis. Right panel: real-time monitoring of 
cleavage reactions by fluorescence anisotropy. Results of anisotropy are 
displayed as changes of Δ〈r〉over a function of time.  Δ〈r〉is obtained 
by subtracting the〈r〉of free probe (A, B) or free probe plus peptide (C) 
from the〈r〉upon RAG and HMGB1 addition. After monitoring 
fluorescence anisotropy for 3 hours, SDS/ProK was added into the 
reaction mixture to disrupt the protein-DNA complex and liberate the DNA.  
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Figure 3. The effect of H3K4me3 on c/cRAG mediated reaction. 
(A) In vitro cleavage reactions mediated by c/fl RAG or c/cRAG, in the 
absence (lanes 1 and 3 ) or presence of partner 23RSS and HMGB1 
(lanes 2 and 4). 
(B) Effect of H3K4me3 peptide on c/cRAG-mediated coupled cleavage 
reaction, analyzed by fluorescence anisotropy. Left, w/o H3K4me3 
peptide. Right, with H3K4me3 peptide. The lifetime τHP-R is indicated in 
each graph. 
A 
B 
c/cRAG 
 
23RSS+HMG            -             +            -            +             
 
Hairpin 
 
Nicked 
 
12RSS 
 
c/flRAG 
 
1            2             3             4 
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Figure 4. Comparison of SEC stability in reactions catalyzed by either 
c/flRAG or c/cRAG, revealing the role of flRAG2 in retaining the SEs. 
(A) SEs retention in SEC analyzed by fluorescence anisotropy. 
(B) In vitro cleavage reaction mediated by c/flRAG and c/cRAG, revealed 
by electrophoresis. 
!"
#"
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CHAPTER 5 
DIRECT REGULATIONS OF PROTEIN LEVEL BETWEEN RAG1 AND 
RAG2  
Introduction 
RAG can generate double strand breaks during the rearrangement 
of immunoglobulin and T cell receptor gene, which is a essential process 
during V(D)J recombination and normal lymphocyte development. RAG1 
or RAG2-deficient mice completely lack mature T and B cells, blocking the 
lymphocyte development at very early stage (1, 2)  However, in addition to 
initiating site-specific excision at antigen receptor gene loci, RAG has also 
been shown to cause DSB at other sites by recognizing illegitimate cryptic 
RSS or certain DNA structure (3–5). The effect of the abnormal and 
excessive RAG activity is detrimental to genome integrity and to an animal 
as a whole, which includes susceptibility to recombination-induced 
translocation, and increased propensity of lymphoid malignancy, as well 
as growth retardation and early death of an animal (6). Considering the 
possible deleterious effect associated with the RAG recombinase, The 
RAG recombinase has to be stringently controlled both temporally and 
spatially throughout the lymphopoiesis as well as the cell cycle.  
The regulatory mechanisms on RAG expression are reviewed in 
Chapter1. Briefly, RAG expression is generally restricted to T and B cells 
and the transcription of RAG mRNA occurs in two waves. Many regulatory 
factors have been identified to regulate the level of RAG mRNA along 
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lymphocyte development (7, 8). In addition, RAG2 can also be regulated 
at the post-translational level in a cell cycle dependent manner.  
Phosphorylation by CyclineA/cdk2 at T490 residue leads to the 
subsequent proteasome-mediated degradation through an Skp2/SCF 
poly-ubiquitinination pathway. The cell cycle-dependent destruction of 
RAG2 couples V(D)J recombination to the cell cycle control and to the 
selection of appropriate DNA repair pathways, which ensures the high 
efficiency and high fidelity of recombination events (9–11).  
Notably, RAG1 has a RING domain in its amino terminal non-core 
region and thus is a potential E3 ligase (12). In vitro assays showed that 
the target of RAG1 E3 ligase includes RAG1 itself, RAG2, KPNA, Histone 
3, etc (12–15). However, the in vivo pathway and substrates associated 
with RAG1 E3 ligase remain largely elusive. Considering the close 
relationship between RAG1 and RAG2 in V(D)J recombination (16, 17), it 
is conceivable to suspect that RAG2 might be modified and regulated by 
RAG1. To this end, previous work in our lab tried to manipulate the 
expression of both RAG1 and RAG2 in order to detect any regulations 
between the two proteins. A pre-B cell line with dual regulatory 
mechanisms of RAG1 vs RAG2 was developed, where RAG1 is regulated 
through a tetracycline-inducible system and RAG2 is under the control of a 
temperature sensitive system. More specifically, a pre-B cell lines 
transformed with temperature-sensitive Abelson-leukemia virus (ts-Abl), 
designated as ts-Abl-pre-B cells, was used to modulate the RAG2 
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expression through temperature manipulation (18, 19). In a non-inducible 
condition, the ts-Abl-pre-B cells were maintained at 33°C, upon 
temperature increase to 39°C, v-Abl is inactivated, which leads to cell 
cycle arrest, up-regulation of endogenous RAG1 and RAG2 and the onset 
of recombination at the immunoglobulin light chain loci (18). Notably, the 
RAG2 protein could be readily detected upon v-abl inactivation, but the 
endogenous RAG1 protein were barely found, despite its apparent activity 
on light chain rearrangement (20), which may be attributed to the 
extremely low levels or labile nature of RAG1. However, the concurrent 
regulation of RAG1 and RAG2 through v-Abl inactivation/reactivation 
makes it impossible to study the influence of RAG1 or RAG2 exerting on 
each other. So a separate system for regulation of RAG1 expression, a 
tetracycline-inducible system was introduced into the aforementioned ts-
Abl-pre-B cells, where expression of the EGFP-RAG1 fusion gene and the 
transcription activator tTA gene are under the control of a tetracycline 
responsive/regulatory element (TRE), see Figure 1 for details. Removal of 
tetracycline (-Tet) from the culture medium results in the binding of tTA 
protein to the TRE, leading to a transcriptional up-regulation of tTA itself 
and EGFP-RAG1 expression in the transfected cells (21, 22). Thus, 
through temperature sensitive- and tetracycline-inducible system, RAG1 
and RAG2 can be regulated independent of each other, which made it 
possible to reveal any cross-regulation between RAG1 and RAG2, as any 
influence on each other would disrupt their individual expression pattern 
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following their own inducible system. With the help of this elegant system, 
it was found that RAG2 level is significantly reduced upon EGFP-RAG1 
induction (Figure 2), and the suppression occurs in the post-transcriptional 
manner, possibly by promoting RAG2 degradation. Indeed, direct 
comparison of the half-life of RAG2 with or without RAG1 revealed that 
induced RAG1 facilitate the degradation of endogenous RAG2. The 
biochemical pathway responsible for the down-regulation of RAG2 by 
RAG1 was not determined, but a proteasome inhibitor, epoxomicin, was 
shown to block the RAG2 reduction in the dose-dependent manner, 
raising the possibility that RAG2 is tagged for degradation by RAG1 E3 
ligase through a proteasome mediated pathway. Interestingly, other than 
epoxomicin, other proteasome inhibitors tested such as MG-132 and 
clasto-lactacystin-β-lactone show no prevention of RAG2 reduction, 
suggesting the presence of other possible pathways.  
Regardless of the exact mechanism, RAG1 seems to directly 
modulate the RAG2 expression level in a pre-B cell background. To 
further dissect whether this phenotype is unique to lymphocytes or it is a 
another regulatory property intrinsic to RAG1 and RAG2, I decided to 
extend this study to a completely different system, where various forms 
RAG1 and RAG2 were transiently transfected into a non-lymphocyte cell 
lines, and their expression level were monitored. 
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Material and methods 
Transient transfection of RAG1 and RAG2 constructs into 293T cell line 
293T cells were transiently transfected with various combinations of 
RAG1 and RAG2, i.e., flRAG1 only, flRAG2 only, fRAG1+ fRAG2, fRAG1+ 
cRAG2, cRAG1+ fRAG2 or cRAG1+cRAG2, where 1:1 ratio of RAG1 to 
RAG2 plasmids was used. Given the extremely low level of fRAG proteins 
in the transfected cells, I also adjusted the plasmid ratio in some 
experiments. In particular, the ratio of fRAG1 to cRAG2 and fRAG2 to 
cRAG1 was made at 4 while fRAG1 to fRAG2 was at 4:4, as compared to 
the amount of crag constructs. Forty-eight hours later, cells were 
harvested, counted and lysed in SDS-PAGE loading buffer at defined 
number of cells per microliter of the buffer. 
Serum deprivation experiment conducted in NIH 3T3 cell line  
Three forms of RAG2, i.e. cRAG2, fRAG2 and TRAG2 were 
tranfected into NIH3T3 cells, either by themselves or co-transfected with 
cRAG1 or fRAG1 plasmids. 1 ug of cRAG1 or cRAG2 were used for each 
transfection, while 4 ug of fRAG1, fRAG2 or TRAG2 plasmid were used 
due to the extremely low level of fRAG, especially fRAG1. 12 hours after 
transfection, cells were subjected to serum deprivation for 48 hours by 
incubating in DMEM medium containing 0.5% serum. Same transfections 
were also conducted in the serum-rich condition, where the cells were 
maintained in DMEM medium with 10% serum after transfection.  
Westernblot 
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Cells were collected and directly boiled at 95°C in 1xSDS-PAGE 
loading buffer (loaded with an equal cell number per lane for the 
transiently transfected 293T cells) were separated on 10% SDS-PAGE 
and then blotted onto nitrocellular membranes (Millipore Inc.). The 
membranes were incubated with primary antibodies specific to MBP 
(Neomarkers), RAG1 (Cell signaling), or tubulin (Santa Cruz) overnight at 
4°C. The proteins recognized by the primary antibodies were revealed by 
HRP-conjugated secondary anti-Rabbit, anti-Rabbit or anti-Mouse (Sigma) 
antibodies followed by chemiluminesence detection (Pierce). 
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Result 
Reduction of full length RAG2 by full-length RAG1 in 293T cells 
I first examined the level of RAG proteins in 293T cells that were 
transiently transfected with various combination of core and full-length 
RAG1 and RAG2 constructs that contain the MBP tag, as detailed in 
Material & Methods. As shown in Figure 3A, the co-transfection with 
cRAG1 and cRAG2 constructs results in the highest level of both cRAG1 
and cRAG2 proteins among all the various combinations. However, the 
co-transfection of fRAG1 with fRAG2 yielded almost undetectable levels of 
RAG proteins. Interestingly, when fRAG1 paired with cRAG2 or cRAG1 
with fRAG2, these full-length RAG proteins could be readily detectable, 
which is consistent with the previous notion that co-transfection with core 
RAG can increase the stability of the partner RAG protein. To make more 
quantitative comparison, I increased fRAG constructs at the ratio four 
times of cRAG plasmids, and compared to the level in the cells transfected 
with single fRAG1 or fRAG2 constructs (also four times of the cRAG) as 
input controls. Again, the presence of cRAG1 and cRAG2 was found to 
increase the level of fRAG2 and fRAG1 proteins, respectively, as 
compared to the single transfection (Figure 3B, comparing lane 2 and 3 to 
5 and 6). However, the co-transfection of fRAG1 and fRAG2 resulted in a 
a very low level of RAG1 or essentially undetectable RAG2, both of which 
were significantly reduced in comparison to the single transfection (Figure 
3B, lane 4 to lane 5 and 6). This finding indicates that the presence of 
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fRAG1 can cause great reduction in fRAG2 while the fRAG2 can also 
result in some diminishment of fRAG1. Thus, N-terminal RAG1 and 
possibly C-terminal region of RAG2 and is important for their mutual 
down-regulation, which seems to occur beyond developing lymphocytes.  
Cell-cycle independent regulation of fRAG2 by fRAG1 
Given the well-known cell-cycle dependent RAG2 degradation, I 
asked the question whether this down-regulation of fRAG2 by fRAG1 is 
mediated through a cell cycle-dependent manner. Toward this end, we 
tested the RAG expression level in cells arrested at G1-phase. 
Specifically, various RAG combinations were transfected into NIH3T3 cell 
lines, which is known to be responsive to the serum-deprivation to 
undergo G1-phase arrest. Twelve hours after transfection, cells were 
maintained in serum-free (0.5%) medium to induce cell cycle arrest at the 
G1 phase. Meanwhile, a T490A RAG2 mutant is also included in the 
comparison because it was shown to be resistant to the cell cycle-
mediated RAG2 degradation (9). As a control, the same sets of 
transfection were performed without the serum deprivation step. Again, to 
balance the level of core RAG and full length RAG, the a 1:4 ratio of core 
RAG to full length RAG DNA transfection was applied in both serum rich 
and serum deprived reactions in the co-transfection, as well as in the 
single transfection controls, i.e., the amount of DNA for full length RAG is 
4 times of core RAG DNA. As shown in Figure 4, flRAG1-mediated 
reduction of flRAG2 was observed in both serum-containing and serum-
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deprived cells (see lane 4-7 in both Fig. 5A & B), indicating the cell-cycle 
independence of the flRAG1-mediated regulation. Again, consistent with 
the finding in Figure 3B, no such reduction was seen in cRAG2 (Figure 4 
lanes 1-3). Interestingly, for the T490A full-length RAG2 mutant, both 
cRAG1 and flRAG1 resulted in a comparable level of reduction in flRAG2, 
indicating an absence of flRAG1-specific effect in reducing this RAG2 
mutant (Figure 4, lane 7-9, 14-15). Taken together, our data suggest that 
the flRAG1-induced reduction of flRAG2 is mediated through the non-core 
region of RAG2, independent of cell cycle progression, but possibly 
dependent on the T490 phosphorylation of the flRAG2.  
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Discussion 
The RAG1/2 proteins are known to play a pivotal role in the 
formation of the adaptive immune system. Impaired control of their 
expression results in abnormal lymphocyte development and/or 
immunodeficiency. Several levels of RAG1/2 regulation have been 
identified during lymphocyte development, such as a stage-dependent 
transcriptional regulation of RAG1/2 genes and a cell-cycle dependent 
degradation of RAG2 proteins. 
RAG2 protein is a very abundant protein inside the nucleus, and its 
expression fluctuates much more drastically than the RAG1 expression 
during different stages of B-cell and T-cell development (20, 23). 
Moreover, RAG2 displays genome-wide binding, which is directed to the 
H3K4me3-enriched chromatin, but independent of the RSS recognition or 
the antigen receptor gene loci (24). Together, the excessive RAG2 protein 
level and its broad binding mode, build a well-designed prerequisite 
platform to allow prompt onset of rearrangement once RAG1 is on board. 
Thus, when RAG1 enters a RAG2 binding site in the RSS site specific 
manner, the V(D)J recombination may occur. Although this strategy is 
advantageous for the generation of a diverse antigen receptor repertoire, it 
may also increase the chance of illegitimate cleavage at non-RSS loci 
mediated by RAG1, which can compromise of the genome stability. 
Therefore, the level of the RAG2 that is in an association with RAG1 must 
be stringently controlled at all times. It is well known that RAG2 is 
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subjected to a cell cycle-dependent degradation via a polyubiquitin-26S 
proteasome pathway (11). However, this type of degradation requires the 
export of RAG2 from the nucleus into cytoplasm. Indeed, it was shown 
that the phosphorylation of Thr490 leads to the translocation of RAG2 
from nucleus into cytoplasm and the disruption of this phosphorylation by 
T490A mutation stabilizes the RAG2 pool in the nucleus, which prevents 
the cell-cycle dependent RAG2 diminishment (25). This regulation 
mechanism seems to only subject to the free form of RAG2 for targeted 
degradation as RAG1 shows no cell-cycle dependent oscillation. Thus, 
this cell-cycle dependent degradation pathway may precludes it from 
acting on the active RAG1/2 recombinase. On the other hand, RAG1/2 
recombinase actually poses more danger to the genome than the RAG2 
alone. To keep this danger to the minimal level, there may be another 
level of control, which results an immediate on-site shut-down of the 
recombinase activity. The RAG1-mediated degradation of RAG2, revealed 
in this study, may fit perfectly to this mission. 
Our in vitro transient transfection system demonstrate that RAG2 is 
indeed down-regulated by RAG1, and this regulation requires the 
presence of non-core region of both RAG1 and RAG2, and is independent 
of cell cycle. This finding substantiates our earlier in vivo finding by using a 
dual-inducible RAG1/2 system. Taken together, I provided strong 
evidence for a novel mechanism to regulate the RAG2 level, besides the 
previously identified regulation mechanisms, i.e., developmental stage 
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dependent transcriptional regulation and cell-cycle dependent 
degradation. This new regulation has been shown at the post-translational 
level of the endogenous RAG2, which, however, needs to be verified in 
the transient transfection system. 
  The direct down-regulation of RAG2 by RAG1 naturally prompted 
us to consider the possibility of RAG1 functioning as an E3 ligase. RAG1 
may either acts alone as E3 ligase as postulated by several groups (13–
15), or recruit other E3-ligase, as discussed in the recent study by 
Swanson’s group. In this study, the authors demonstrate that full length 
RAG1 interacts with VprBP directly, and the latter is known to be a 
component of multi-subunit cullin RING E3 ligase, 
VprBP/DDB1/Cul4A/Roc1 (VDCR) (26, 27). Furthermore, they found that 
the non-core region of full-length RAG1 could enhance the activity of 
VDCR in an in vitro ubiquitinylation assay. Based on these findings, this 
group concludes that through VprBP, RAG1 may recruit cullin RING E3 
ligase to the recombination machinery for ubiquitination and subsequent 
degradation, although the endogenous substrate of RAG1-VDCR complex 
mediated ubiquitintion has not been identified. Our finding that RAG2 is 
down-regulated only by full length RAG1 but not core RAG1 is in line with 
this scenario, highlighting the essential role of the non-core region of the 
full length RAG1 in regulating RAG2 level, presumably by recruiting 
VprBP/DDB1/Cul4A/Roc1. If RAG2 is indeed subjective to this 
modification, it may promote rapid removal of RAG1/2- complexes, 
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including both pre-cleavage and post-cleavage complexes, which facilitate 
the sustainability of a very delicate level of active recombinase to carry out 
effective antigen receptor gene assembly without causing genome 
instability. According to this postulation, the RAG1-dependent RAG2 
degradation is likely mediated through a proteasome pathway. I attempted 
to inhibit proteasome activity by using several proteosome inhibitors. The 
RAG1-mediated RAG2 degradation was found only inhibited by 
epoxomicin, which is a selective proteosome inhibitor by binding to the β5 
subunit and inhibiting the chymotryptic activity of the 20S proteosome. The 
application of other commonly used proteasome inhibitors, such as MG-
132, fail to retard the RAG1-mediated degradation of the endogenous 
RAG2. It is unclear whether RAG1 relies on the conventional 26S 
proteasome pathway or it collaborates with other pathways for the final 
degradation. Future studies will be needed to delineate the role of 
proteosome components in this regulation.  
On the other hand, it is importantly to note that proteasomes are 
present and functional in both cytoplasm and nucleus, and the nuclear 
proteasome can directly target the nucleus proteins for degradation (28). It 
is possible that the inability of these proteasome inhibitors to delay RAG2 
degradation may reflect the their inability of to act on the nuclear 
proteasome. If that were the case, the RAG1-mediated RAG2 degradation 
might be relying on a nuclear proteasome pathway, possibly 20S 
proteasome. The idea is compatible with our earlier argument that instead 
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of using the cytoplasm proteasome, a nuclear pathway may exist to 
ensure the on-site control of RAG2 level. However, further investigations 
are required to fully elucidate this possibility. 
Although the exact pathway remains to be defined, the fact that 
RAG2 is subjected to direct RAG1 regulation is of considerable 
significance. RAG1 and RAG2 function tightly together to carry out V(D)J 
recombination and play a central role in lymphocyte development as well 
as the adaptive immune system. So the direct-regulation between the two 
seems conceptually suitable to fine-tune the activity of RAG recombinase, 
because it can influence the formation of recombination excision 
machinery, the stability of post-cleavage complex and subsequent 
transition into NHEJ-mediated end resolution process. Furthermore, the 
direct regulation introduces another check-point to quickly shut-down 
recombination machinery in the nucleus, and to reduce mis-targeting 
and/or to minimize transposition by restricting the level and the time-span 
of the unresolved SEC, even in the absence of cell cycle progression. 
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Figure 1. Tetracycline inducible system (Made by Zhi Li) 
Activation of the transactivator tTA, a fusion protein consisting of the tet-
repressor (tetR) and Vp16 activation domain, by removing tetracycline (-
Tet) from the culture medium results in the binding of tTA to the tet-
responsive element (TRE) and transcription of tTA and EGFP-RAG1 
genes in the transfected cells. Inactivation of the tTA by adding 
tetracycline (+Tet) to the medium turns off the transcription of target 
genes. 
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Figure 2. Reduction of RAG2 proteins in RAG1-inducing cells (Made by 
Zhi Li) 
(A) Experimental design: cells were cultured at 33°C (33), 39°C for 1day 
(391), 39°C for 2 days (39) in the presence of tetracycline (+Tet). Or 
tetracycline was removed as indicated 1 day right before harvest (-Tet) 
while the cells were kept at 39°C for 2 days (39). Black arrows indicate 
harvesting points.  
(B) Reduction of RAG2 proteins in RAG1-inducing cells. E4 and H10 cells 
were cultured at 39°C for 2 days in the presence (+Tet) or absence of 
tetracycline (-Tet) as described above. Total cell lysates were 
immunoblotted for EGFP-RAG1, RAG2, tTA and actin.  
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Figure 3. In vitro analysis of the regulation between RAG1 and RAG2. 
Various MBP-fused-RAG plasmid combinations were transfected into 
293T cells and total cell lysates were immunoblotted for MBP and tubulin.  
(A) Reduction of flRAG2 was observed in the presence of flRAG1 (lane 4) 
but not in cRAG1 (lane 3). cRAG and flRAG plasmids were transfected at 
1:1 ratio (1ug). cRAG2 level is not influenced by cRAG1 or flRAG1. 
(B) Comparison of the co-expression of RAG1/2 (lane 1-4) versus single 
transfection of flRAG1 or flRAG2 (lane 5 and 6). cRAG and flRAG 
plasmids were transfected at 1:4 ratio (1ug:4ug).  
(C) Comparison of the ratio of the flRAG expression level in co-transfected 
cells versus in single transfected cells. Protein bands were quantitated by 
Imgae J program and the intensity of each band was normalized to the 
intensity of input control (tubulin).  
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Figure 4. Cell-cycle independent flAG2 degradation mediated by flRAG1. 
Various MBP-fused-RAG plasmid combinations were transfected into 
NIH3T3 cells, which were subjected to serum depravation by incubating in 
the medium containing 0.5% serum for 48hs (lane 11-17). As a control, 
cells transfected with the same combinations of RAG plasmids were 
incubated in serum rich medium (lane 1-10). A mutant RAG2 plasmid is 
also included, tRAG2, which is defective in cell-cycle dependent RAG2 
degradation. Total cell lysates were immunoblotted for MBP, RAG1 and 
tubulin. flRAG1 protein expression was confirmed with anti-RAG1 since it 
was not visible when probed with anti-MBP. 
Reduction of flRAG2 was observed when co-expressed with flRAG1 in 
both serum-containing and serum-deprived condition (lane 5 and 12). 
Protein bands were quantified by Image J and normalized to tubulin, and 
the relative intensity was shown below each lane.  
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CHAPTER 6 
CONCLUSIONS 
V(D)J recombination is a elegant and sophisticated genetic process that 
assembles different gene segments to encode for the variable region of a 
antigen receptor (immunoglobulin or T cell receptor), therefore it primarily 
accounts for the enormous diversity of the antigen receptor repertoire, 
which is fundamental to the adaptive immune response. Notably, the 
generation of double strand breaks by RAG recombinase is prerequisite 
for a complete V(D)J recombination, despite the fact that double strand 
breaks are  considered the most dangerous lesion to a cell and thus has 
to be resolved rapidly and appropriately. Furthermore, even though the 
double strand breaks are properly attended without causing danger to the 
cell, a functional rearrangement is frequently accompanied with several 
unsuccessful rearrangement events arising from the random end 
processing by the imprecise end-joining pathway, which can potentially 
compromise the genome integrity. Therefore, the diversity achieved by 
V(D)J recombination is at great expense of the genome stability. In order 
to maximize the diversity yet maintain the genome stability, V(D)J 
recombination has to be stringently controlled at various levels, as detailed 
in chapter1. Our studies introduce several new regulatory mechanisms 
into this already delicate regulatory network, 1) Mg2+, as the physiological 
cation of V(D)J recombination, helps to stabilize the coding end complex, 
in addition to its well-known role that ensures the controlled cleavage 
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through synapsis formation. Thus, our finding extend the importance of 
metal ion cofactor in V(D)J recombination, i.e. it not only affects the 
structure of the pre-cleavage complex and the catalysis step, but also 
modulates the stability of post-cleavage complex. 2) The integrity of core 
RAG2 is essential for the correct assembly of the pre-cleavage complex 
as well as the sufficient retention of the signal ends in the signal end 
complex, because a frame-shift RAG2 mutant was found to induce an 
abnormal pre-cleavage complex and a less stable signal end complex, 
which may account for its high propensity of aberrant end joining. 3) The 
presence of non-core region of RAG2 enhances the stability of both CEC 
and SEC, which are necessary for the appropriate end repair. Our findings 
substantiate the indispensible role of non-core region of RAG 
recombinase to ensure the efficiency and fidelity of V(D)J recombination. 
4) RAG2 protein level is directly controlled by RAG1 through a RAG1-
mediated degradation manner, which provides a novel pathway to control 
the endogenous RAG2 protein, especially the RAG2 that are in close 
proximity with RAG1, possibly in the same complex, i.e. targeted 
destruction of the post-cleavage complex or signal end complex. My 
studies further enrich the idea that the in vivo V(D)J recombination is 
stringently regulated at multifaceted levels, and highlight the importance of 
the balance between the antigen receptors diversity and the genome 
stability during V(D)J recombination. Furthermore, I validate and develop 
several parameters (RAG recombinase, metal ion cofactor) and several 
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aspects (pre-cleavage complex assembly and post-cleavage complex 
stability) for future diagnosis of the potential defect in V(D)J recombination 
and thus is big step forward to understand and dissect the mechanism of 
V(D)J recombination. In addition, my studies pave the way to identify and 
characterize more factors that might potentially influence the fidelity and 
efficiency of V(D)J recombination.  
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